<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2026-01-19 09:27:46 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>139</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>77</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="Identifying host factors that mediate protection against newly-emergent viruses is needed for improved pandemic preparedness. Here, we analysed pre- and early post-exposure immune factors associated with resisting SARS-CoV-2 infection after human challenge in seronegative individuals, using multiplex protein, cytometric and RNA sequencing approaches in the nasopharynx and circulation. Pre-existing cross-reactive antibodies correlate poorly with clinical outcome. Instead, protection is associated with heightened nasopharyngeal CCL13 levels locally produced by conventional dendritic cells and monocytes, along with cross-reactive T cells and less differentiated NK cells. Conditional independence network analysis implicates nasal CCL13 as the central node connected to pre-existing non-structural protein-specific T cells by CD1c+ DCs. In those who became infected, baseline cross-reactive T cell and less differentiated NK cell frequencies also correlate with shorter infection duration. Thus, pre-existing mucosal chemokine levels may promote rapid innate and innate-like responses that effectively block infection. ClinicalTrials.gov identifier NCT04865237. Human challenge studies with SARS-CoV-2 have shown changes in the innate and adaptive immune response. Here the authors are examining potential correlates of infection in virus challenged recipients by assessing baseline immune parameters and how this predicts virus control.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/491d4d516b113109ac72078677aee9124493f965" target='_blank'>
              Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Helen R. Wagstaffe, R. Thwaites, Jasmin K. Sidhu, Rik G. H. Lindeboom, Lorenz Kretschmer, Kaylee B. Worlock, L. Dratva, Ao Huang, S. Ascough, L. Papargyris, Richard McKendry, Ashley M. Collins, Jiayun Xu, Nana-Marie Lemm, Ben Killingley, M. Kalinova, Alex J. Mann, A. Catchpole, Leo Swadling, J. Tsang, MK Maini, M. Noursadeghi, Marko Z. Nikolić, Sarah A. Teichmann, P. Openshaw, Christopher Chiu
          </td>
          <td>2025-12-07</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f1f74512f2c8fb2837ffe4b5130c19b0f4eb9b9" target='_blank'>
              Primary Human Reactive Microglia Display Mitochondrial Dysfunction and Metabolic Imbalance Upon Lipopolysaccharide Exposure
              </a>
            </td>
          <td>
            Gabriel Fontes, Lívia de Sá Hayashide, Daniel Fernandes Messor, Mariana Marques, Vitor Emanuel Leocadio, Pedro Amorim, A. Minho, Elaine Paiva-Pereira, L. Savio, Patricia Dias Fernandes, Rafael Serafim Pinto, L. P. Diniz
          </td>
          <td>2026-01-07</td>
          <td>Neurochemical Research</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Severe pneumonia is associated with an increased risk of cognitive decline and dementia, particularly in the elderly. Changes in microglia, the most abundant immune cell population in the brain, are also associated with cognitive decline and dementia, including the emergence of a transcriptional cell state referred to as disease-associated microglia (DAM). We sought to test the hypothesis that non-neuroinvasive influenza A virus (IAV) pneumonia results in transcriptional responses in brain microglia that drive premature expansion of DAM. Using bulk and single-cell RNA-sequencing, metabolomics, and spatial transcriptomics, we profiled neuroimmune populations in young, middle-aged, and old male mice during IAV infection and recovery. We observed an increased abundance of DAM, interferon-responsive microglia (IRM), CD4+ T cells, and CD8+ T cells in white matter regions beginning in middle age and persisting in old animals, irrespective of IAV infection. DAM exhibited a metabolic shift toward aerobic glycolysis with disrupted TCA cycling, citrulline depletion, and an elevated itaconate/α-ketoglutarate ratio. Spatial transcriptomic profiling of the human middle frontal gyrus (MFG) in normal agers, SuperAgers, and patients with dementia revealed an analogous accumulation of DAM and CD8+ T cells in white matter. IAV pneumonia induced a transient immunosenescent-like response in microglia, marked by glucocorticoid-responsive gene expression and Ccnd3 upregulation. In response to IAV pneumonia, DAM expanded in middle-aged mice, whereas old mice were elevated at baseline and were largely unaffected by IAV infection. The age-related expansion of DAM was unaffected by pharmacological depletion and repopulation of microglia with a CSF1R antagonist or genetic gain or loss of function of the phagocytic receptor MERTK, suggesting the DAM phenotype is driven by the CNS microenvironment, rather than cell-intrinsic mechanisms. Our findings suggest that IAV pneumonia induces an acute immunosenescence response in microglia and accelerates the age-dependent expansion of DAM in white matter.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fda447848e1da3e24e80cd9f6f09a302a4923b4" target='_blank'>
              Influenza A infection accelerates disease-associated microglia formation during physiological aging
              </a>
            </td>
          <td>
            R. Grant, C. Runyan, Grace Minogue, J. Stoolman, Satoshi Watanabe, Fei Chen, Karolina J. Senkow, L. Cusick, M. Schleck, R. Nafikova, Ziyan Lu, E. Bunyan, H. Abdala-Valencia, Jacob I. Sznajder, Robert J. Vassar, Rudy J Castellani, Changiz Geula, T. Gefen, Navdeep S. Chandel, A. Misharin, G. S. Budinger
          </td>
          <td>2025-12-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/89e57c5a7f035383eefb5a4b2a2612ea3055f379" target='_blank'>
              Myeloid PINK1 represses mtDNA release and immune signaling that impacts neuronal pathology in patient-derived idiopathic PD models
              </a>
            </td>
          <td>
            S. Recinto, A. MacDonald, Shobina Premachandran, Lin Liu, Armin Bayati, Lilia Rodriguez, Mai Nguyen, Florence Petit, Sriparna Mukherjee, Julien Larmanjat, Alexis Allot, Moein Yaqubi, Peter McPherson, T. Durcan, S. Gruenheid, L. Trudeau, J. Drouin-Ouellet, Heidi M. McBride, J. Stratton
          </td>
          <td>2026-01-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="COVID-19 vaccines provide robust protection against severe disease, hospitalization, and death. Neutralizing antibodies are a strong correlate of protection and can prevent SARS-CoV-2 infection of the lungs. We used a conventional laboratory mouse model combined with high- or low-dose vaccination to understand the early immunological response following SARS-CoV-2 infection in the lungs of vaccinated mice. The lungs of high-dose vaccinated mice were completely protected against SARS-CoV-2 infection whereas low-dose vaccinated mice were partially protected. We observed a greater influx of total monocytes, macrophages, dendritic cells, neutrophils, and eosinophils in the lungs of low-dose vaccinated mice compared to naïve infected mice. The different proportions of innate immune cells in the lungs indicated that infection in low-dose vaccinated mice induces a unique inflammatory environment compared to naïve infected or uninfected mice. A prominent feature of infection of low-dose vaccinated mice was infiltration of eosinophils in the lungs, which we observed across different COVID-19 vaccines and SARS-CoV-2 variants. Single cell transcriptional profiling of lung parenchymal immune cells showed that viral RNA was predominantly associated with eosinophils. Eosinophils from low-dose vaccinated mice were transcriptionally distinct from naïve mice after challenge and showed an IFN-γ biased signature. Further, monocytes from low-dose vaccinated mice expressed eotaxin-2, suggesting a monocyte-eosinophil signaling axis. Antibody mediated depletion of eosinophils in low-dose vaccinated mice resulted in increased virus replication and dissemination in the lungs. These findings demonstrate the protective nature of eosinophils during SARS-CoV-2 infection in the context of vaccination and highlight quantitative and qualitative differences in the immune response in a model for vaccine breakthrough infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/206331da0365bbfba8d623c1563fc323742af9bb" target='_blank'>
              Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2
              </a>
            </td>
          <td>
            Kathryn M. Moore, Stephanie L. Foster, Meenakshi Kar, K. Floyd, Elizabeth J. Elrod, M. E. Williams, Jacob Vander Velden, M. Ellis, Ansa Malik, B. Wali, Stacey A. Lapp, Amanda Metz, S. Bosinger, Vineet D. Menachery, Robert A. Seder, R. Amara, Jacob E. Kohlmeier, Arash Grakoui, M. Suthar
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Acute neuroinflammation rapidly activates brain immune responses, but its lasting effects on microglia are unclear. Using systemic LPS administration and LCMV-Armstrong infection, we found that blood–brain barrier disruption and cytokine shifts resolved within 30 days, yet microglial recovery was incomplete—marked by persistent numerical loss and an IFN-γ–low phenotype in the LPS model and reduced relative abundance in the LCMV model. Single-cell RNA sequencing revealed sustained transcriptional alterations, including disease-associated microglia (DAM) features and a distinct recovery-biased population. These acute signatures overlapped with profiles from Alzheimer’s model mice and were enriched in human microglia from multiple sclerosis, Alzheimer’s disease, and other neuroinflammatory conditions. Although our observation period was shorter than the chronic course of these diseases, the persistence of disease-like microglial states suggests that transient inflammation can prime the brain for long-term vulnerability. Targeting this primed state may offer new strategies to prevent or mitigate neurodegenerative pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8721848b4335622c9d56e1c1301ae59339a8f8e0" target='_blank'>
              Acute neuroinflammation induces prolonged transcriptional reprogramming in microglia
              </a>
            </td>
          <td>
            Sehoon Moon, Cheol Gyun Kim, Young-Kwang Kim, Cheol-Heui Yun, Min-Kyoo Shin, Hyungseok Seo
          </td>
          <td>2025-12-01</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Aging and cerebrovascular pathology drive neuroinflammation in vascular dementia (VaD) but immune mechanisms underlying this interplay remain unresolved. Leveraging multi-modal high-dimensional imaging, flow cytometry, and split pool ligation transcriptomic sequencing in a mouse model of VaD, we constructed a brain immune cell atlas spanning young and aged mice in health and disease. We profiled microglia, T cells, macrophages, neutrophils, and B cells and integrated transcriptomics, cell-cell communication, multiplex imaging, and comparative analysis with human microglia. We found striking depletion of Ccr7+ naïve T cells and expansion of Gzmk+ cytotoxic Cd8+ effector memory T cells in the aging brain. At the same time, microglia shifted toward a pro-inflammatory state with enhanced activity of major histocompatibility class complex I (MHC-I) to T cell receptor and co-stimulation from CD86 to CD28. These shifts suggest enhanced neuroinflammatory polarization within the aged brain and in VaD. These signals were strongest from activated microglia to Gzmk+ Cd8+ TEM cells, indicating that age-related microglial polarization may sustain cytotoxic T cell activation in the aged brain. Our findings suggest pro-inflammatory microglia and Gzmk+ CD8+ TEM cells are central drivers of immune brain aging and highlights a therapeutic potential to disrupt age-related neuroinflammatory cascades in VaD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42ac3a3908e79bc0f916a88d264039358a6730c2" target='_blank'>
              High-Dimensional Single-Cell Analysis Reveals Coordinated Age-Dependent Neuroinflammatory Microglia-T cell Circuits in the Brain
              </a>
            </td>
          <td>
            Md Akkas Ali, Md. Hasanul Banna Siam, Donald Vardaman, Chase Bolding, J. N. Brazell, Ashleigh D. Whatley, Christopher A. Risley, Harrison Tidwell, Syed Nakib Hossain, Juhi Samal, Ashley S. Harms, Mallikarjun Patil, Daniel J. Tyrrell
          </td>
          <td>2025-12-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ebc988a2e535f97628e98387b125e8c2474e58f" target='_blank'>
              A CAR-T Cell-Based Strategy for Eliminating Pathogenic Microglia in ALS
              </a>
            </td>
          <td>
            M. Cicardi, Daniela Tejada-Martinez, S. Markandaiah, Karthik Krishnamurthy, Chiara Scopa, Brij Oza, Ivette Martorell Serra, Andrea Feci, Edoardo Manca, Adam E. Snook, A.R. Haeusler, P. Pasinelli, Davide Trotti
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Long COVID (LC) involves a spectrum of chronic symptoms after acute severe acute respiratory syndrome coronavirus 2 infection. Current hypotheses for the pathogenesis of LC include persistent virus, tissue damage, autoimmunity, endocrine insufficiency, immune dysfunction and complement activation. We performed immunological, virological, transcriptomic and proteomic analyses from a cohort of 142 individuals between 2020 and 2021, including uninfected controls (n = 35), acutely infected individuals (n = 54), convalescent controls (n = 24) and patients with LC (n = 28). The LC group was characterized by persistent immune activation and proinflammatory responses for more than 180 days after initial infection compared with convalescent controls, including upregulation of JAK-STAT, interleukin-6, complement, metabolism and T cell exhaustion pathways. Similar findings were observed in a second cohort enrolled between 2023 and 2024, including convalescent controls (n = 20) and patients with LC (n = 18). These data suggest that LC is characterized by persistent activation of chronic inflammatory pathways, suggesting new therapeutic targets and potential biomarkers of disease. Long COVID (LC) involves a spectrum of chronic symptoms after resolution of acute severe acute respiratory syndrome coronavirus 2 infection. Barouch and colleagues show that LC is characterized by persistent activation of chronic inflammatory pathways and T cell exhaustion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aab56a374cbf5ee6260c69533626e491afa089f3" target='_blank'>
              Long COVID involves activation of proinflammatory and immune exhaustion pathways
              </a>
            </td>
          <td>
            Malika Aid, Valentin Boero-Teyssier, K. McMahan, Rammy Dong, Michael Doyle, Nazim Belabbaci, E. Borducchi, A. Y. Collier, J. Mullington, D. Barouch
          </td>
          <td>2025-12-12</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>117</td>
        </tr>

        <tr id="Abstract After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a minority of patients experience persistent or emerging symptoms, termed ‘long coronavirus disease (COVID)’ or post-acute sequelae of COVID-19. The molecular causes of long COVID remain unclear, but disrupted immune functions, such as inflammation and immune deficit, have been posited as factors. In this retrospective cohort study, we measured markers of immune function in a group of patients with long COVID up to 40 months post infection. As proxies for immune function, we measured serum antibody levels, antibody neutralizing capability and production of IFN gamma (IFN-γ) and IL-2 against SARS-CoV-2 and other viral peptides. As expected, serum antibody levels increased over time with vaccinations and reinfections with later variants of SARS-CoV-2. Patients also showed corresponding increasing SARS-CoV-2-specific IL-2 responses and stable IFN-γ responses. We observed no significant differences in immune responses among patients with ongoing long COVID, those who had recovered from it or individuals who recovered from acute COVID-19. Overall, we found no indication of a reduction in these aspects of immune function after SARS-CoV-2 infection. This study provides a valuable foundation for further research aimed at understanding the causes of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd9f2a9af816e4527bff007fe6bd487c949ce190" target='_blank'>
              Robust antibody and T cell responses tracked longitudinally in patients with long COVID
              </a>
            </td>
          <td>
            M. Metaxaki, Ranjana Ram, Marianne Perera, Mark Wills, Ben Krishna, N. Sithole
          </td>
          <td>2025-12-01</td>
          <td>The Journal of General Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Acute viral infections are usually cleared by an efficient anti-pathogen immune response, following which immune homeostasis is restored. Occasionally, such pathogen-induced immune response fails to abate despite clinical recovery, but how this occurs in humans has not been thoroughly investigated. Here, we perform a detailed analysis of T cell homeostasis following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which reveals persistent activation and dyshomeostasis of CD4+ and CD8+ T cells for 6–12 months after acute infection. Compared to steady-state and unlike T cell responses following vaccination, interleukin (IL)−2 receptor and IL-7 receptor expression remains altered on both SARS-CoV-2-specific and bystander T cells for 6–12 months after acute infection. These alterations correlate with increased IL-7 and IL-15 serum levels and are reproduced by in vitro stimulation by IL-7 and IL-15, but surprisingly not by IL-2. Collectively, our study demonstrates prolonged T cell dyshomeostasis driven by dysregulated homeostatic cytokine signals following acute viral infection. Acute viral infections induce the activation and expansion of virus-specific T cells which eventually abate, but in some situations can persist. Here the authors show a dysregulation of homeostatic cytokine receptors in patients with prolonged T cell activation following acute SARS-CoV-2 infection">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4b30b34de10d73c9f922bb678272c07c41f6fdb9" target='_blank'>
              Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans
              </a>
            </td>
          <td>
            Laura Ceglarek, Patrick Taeschler, Alp Inci, Yves Zurbuchen, Sarah Adamo, Carlo Cervia-Hasler, M. E. Raeber, O. Boyman
          </td>
          <td>2025-11-27</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="Despite systemic viral suppression, people living with HIV (PLHIV) on antiretroviral therapy (ART) remain highly susceptible to pneumococcal colonisation and disease. Here, we show that long-term ART does not restore nasal mucosal immunity. Using flow cytometry, single-cell transcriptomics, and neutrophil functional assays, we identify a persistent mucosal immune signature in PLHIV-ART > 1 yr marked by epithelial-driven neutrophilic inflammation, T cell exhaustion, and cellular senescence. Neutrophils exhibit mitochondrial stress, senescence-associated secretory phenotype (SASP) gene expression, and impaired oxidative burst, particularly in individuals with pneumococcal carriage. Epithelial cells express elevated neutrophil-recruiting ligand genes, while nasal T cells display pro-apoptotic and exhaustion gene profiles. Neutrophilic inflammation is strongly associated with pneumococcal carriage density, implicating a feedforward loop between inflammation and microbial persistence. Our findings reveal tissue-specific immune dysregulation despite ART and suggest that targeting epithelial-immune signalling or neutrophil senescence may offer novel therapeutic avenues to reduce respiratory pathogen burden in PLHIV. People living with HIV (PLHIV) on antiretroviral therapy (ART) remain highly susceptible to pneumococcal colonisation and disease. In an analysis of 132 adults in Malawi, the authors report that long-term ART does not restore nasal mucosal immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a4a931320861dfa1656d868c4d925aa230a71ef" target='_blank'>
              Persistent pneumococcal colonisation in antiretroviral-treated HIV infection is associated with nasal inflammation
              </a>
            </td>
          <td>
            J. Phiri, L. Sibale, Gloria Kapira, Lukerensia Mlogoti, James Nyirenda, N. Mitole, A. Kusakala, Charles Ndovi, Precious Chigamba, Aaron P. Chirambo, Klara Doherty, Robert K Nyirenda, T. Kayembe, J. Zambezi, E. Lisimba, Memory Mvula, David V Mhango, Leonard Mvaya, S. Gordon, Benjamin Kumwenda, Christopher Moxon, Daniela M Ferreira, Henry Mwandumba, K. Jambo
          </td>
          <td>2025-12-15</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Chronically inflamed, reactive microglia represent a prominent feature of secondary progressive multiple sclerosis (SPMS). Especially their interplay with encephalitogenic T cells promotes neuroaxonal damage associated with disease progression. In our study, we aimed to explore the potential of siponimod, a sphingosine-1-phosphate modulator approved for the treatment of active SPMS, to inhibit disease-associated T cell-microglia interactions using a chronic murine experimental autoimmune encephalomyelitis (EAE) model of MS. We found that therapeutic siponimod treatment of chronic EAE improved clinical severity accompanied by reduced demyelination and neuroaxonal damage, diminished CNS T cell infiltration and altered proinflammatory microglia responses. This effect was partly attributed to a direct effect on microglia, as siponimod pretreatment inhibited interferon-γ-elicited responses of primary mouse microglia in vitro and limited their ability to induce T cell activation and proliferation in T cell-microglia co-cultures. Additionally, we observed reduced peripheral T cell numbers in our EAE model, with a pronounced shift to immunosenescent and regulatory T cell subsets, a pattern which we similarly detected in a cohort of SPMS patients following siponimod treatment. These findings indicate that siponimod dampens compartmentalized CNS inflammation by disrupting detrimental interactions between T cells and microglia through a dual central and peripheral mechanism of action.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/83f2db773998fbd7481c31e492b0b69aae1f4480" target='_blank'>
              Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis
              </a>
            </td>
          <td>
            Leila Husseini, Anastasia Geladaris, Marlene C. J. Steinleitner, Darius Häusler, Martin S. Weber
          </td>
          <td>2025-12-01</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Alzheimer´s disease (AD) is dominated by a complex cellular pathology which involves most brain cell types with glial cells increasingly recognized as playing fundamental roles in neurodegeneration. Astrocytes, which perform essential functions in preserving brain homeostasis, present a reactive phenotype in the AD brains with still unknown consequences. In this study, we generated and characterized human induced pluripotent stem cell (hiPSC)-derived astrocytes from AD patients harboring the APOE4/4 genotype, the greatest genetic risk factor for late-onset AD. Disease astrocytes showed a reactive phenotype. In addition, they showed altered mitochondrial network including perinuclear clustering of mitochondria, enhanced mitochondrial fusion and higher production of reactive oxygen species which, unexpectedly, were coincident with increased oxidative phosphorylation and glycolysis. As these mitochondrial features are related to the acquisition of cell senescence, we evaluated this at the transcriptome level and found that these AD-derived astrocytes significantly upregulated gene signatures of cellular senescence and displayed a senescence-associated secretory phenotype (SASP). To verify this finding, we observed senescence-related DNA damage response in a significant proportion of cells in the cerebral cortex of AD patients, with most of these cells being astrocytes. Finally, we confirmed that this astrocytic senescent and proinflammatory phenotype is associated with a reduced neuronal support, evidencing that APOE4/4 AD astrocytes present intrinsic features that may compromise brain homeostasis and promote neurodegeneration. Addressing the causes and consequences of this astrocytic dysfunctionality should help to elucidate novel therapeutic targets able to modify the neurodegeneration present in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb7d32fdd86ae0120bf83566cd83dd24e2f344b9" target='_blank'>
              Human iPSC-derived APOE4/4 Alzheimer´s disease astrocytes exhibit a senescent and pro-inflammatory state that compromises neuronal support
              </a>
            </td>
          <td>
            Laura Cáceres-Palomo, E. Sánchez‐Mejías, Laura Trujillo-Estrada, Juan J. Pérez-Moreno, Tau Elba Lopez-Oliva, En Lim, Leah DeFlitch, Serena H. Chang, Lucas Kampman, Ryan Corces, Mathew Blurton-Jones, Inés Moreno-González, Alberto Pascual, J. Vitorica, Juan Antonio, Antonia Gutierrez
          </td>
          <td>2025-12-12</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab1f2f4806c4c9f5ee207406f2f653b5c11d67d7" target='_blank'>
              Persistent CD4+ T cell functional deficits during recovery from prolonged symptomatic SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Jadith Ziegler, Christina Lawrence, Sean Turner, Nathan P. Pezant, Nancy Redinger, Carla Guthridge, Kenneth Smith, Jingrong Chen, J. Guthridge, Judith A. James, Susannah Rankin, Linda F. Thompson, A. Farris, S. Kovats
          </td>
          <td>2025-12-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) remains a leading cause of chronic neurological impairment, yet the cellular mechanisms underlying long-term neurodegeneration in TBI remain incompletely understood. Astrocytes, the most abundant glial cell type, are central to maintaining neuroglial and neurovascular homeostasis. Following TBI, however, astrocytic activation contributes to sustained inflammation and neurotoxicity. In this study, we employed immunohistochemistry and RNA sequencing to longitudinally profile astrocyte morphology and transcriptional states at acute (2 days), subacute (2 weeks), and chronic (1 year) stages after controlled cortical impact in mice. We identified a temporally evolving astrocyte response—beginning with a pro-inflammatory profile acutely, transitioning through a profile suggestive of mixed inflammatory and neurodegenerative signatures subacutely, and culminating in a chronic state marked generally by expression of Alzheimer’s and Parkinson’s disease-associated genes. Notably, a subset of astrocyte-derived progenitor cells also was found up to one-year post-injury, expressing markers associated with neurogenesis. These findings reveal that astrocyte activation is not transient but persists chronically, undergoing a dynamic shift from inflammation to degeneration. The observed parallels between astrocyte states in chronic TBI and neurodegenerative disorders underscore their potential role in post-traumatic cognitive decline and highlight astrocyte-targeted interventions as a promising avenue for therapeutic development. Transcriptomic analysis of astrocytes in the acute, subacute, and chronic phases after traumatic brain injury reveal an evolving dynamic shift from neuroinflammation to neurodegeneration, and to a limited extent, regeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c70e1566bf8218bb883f7cd7c00852baff7513e" target='_blank'>
              Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration
              </a>
            </td>
          <td>
            Hadi Abou-El-Hassan, Taha Yahya, Benjamin E. Zusman, Omar Albastaki, Harm T. Imkamp, Jessica J. Ye, Francesca Percopo, Jonathan R Christenson, Maryam H. Al Mansi, Kuan-Jung Lu, Galina Gabriely, Bruna K. Tatematsu, K. Habashy, Juliana R Lopes, A. Maghzi, R. M. Rezende, F. Quintana, Howard L. Weiner, Saef Izzy
          </td>
          <td>2025-12-01</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Aging exacerbates post-stroke inflammation, contributing to worse neurological outcomes. However, the mechanisms underlying this age-dependent immune dysregulation remain unclear. Because immune cell metabolism critically shapes inflammatory responses, we investigated whether the metabolic state of circulating monocytes, key immune cells that traffic to the ischemic brain, is altered by age after stroke. We further examined whether enhancing cellular NAD+ availability with nicotinamide riboside (NR) could mitigate age-associated neuroinflammatory responses and improve stroke outcome. Ischemic stroke was induced in young and aged mice using the distal middle cerebral artery occlusion model. We assessed monocyte metabolic profiles via untargeted metabolomics, mitochondrial function assays, multi-analyte cytokine/chemokine profiling, and flow cytometry. Given the contribution of monocyte-derived intestinal macrophages to gut barrier disruption after stroke, we evaluated gut barrier integrity, immune cell composition, and systemic inflammation. Stroke outcomes were also determined by infarct size, motor function, and brain inflammatory status. Our findings show that the availability of the essential energy co-factor, NAD+, is a key age-dependent factor that regulates monocyte and intestinal macrophage immune responses after stroke. Aged monocytes showed decreased NAD+ levels and increased inflammatory responses compared to young monocytes. Pretreatment with NR elevated cellular NAD+ levels in aged monocytes, normalized intestinal macrophage numbers and activation states, preserved gut barrier integrity, reduced systemic and brain inflammation, and improved stroke outcomes in aged mice. These findings highlight the importance of NAD+ in mitigating the post-stroke response in aging and the potential of NAD+ supplementation as a preventive strategy for patients at risk for cerebrovascular disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d64b0b6f130e8a7f750d74183c97ac679927931b" target='_blank'>
              NAD+ depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside
              </a>
            </td>
          <td>
            Mica Cabrera, Brent Eastman, Hannah Ennerfelt, Abrar I. Alsaadi, Ludmila Alexandrova, Y. Ay, Jolie Huang, Qian Wang, E. Blacher, Melanie R. McReynolds, K. Andreasson, C. A. Iweka
          </td>
          <td>2025-11-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Natural killer (NK) cells are key effector lymphoid cells involved in both innate and adaptive immunity and are capable of clearing abnormally aggregated α-synuclein (αSyn). In preclinical Parkinson’s disease (PD) models, NK cell depletion worsens motor deficits and increases insoluble αSyn accumulation, suggesting a neuroprotective role. However, the therapeutic potential of NK cell transfer in modulating αSyn pathology and neurodegeneration remains unexplored. To assess the efficacy of NK cell therapy, we administered biweekly systemic injections of untouched NK cells isolated from B6C3H donor mice into 2-month-old presymptomatic homozygous M83 transgenic mice injected with human αSyn preformed fibrils. Neurological function was assessed via clasping behavior and clinical scoring. αSyn pathology and dopaminergic neurodegeneration were evaluated via immunohistochemistry. CyTOF-based immune profiling and multiplex ELISA were performed to characterize central and peripheral immune responses. Adoptive NK cell transfers improved motor function and reduced αSyn pathology in a region- and dose-dependent manner, with significant reductions in phosphorylated-αSyn inclusions and tyrosine hydroxylase-positive neuronal loss in the substantia nigra. NK cell transfer modulated the CNS immune landscape by reducing CD11b+CD45high and MHCII+ activated microglial, CD4⁺ T cells, and neutrophil infiltration, while promoting CD19+ B and CD8+ T cells. Similar immunomodulatory effects were observed in the periphery, including restoration of follicular B cells and reduced neutrophil frequencies. Mechanistically, αSyn exposure downregulated activating NK ligands and upregulated inhibitory receptor ligand mQa1b, along with p21 induction in microglia, suggesting a senescence-associated, immune-evasive phenotype that may contribute to reduced therapeutic efficacy at later disease stages. Our study provides direct evidence of NK cells exerting neuroprotective and immunomodulatory effects in a preclinical model of synucleinopathy. These findings support NK cell transfer as a novel therapeutic strategy for PD and related neurodegenerative disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/08d6125cc4713c1f0002875bc8d5ea64fa5c7ea8" target='_blank'>
              Adoptive NK cell transfer confers neuroprotection by attenuating neuroinflammation and alpha-synuclein pathology in a mouse model of synucleinopathy
              </a>
            </td>
          <td>
            Adetutu Adebowale, J. Byun, Jaegwon Chung, Hyun Joon Lee, Declan Gresham, Jina Lim, Jae-Kyung Lee
          </td>
          <td>2025-11-27</td>
          <td>Molecular Neurodegeneration Advances</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/34649c6562aa2175c877d0871438b8882a670ac3" target='_blank'>
              Integrated single-cell analysis reveals interferon-driven immune signatures in a DENV1 human infection model
              </a>
            </td>
          <td>
            A. Vermeersch, T. Verdonckt, C. Struyfs, E. De Meester, A. Waickman, S.J. Thomas, K. Ariën, O. Lagatie, F. van Nieuwerburgh
          </td>
          <td>2026-01-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f17946ac3dbb8efa92226c7ce4112035350abc3" target='_blank'>
              STAT1-Mediated Regulation of IL-17A/CEBPB/NF-κB Axis in HIV-1 Infected Human Cerebral Organoids Reveals Therapeutic Targets for Neuroprotection
              </a>
            </td>
          <td>
            Karthick Chennakesavan, Malaroviyam Samikkannu, Shreyan Gupta, Olasunkanmi Israel Tayo, Arpan Acharya, James J. Cai, S. Byrareddy, T. Samikkannu
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Infection rates involving bacterial and viral pathogens have increased precipitously after the COVID-19 pandemic. While it has been speculated that higher infection rates resulted from increased hospitalizations throughout the pandemic or greater use of antibiotics, precisely why rates remain high today has remained unexplained. Mitochondrial dysfunction is known to occur post-COVID and may disrupt immune responses. Within T cells, SARS-CoV-2 infection is linked to low mitochondrial membrane potential, increased mitochondrial apoptosis, and decreased mitochondrial respiration, which together impact cellular activation and function beyond the acute phase of illness. Here, we demonstrate that decreased mitochondrial function in antigen-specific T cells post-COVID may contribute to higher infection susceptibility by metabolically immobilizing T cell memory responses. Using donor-matched peripheral blood samples from 31 COVID-naïve individuals who subsequently contracted COVID-19, we tracked how influenza A (IAV), Staphylococcus aureus (SA), and Varicella-zoster virus (VZV) T cell responses were impacted by COVID-19 infection. We found that gene expression linked to T cell activation decreased but mitochondrial redox pathways increased in CD4 memory T cells post-COVID. However, mitochondrial flux and reactive oxygen species production were limited in a plurality of post-COVID memory T cells after stimulation with IAV, SA, and VZV. Furthermore, we found a disordered relationship between memory T cell mobilization of glycolysis, fatty acid metabolism, and oxidative phosphorylation pathways post-COVID which resulted in diminished use of catabolic pathways including glycolysis and fatty acid oxidation in antigen-specific T cells. Modulation of mitochondrial function with metformin and ubiquinol partially rescued the post-COVID decline in T cell catabolism. Collectively, these findings indicate that COVID-19 infection may have lasting effects on inhibiting T cell memory responses to commonly encountered community-acquired pathogens which can be corrected with commonly available medications. This has significant implications for the clinical care of immunologically vulnerable populations in the post-pandemic era.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/826971fe690f6be31807f55457f0b21244f3d4b9" target='_blank'>
              Post-COVID impairment of memory T cell responses to community-acquired pathogens can be rectified by activating cellular metabolism
              </a>
            </td>
          <td>
            Daniel D. Carroll, Kamacay Cira, Jack Archer, Jason Shapiro, Ue-yu Pen, David Tieri, Lucia Leonor, Neda D. Roofchayee, Samantha S. Yee, Marc Wahab, Igor J. Koralnik, John C. Alverdy, Arjun S. Raman, L. Visvabharathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) causes a highly lethal respiratory infection for which no vaccines or antiviral therapeutics are currently available. Understanding the immune response is critical for designing effective therapeutics. Here, we comprehensively characterized the dynamics of B-cell responses in severely infected MERS-CoV patients and survivors with SARS-CoV-2 exposure history. Infected patients developed robust neutralizing antibody responses within 1 month of illness, with moderate-to-high cross-neutralization activity against SARS-CoV-2. The enhanced neutralization activity coincided with an increased abundance of specific mutated, class-switched IgG clones. Notably, one such clone was detected at moderate prevalence in both patients, and its expansion was accompanied by high neutralization activity against both viruses. Conversely, MERS-CoV survivors demonstrated higher neutralization activity against MERS-CoV after vaccination, despite minimal changes in antibody titers and limited alterations in B-cell repertoire properties. This suggests that the enhanced neutralization activity may be mediated by the reactivation and expansion of cross-reactive memory B cells targeting conserved epitopes, originally generated in response to the virus that triggered the primary immune response. These findings provide valuable insights into the B-cell repertoire landscape during natural MERS-CoV infection and highlight the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. IMPORTANCE This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1207eb36a1ae9d0a38874b4fd9dcc3679243cee7" target='_blank'>
              Dynamics of B-cell response in MERS-CoV patients and survivors with hybrid immunity
              </a>
            </td>
          <td>
            H. Al-Khatib, Fatma H. Ali, H. Zedan, M. Smatti, Peter V. Coyle, Sara Taleb, A. A. Hssain, Asmaa A Al-Thani, H. Yassine
          </td>
          <td>2025-12-16</td>
          <td>mBio</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e3390d47a05cc167afea6dd6713ed3857300502" target='_blank'>
              PPARδ activation in microglia drives a transcriptional response that primes phagocytic function while countering inflammatory activation
              </a>
            </td>
          <td>
            Jacob S. Deyell, J. Hasselmann, Linda Stroud, Urmimala Raychaudhuri, Yunzi Guo, Byeonggu Cha, Christopher Karma, Deavin Tendean, Minh-Huy Vu Tran, Anastasia Gromova, Audrey S. Dickey, Mathew Blurton-Jones, Albert R. La Spada
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/91babd22d3b6b86432a313b4b21fca0bc39e8c82" target='_blank'>
              Single cell RNA sequencing reveals limited effects of Lrrk2 genotype in a mouse model of acute CNS inflammation
              </a>
            </td>
          <td>
            Alice Kaganovich, Liam Horan-Portelance, Natalie Landeck, Dominic J. Acri, Jinhui Ding, R. Langston, Mark R. Cookson
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Microglial cells exhibit crucial metabolic adaptations to maintain neural homeostasis. However, their dysregulated activation during infections can lead to neurotoxicity and contribute to the development of neuroinflammatory disorders. Understanding the physiological and metabolic changes of microglia during immune activation is crucial for identifying protective targets against neuroinflammation. This study investigates how the Zika virus (ZIKV) alters microglia metabolism during inflammation, highlighting cellular adaptations that sustain oxidative metabolism linked to cell survival during cellular activation and viral replication. After identifying an enriched abundance of proteins related to oxidative phosphorylation and cellular component organization in the global proteomics of mouse brains following ZIKV exposure, we investigated the relevance of these pathways during in vitro infection of human microglia. ZIKV infection led to cytoskeleton remodeling via β-tubulin reallocation, which characterized an ameboid-like phenotype. Despite the indication of a shift toward increased glycolytic activity due to decreased intracellular glucose, which suggests its consumption, and the accumulation of tricarboxylic acid cycle (TCA) intermediates, ZIKV-infected microglia exhibit enhanced respiratory capacity and an abundance of smaller-sized mitochondria in the perinuclear region. The accumulation of citrate, succinate, and malate, while maintaining mitochondrial function, suggests an important metabolic adaptation that supports biosynthetic pathways and sustains cell viability under stress. Decreased intracellular glutamate abundance supports mitochondrial oxidative metabolism. Pre-treatment with the anti-inflammatory docosahexaenoic acid (DHA) mitigates ZIKV-induced metabolic alterations by reducing pro-inflammatory markers, downregulating viral entry receptors, and lowering microglial activation and viral load. This study reveals that while ZIKV induces cell death in neuronal-like cells, the mitochondrial adaptation observed in microglial infection could be a key to maintaining cell survival throughout neuroinflammation. Our findings elucidate a novel cellular adaptation during ZIKV infection involving β-tubulin reorganization and metabolic dynamics, reflecting microglial flexibility and resistance during neuroinflammation, and demonstrating the therapeutic potential of DHA in mitigating ZIKV-induced pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6d680f6e601874de149962588421e3e6c0a8d4a6" target='_blank'>
              Zika Virus Reprograms Microglial Mitochondrial Metabolism to Support Immune Activation and Viral Replication: Omega-3 DHA Counteracts Neuroinflammation and Viral Persistence
              </a>
            </td>
          <td>
            Heloísa Antoniella Braz-De-Melo, Fernanda Gomes Lago, Rafael Corrêa, I. Santos, P. Bellozi, R. Almeida, Wagner Fontes, Mariana S Castro, Aline Maria Araújo Martins, R. M. de Oliveira, Nadia Martins Serpa Rossi, Gabriel Pasquarelli-do-Nascimento, Ana Luiza Gouvea, Paulo Sousa Prado, A. D. de Bem, Sônia Nair Báo, B. M. Ribeiro, S. Rehen, Thomas Christopher Rhys Williams, Gary P. Kobinger, Kelly Grace Magalhães
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="The innate immune response involves interferons (IFNs), antiviral cytokines that upregulate numerous IFN-stimulated genes, many of which have uncharacterized functions and mechanisms. Here we performed transcriptomic profiling of lung tissues from wild-type and IFNAR−/− mice infected with SARS-CoV-2 and single-cell RNA sequencing of bronchoalveolar lavage fluid and peripheral blood mononuclear cells from patients with COVID-19. We identified O-GalNAc transferase 2 (GALNT2), an N-acetylgalactosaminyltransferase, as an antiviral IFN-stimulated gene restricting the replication of multiple coronaviruses and influenza A viruses in vitro and in vivo, contributing to viral clearance and reducing disease severity. Mechanistically, GALNT2-dependent O-linked glycosylation may regulate viral glycoprotein proteolytic processing and impair viral growth by blocking virus–cell fusion. In addition, we found that serine residues at 810/813 in the viral spike protein undergo O-glycosylation and function as the primary genetic determinants of sensitivity or evasion towards GALNT2. Human genetic data analysis revealed that individuals with GALNT2 variants that lost antiviral function had elevated risk of hospitalization following SARS-CoV-2 infection. This study establishes GALNT2 as an antiviral factor against some respiratory virus infections. The authors find that O-GalNAc transferase 2 (GALNT2) restricts viral infection, probably through the regulation of the proteolytic processing of viral glycoproteins via its O-linked glycosylation activity, impairing virus–cell fusion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4edc78ea59897eb7bd96425cec0afc43cf52263b" target='_blank'>
              Interferon-stimulated gene GALNT2 restricts respiratory virus infections
              </a>
            </td>
          <td>
            Wei Ran, Jinghong Yang, Shi Yu, Qingtao Hu, Yuqi He, Shengjun Wang, Cheng Wei, Jing Sun, Airu Zhu, Fang Li, Lu Zhang, Pengfei Li, Huina Hu, Ruangang Pan, Yanying Yu, Yanqiu Yuan, Lingyu Sun, Yanqun Wang, Zhaoyong Zhang, Zhao Chen, Donglan Liu, Qihong Yan, Dong Wang, Kuai Yu, Yiliang Wang, Jianfen Zhuo, Zhuan Zhen, Hua Tao, Qiuhui Zeng, Kaixin Zhou, Feng Chen, Wenxuan Tang, Yuzheng Zhou, Rong Bai, Yonghao Xu, Na Li, Jun Dai, Hongyu Zhao, Jung-Eun Park, Tao Wang, Qiang Ding, Stanley Perlman, Jingxian Zhao, Yang Mao, Shaobo Wang, Jincun Zhao
          </td>
          <td>2025-12-12</td>
          <td>Nature Microbiology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/687800177db6f90a1dee9be6bba3ed7087d04c6e" target='_blank'>
              Oncolytic Reovirus mediates innate-driven SARS-CoV-2 elimination in the absence of cell toxicity
              </a>
            </td>
          <td>
            Samantha Garcia-Cardenas, Gemma Swinscoe, Amy Moran, Liam Barningham, Graham P. Cook, A. Samson, Sam J. Wilson, Michael Malim, Russell Hughes, Stephen Griffin
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="West Nile virus (WNV) is a mosquito-borne virus that causes severe neurological disease in humans. Despite substantial advances, our knowledge of the mechanisms involved in damaging the human brain is still limited. To address this gap, we developed a physiologically relevant in vitro model using human neuronal/glial cells and aimed to determine WNV tropism, assess whether the virus induces innate immune and inflammatory responses, and elucidate the resulting pathophysiological consequences. We found that WNV productively infected glial cells, whereas neurons exhibited a remarkable and unexpected resistance to infection. Despite the induction of a robust innate immune response mediated by IFN signalling and a rapid control of WNV replication in glial cells, we observed substantial death of astrocytes, oligodendrocytes, and neurons. Analysis of cytokine and chemokine expression further revealed that infection triggered an inflammatory response, potentially contributing to bystander cell death. We also showed that IFN signaling did not contribute to the resistance of neurons and identified IFI6 as an effector of the antiviral response in human glial cells. Together, our results underscore the importance of human neural models for confirming previous findings obtained in less physiologically relevant models and for unravelling novel cellular and molecular mechanisms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/435c1519049ea8d464c2e723fc442d3c3c80d655" target='_blank'>
              Role of innate immune and inflammatory signaling in West Nile virus tropism and neuronal and glial cell death
              </a>
            </td>
          <td>
            Valentine Chaillot, François Piumi, Kamila Gorna, Noémie Berry, Jennifer Richardson, Alexandra Benchoua, Muriel Coulpier
          </td>
          <td>2025-12-01</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Abstract The remaining unacceptably high mortality of influenza-induced acute respiratory distress syndrome underscores the urgent need to identify key cellular drivers of host responses. Endothelial cells (ECs) are increasingly recognized for their immunomodulatory roles, but whether they function as antigen-presenting cells (APCs) following respiratory viral infection remains unknown. Here, we show that influenza A virus H1N1 restrictively infects pulmonary microvascular ECs (PMVECs) during late-stage acute lung injury, triggering robust MHC class I (MHC-I) upregulation in vitro, in vivo, and in ex vivo human precision-cut lung slices. Infected PMVECs present H1N1 antigens via MHC-I and co-stimulatory CD40 to lung-resident CD8⁺ T cells, driving their proliferation and effector function (Granzyme B, IFNγ) to promote viral clearance and resolve inflammation. This process is IFNγ-dependent and STAT1-regulated, forming a positive feedback loop that enhances PMVEC antigen presentation and CD8⁺ T cells activation. By contrast, the emerging H5N1 (A/Texas/37/2024) infect pulmonary ECs earlier and more broadly but elicits weaker pulmonary EC-driven CD8 + T cell responses, potentially contributing to its higher pathogenicity. These findings reveal PMVECs as active APCs in antiviral defense and highlight new avenues for immunotherapeutic intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df01e5b451a6c1d5dc9572e59192186af7ff334d" target='_blank'>
              Pulmonary Microvascular Endothelial Antigen Presentation Activates Resident CD8⁺ T Cells to Restrain Influenza Lung Injury
              </a>
            </td>
          <td>
            Lianghui Zhang, Yuanyun Ao, Kamal Bagale, Sophia Hu, Ahmed Mostafa, Chengjin Ye, Kienan Salvadore, Gregory Gibson, Ricardo Pineda, Jiayue Lu, Rachel Covitz, Dejuanna Chan, Ryan Langlois, James Zimring, William Duprex, C. S. Croix, John Alcorn, Jalees Rehman, Melanie Koenigshoff, Luis Martinez-Sobrido, Jianhua Xing
          </td>
          <td>2026-01-08</td>
          <td>Research Square</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Zika virus (ZIKV) poses a significant threat to neural tissue, causing substantial damage to unborn children exposed to the virus in utero, with consequences that can manifest even after birth, despite being born with a normal head circumference. Regardless of the extensive research, the interactions between ZIKV and the nervous system cells remain insufficiently understood, particularly regarding how neuronal responses influence broader inflammatory and viral dynamics especially in postnatal stages of development. This study evaluated the susceptibility to ZIKV infection, viral replication, immune response, and survival of neurons, astrocytes and microglial cells during postnatal developmental stages, using both in vivo and in vitro mice models. In vivo, a non-lethal but extensive infection of neurons and microglia was shown. The infection caused a robust but controlled immune response with elevated levels of MCP-1, TNF-α, and IL-6, that prevented severe neuronal damage. In vitro, neurons exhibited high susceptibility to ZIKV, with elevated levels of pro-inflammatory cytokines and IFN-β, indicating a strong inflammatory response. In contrast, astrocytes and microglia displayed varied responses, contributing to a pro-inflammatory feedback loop. These findings offer critical insights into the cellular dynamics of ZIKV infection, enhancing our understanding of its effects during postnatal nervous system development. By clarifying the interactions between ZIKV and neuronal cell types, this study deepens the comprehension of the virus’s pathophysiology and its broader implications for neurodevelopmental outcomes, extending beyond the well-documented association with microcephaly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80aee6bf94647ce0fef40ccbfab9270cf8289aa9" target='_blank'>
              In vivo and in vitro susceptibility and inflammatory response of postnatal mouse cortical neurons and glial cells to zika virus infection
              </a>
            </td>
          <td>
            M. Calderón-Peláez, M. Velandia-Romero, Jaime E Castellanos
          </td>
          <td>2025-12-31</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/96f7e56783abd7239f00cfcbfc5e36a8886e57fd" target='_blank'>
              Semaglutide Attenuates Neuroinflammation in Mice
              </a>
            </td>
          <td>
            Dylan M. Rausch, Mette Q. Ludwig, Marie A. Bentsen, Stine N. Hansen, Anna Secher, Dorte Holst, Jaime Moreno, Vivek Das, K. L. Egerod, Anne-Mette Bjerregaard, Kristoffer Niss, Sarah Bau, Charles Pyke, Kevin Dalgaard, Myrte Merkestein, Franziska Wichern, Charlotte Thim Hansen, Joseph Polex-Wolf, L. Bjerre Knudsen, T. Pers
          </td>
          <td>2026-01-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>73</td>
        </tr>

        <tr id="ABSTRACT Porcine reproductive and respiratory syndrome virus (PRRSV), a major immunosuppressive pathogen, inflicts substantial economic losses on the global swine industry. Despite extensive research into PRRSV pathogenesis, the mechanisms by which PRRSV induces immune dysfunction in vivo remain incompletely understood. Here, we performed single-cell RNA sequencing on cells isolated from the lung of PRRSV-infected piglets, generating transcriptomic profiles for 46,922 single cells encompassing 15 major cell types. We observed a significant reduction in the number of macrophages in lung tissues, which was primarily attributed to the extensive apoptosis of macrophages induced by PRRSV infection. PRRSV infection triggered aberrant differentiation of macrophage, and the SPP1high macrophage subpopulation was identified as the primary target cells for PRRSV infection. Cell-cell communication analysis revealed that PRRSV infection enhanced ligand-receptor interactions between macrophages and other cell types, associated with inflammatory responses, activation of T cells and B cells, and cell adhesion. In addition, monocytes exhibited a tendency to differentiate into macrophages, potentially compensating for the depletion of macrophages caused by PRRSV infection. Moreover, PRRSV infection caused abnormal development of B cells and incomplete activation of cytotoxic T lymphocytes in the lungs. This study provides a comprehensive characterization of how PRRSV perturbs pulmonary immune cell populations, offering valuable insights into the mechanisms underlying PRRSV-induced lung injury. IMPORTANCE Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection. Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a411b9a7f498fc257495d61e60998a9d94a15046" target='_blank'>
              Deciphering immune features and cellular heterogeneity in PRRSV infection via single-cell RNA sequencing
              </a>
            </td>
          <td>
            Jianda Li, Yue Liang, Yuyu Zhang, Yulin Xu, Fei Liu, Luogang Ding, Yu Wang, Zhihao Zhang, Zhi Chen, Wenbo Sun, Jiang Yu, Jiaqiang Wu
          </td>
          <td>2025-12-30</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Background Ischemic stroke remains a leading cause of mortality and disability worldwide. Microglia, the resident immune cells of the central nervous system, perform critical roles in immune surveillance, debris clearance, and tissue repair. Analyzing the heterogeneity, activation trajectories, and metabolic states of microglia in ischemic stroke is essential for discovering therapeutic targets. Methods We performed single-cell RNA sequencing (scRNA-seq) on brains from ischemic and control rats and identified transcriptionally distinct microglial subpopulations. We conducted differential expression, pathway enrichment, pseudotime analysis, regulatory network inference, and cell-cell communication mapping to characterize functional states, key transcription factors, and intercellular crosstalk underlying microglial responses following cerebral ischemia-reperfusion injury. We used Real-Time Quantitative PCR (RT-qPCR), Western blot, and immunohistochemistry to measure relative RNA and protein expression levels. Results We identified seven microglial subclusters with distinct transcriptional signatures. Ischemia-associated clusters exhibited strong activation of inflammatory pathways, increased glycolysis and lipid metabolism, and suppressed TCA cycle and oxidative phosphorylation (OXPHOS), reflecting a shift toward proinflammatory, energy-demanding phenotypes. Pseudotime analysis revealed transitions from homeostatic to pathological states, highlighting potential therapeutic windows. Regulatory network analysis identified activating transcription factor 3 (ATF3) as a central regulator controlling the expression of cholesterol 25-hydroxylase (CH25H) and secreted phosphoprotein 1 (SPP1). Notably, ATF3 overexpression enhanced CH25H expression and selectively increased proinflammatory cytokine production, linking metabolic reprogramming to neuroinflammatory responses. Cell-cell communication analysis further revealed extensive remodeling of interactions with astrocytes, endothelial cells, and fibroblasts, potentially amplifying postischemic neuroinflammation. Conclusion Our study demonstrates that cerebral ischemia induces transcriptionally and functionally distinct microglial subpopulations, characterized by metabolic reprogramming and proinflammatory activation. ATF3 serves as a central regulator linking CH25H-mediated metabolic changes to cytokine-driven neuroinflammation, highlighting potential therapeutic targets for modulating microglial responses and mitigating ischemia-induced brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21c20effa3ad945d21b01c8ec4f5a72133113a12" target='_blank'>
              Single-Cell RNA Sequencing Reveals Microglial Heterogeneity and Functional States After Cerebral Ischemia-Reperfusion Injury
              </a>
            </td>
          <td>
            Yu-jing Tang, Qi Zhang, Yewei Qu, Lian Yi, Fangqin Li, Changda Qu, Shanshan Shi, Byron Fei Pan, Shirong Wen, Ruohan Sun, Yujun Pan
          </td>
          <td>2025-12-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23fe51bd03b4e6b215bef750c8f1bc98b4664ab0" target='_blank'>
              Mechanism of neuroinvasion and interferon response in human choroid plexus organoids during Japanese encephalitis virus infection
              </a>
            </td>
          <td>
            Y. Kumsang, Atsadang Boonmee, Chatpong Pethrak, Pisut Pongchaikul, U. Anurathapan, Chatchai Muanprasat, Phisit Khemawoot, Bunpote Siridechadilok, Natapong Jupatanakul, Nithi Asavapanumas, Nunya Chotiwan
          </td>
          <td>2025-12-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Abstract Objective Examine the role of T cells in shaping and sustaining humoral immunity to SARS‐CoV‐2 and identify immune factors associated with durable antibody responses. Methods Unvaccinated adults (n = 67) with SARS‐CoV‐2 infection (Wuhan) of any severity were followed longitudinally for up to 14 months. Anti‐Spike (S) binding and neutralising antibodies were measured. Bulk T cell IFNγ and IL‐2 responses were assessed by Fluorospot to multiple viral proteins. S‐specific T‐cell subsets and functions were analysed in detail by flow cytometry in a subset of participants (n = 14), combining activation‐induced markers (AIMs) and cytokines. Correlations between S‐specific T‐cell subsets, their polyfunctionality and antibody levels over time were defined. Results Over 14 months post infection, anti‐S IgG and neutralising antibodies declined significantly but remained detectable in > 85% of participants. Bulk T‐cell IFNγ and IL‐2 responses persisted without significant reduction. However, S‐specific CD4 T cells declined over time. A large proportion of these were peripheral helper T cells (Tph; CXCR5−PD‐1+), which were the main producers of IL‐21 and showed marked polyfunctionality during early convalescence, in contrast to circulating follicular helper T cells (cTfh). The early presence of polyfunctional, IL‐21‐producing Tph strongly correlated with S‐specific IgG and neutralising antibodies early post‐infection and predicted neutralising antibody maintenance a year later. Older age correlated with higher Tph and antibody levels. Conclusion Early S‐specific T‐cell responses—particularly polyfunctional, IL‐21‐producing Tph cells—play a key role in sustaining durable antibody levels post‐infection, offering insights for future vaccine strategies and understanding long‐term immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/63995037b8ae83290f6bb5ffec2deaef5580d4b2" target='_blank'>
              Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐19
              </a>
            </td>
          <td>
            Katie Tungatt, Gabriela Martins Costa Gomes, Nicole L. Fewings, Aija Stubis, C. Doyle, V. Merheb, A. Aggarwal, K. Byth, Harry Robertson, S. Dervish, Susan Maddocks, Janette Taylor, R. Bull, M. Martinello, F. Brilot, S. Turville, Anthony L. Cunningham, K. Sandgren
          </td>
          <td>2025-01-01</td>
          <td>Clinical & Translational Immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Severe COVID‐19 is an immunological disorder characterized by excessive immune activation following infection with SARS‐CoV‐2, which typically occurs around the time of seroconversion. Anti‐spike IgG of critically ill COVID‐19 patients induces excessive inflammation by activation of Fc gamma receptors (FcγRs) on human alveolar macrophages, leading to tissue damage, pulmonary edema, and coagulopathy. While metabolic reprogramming of immune cells is critical for the induction of inflammatory responses, still little is known about the metabolic pathways that are involved in COVID‐19‐specific hyperinflammation. In this study, we identified that anti‐spike IgG immune complexes (ICs) induce rapid metabolic reprogramming of alveolar macrophages, which is essential for the induction of inflammation. Through functional inhibition, we identified that glycolysis, fatty acid synthesis, and pentose phosphate pathway (PPP) activation are critical for anti‐spike IgG‐induced hyperinflammation. Remarkably, while excessive proinflammatory cytokine production by macrophages is critically dependent on simultaneous stimulation with viral stimuli and anti‐spike IgG complexes, we show that the required metabolic reprogramming is specifically driven by anti‐spike IgG complexes. These findings provide new insights into the metabolic pathways driving hyperinflammation by macrophages in the context of severe COVID‐19. Targeting of these pathways may reveal new possibilities to counteract pathological inflammatory responses in severe COVID‐19 and related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7d09f7fb7e4fd28a04356b3213eb05a7c8386673" target='_blank'>
              Hyperinflammation by Human Macrophages Induced by SARS‐CoV‐2 Anti‐Spike IgG Is Dependent on Glucose and Fatty Acid Metabolism
              </a>
            </td>
          <td>
            Chiara E. Geyer, Luís Almeida, Lynn Mes, F. Otto, W. Ashwin Mak, Graham A Heieis, Jennifer Veth, S. D. de Taeye, Tom G. Caniels, Tom P. L. Bijl, M. V. van Gils, M. D. de Winther, Jan Van den Bossche, Hung-Jen Chen, R. Houtkooper, Bart Everts, J. den Dunnen
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Infection-associated thymic atrophy is common and results in T-cell imbalance and immune dysfunction. Severe dengue, caused by infection with the dengue virus (DV), is associated with perturbation of T cell functions. However, it is unclear whether perturbation of T cell functions is linked to changes in thymic function during dengue infection. Herein, we employed a dengue virus serotype 2 (DV-2)-infected mouse model and Neonatal Thymic Organ Culture (NTOC) to study the impact of DV-2 infection on thymic function. Further, the contribution of infiltrating immune cells, especially myeloid cells, and reactive oxygen species (ROS) in the thymus on DV-2-induced thymic atrophy was studied by depleting Gr-1 + myeloid cells and quenching ROS in mice. We have demonstrated that DV-2 infection caused a massive thymic atrophy, dominated by a loss of CD4+ CD8+ double-positive (DP) thymocytes, reduction in naïve T cells in blood and spleen, a significant increase in the infiltration of myeloid cells, and a reactive oxygen species (ROS) burst in the thymus. Using Neonatal Thymic Organ Culture (NTOC), we confirmed that DV-2 infection alone cannot induce thymic atrophy. Further, we documented that depletion of Gr-1 + myeloid cells, or quenching of ROS using N-acetylcysteine (NAC) during DV-2 infection, partially protected thymic architecture. This protection of thymus function is also reflected in the thymic interstitial fluid proteome profile, where myeloid cells depletion or NAC treatment in DV-2-infected mice confirmed the reversal of protein expression associated with oxidative stress and neutrophil degranulation pathways within the thymus. Further, managing oxidative stress also influenced cytokine production by T cells in the spleen of infected mice. Thus, our study confirms that thymic atrophy does not depend on viremia level but on the interaction between immune cells and the virus, highlighting the contribution of infiltrating myeloid cells and, thus, ROS in DV-2-associated thymic atrophy. Dengue virus serotypes 2 & 3 (DV-2, DV-3) infection, but not serotype 1 (DV-1), leads to thymic atrophy in an experimental mouse model. Thymic atrophy depends not on the viremia level but on the specific host-virus interaction. Myeloid cells abundance and ROS level affect thymic output in severe dengue. The thymic interstitial fluid (TIF) protein profile reflects the atrophied. and non-involuted thymus status. Myeloid cells depletion or ROS quenching reverses the thymic atrophy-associated proteins in the TIF. ROS inhibition modulates the cytokine expression profile of T cells in the splenocytes of DV-2-infected mice.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8942ce52edd462ca76dfcec73d01cf4c11f1f50e" target='_blank'>
              Depletion of myeloid cells in AG129 mice reduces the infection-mediated oxidative stress and restrains dengue virus-induced thymic atrophy
              </a>
            </td>
          <td>
            B. Kusuma, Surender Rawat, Oindrila Saha, Sakshi Nimesh, Srikanth Sadhu, Amit Awasthi, T. K. Maiti, Arup Banerjee
          </td>
          <td>2025-12-06</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="

 The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted significant variability in disease severity, ranging from asymptomatic cases to severe acute respiratory distress syndrome.



 Understanding the immune responses that contribute to this variability, particularly among healthcare workers (HCWs) frequently exposed to the virus, is essential.



 This was a prospective single-center longitudinal cohort study. We included hospitalized COVID-19+ patients, classified as having mild or moderate-to-severe symptoms, and unvaccinated HCWs with low susceptibility. Peripheral blood mononuclear cells (PBMCs) were collected and analyzed using flow cytometry. We measured the frequencies of key immune subsets, including plasmablasts, plasmacytoid dendritic cells (pDCs), and Natural Killer (NK) cells. SARS-CoV-2 neutralizing antibodies (NAbs) were quantified using pseudotyped HIV particles.



 COVID-19+ patients exhibited a significant increase in plasmablasts, a B-cell subset responsible for producing neutralizing antibodies, which correlated with disease severity (p=0.0082). Conversely, uninfected HCWs had low levels of plasmablasts but significantly higher levels of plasmacytoid dendritic cells (pDCs) (p<0.0001), which produce interferons upon activation by viral antigens. Additionally, HCWs had a higher percentage of CD56bright NK cells than the susceptible patients (p=0.02).



 Our findings suggest that immune dysregulation, characterized by increased plasmablasts and reduced pDC and NK cell responses, contributes to COVID-19 severity. Strong pDC and NK cell responses may confer protection against SARS-CoV-2. These insights into immune responses may inform strategies for therapeutic interventions and vaccine development.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b2b12f86783468a8a58cf46dfd373285bb90b7e" target='_blank'>
              Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics
              </a>
            </td>
          <td>
            Laura Martín-Pedraza, Eulalia Rodríguez-Martín, Erick De La Torre-Tarazona, Elena Moreno, Roberto Pariente-Rodríguez, P. Walo-Delgado, J. García-Pérez, , Laura Luna, Mario Rodríguez-Domínguez, Juan Carlos Galán, Claudia Geraldine Rita, Ana Del Amo-de Palacios, Roser Navarro-Soler, María Fons, José Alcamí, Santiago Moreno, L. M. Villar, Sergio Serrano-Villar
          </td>
          <td>2026-01-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="There is a subgroup of people infected with the SARS-CoV-2 virus who manifest lingering sequelae (LongC), with neurological symptoms (nLongC). We recruited 86 COVID-19 volunteers, 35 of whom were fully recovered (Cov) and 51 who had neurological symptoms (nLongC) 4–53 months after infection and compared them to 51 healthy pre-pandemic controls (HC). Thirty-five percent of nLongC individuals carried the apolipoprotein E4 (APOE4) gene, compared to 11% of Cov. Four plasma proteins, interleukin 1 beta (IL-1β), interleukin 8 (IL-8), glial fibrillary acidic protein (GFAP), and hemopexin, continued to be elevated in both Cov and nLongC compared to HC. Soluble CD14 was elevated in nLongC but not Cov. As a group, IL-1β decreased over time in Cov but not nLongC. Two of the elevated proteins, IL-8 and GFAP, correlated with age, with both Cov and nLongC showing higher levels than HC. Using a combination of four plasma proteins, along with age, body mass index, and APOE4 presence, we were able to achieve an area under the curve (AUC) of 0.81. These results suggest that SARS-CoV-2 infection causes a low-grade inflammatory process that, even months or years after infection, does not return to pre-COVID-19 levels, which may contribute to neurologic sequelae and accelerated aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6dc097b9097119d707ae7261b40c50b96e52a07" target='_blank'>
              Chronic Inflammation and Altered Immune Responses in LongCOVID Associate with Neurological Manifestations and Accelerated Aging
              </a>
            </td>
          <td>
            Norina Tang, Judith M. Ford, Kaitlyn Dal Bon, Lynn Pulliam
          </td>
          <td>2025-11-26</td>
          <td>Cells</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92b1464e350c468b0e960f74f8db814fa5f708d3" target='_blank'>
              Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey
              </a>
            </td>
          <td>
            Tomoyuki Suzuki, Yoshihiro Kita, Keisuke Yanagida, Kenji Maeda, T. Hashidate-Yoshida, Hiroki Nakanishi, Takayo Ohto-Nakanishi, J. Terada-Hirashima, Yoshie Tsujimoto, Masayuki Hojo, H. Mitsuya, Takao Shimizu, Hideo Shindou
          </td>
          <td>2025-12-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0b1d9f79a0aea2296171fb92a1b3d1203b20d46c" target='_blank'>
              IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans
              </a>
            </td>
          <td>
            Jaime A. Cardona-Ospina, Vicky Roy, Dorca E Marcano-Jiménez, S. Bos, Elias M. Duarte, J. V. Zambrana, Agamjot Bal, Boyeong K An, A. G. Dias, Julia A. Zhiteneva, J. Huffaker, C. Montenegro, G. Kuan, M.J. Ramos-Benitez, Á. Balmaseda, G. Alter, Eva Harris
          </td>
          <td>2026-01-01</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>67</td>
        </tr>

        <tr id="Hyperactivated immunity underpins severe outcomes of respiratory viral infections, yet specific immune perturbations are ill-defined. Our recent findings identified OLAH (oleoyl-ACP-hydrolase) as a driver of life-threatening viral diseases. In the same patient cohorts, we now identify the gene encoding IL-18Rα chain (IL18R1), as being highly expressed in life-threatening influenza, COVID-19, RSV and multisystem inflammatory syndrome in children (MIS-C) and demonstrate markedly elevated surface protein IL-18Rα expression on CD8 T cells in these infections. Using a mouse model of severe influenza, we further show that high IL-18Rα expression on effector T cells is associated with increased disease severity. We find that IL-18Rα expression on CD8 T cells is inversely associated with cytotoxicity-related genes, including granzyme A, granzyme B, perforin, Eomes, and KLRG-1. Our study demonstrates that IL-18Rα is associated with severe and fatal respiratory disease outcomes and proposes the use of IL-18Rα as a potential biomarker for severe respiratory viral disease. The authors previously pinpointed OLAH (oleoyl-ACP-hydrolase) as a driver of life-threatening viral diseases. Here, the authors identify increased IL-18Rα expression on CD8+ T cells, which acquire a reduced cytotoxic signature, correlates with severe respiratory viral infection of influenza A virus, RSV and COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6dcd9c2feb67dc8df25c889f6ca091e2fc94480c" target='_blank'>
              High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures
              </a>
            </td>
          <td>
            Aira F. Cabug, J. Crawford, Hayley A. McQuilten, Isabelle J. H. Foo, L. Allen, Deborah Gebregzabher, R. Mettelman, Tanya Novak, Janet Chou, L. Rowntree, Ruth R. Hagen, Abby J. Thomson, Genevieve E. Martin, Brad Gilbertson, Michael N. T. Souter, Fiona James, Emma Goodall, Simone Rizzetto, T. Flerlage, Xiaoxiao Jia, Lee-Ann Van de Velde, So Young Chang, Fabio Luciani, R. Thwaites, Jason A. Trubiano, Tom C. Kotsimbos, Allen C. Cheng, A. Randolph, P. Thomas, Jianqing Xu, Zhongfang Wang, Thi H. O. Nguyen, B. Chua, Lukasz Kedzierski, K. Kedzierska
          </td>
          <td>2025-11-24</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>72</td>
        </tr>

        <tr id="Long COVID (LC) is a long-term debilitating disease of which the exact pathophysiology is unknown. A dysregulated immune response resulting in hyperresponsive immune cells is hypothesized as a key mechanism in the development of LC. Several studies suggest that acute infections can leave lasting epigenetic changes, which result in heightened immune reactivity. Upon stimulation, these primed immune cells may exhibit exaggerated responses. This form of epigenetic memory can contribute to altered immune dynamics, particularly in response to induction of type I Interferons (IFN-I) pathway activation using a viral mimic. Therefore, we investigated if LC patients exhibit a hyperresponsive response towards viral mimics in comparison with healthy controls (HC). PBMCs of two distinct LC cohorts, characterized by a different disease course and duration, were collected and transfected using Lyovec with the cGAS and RIG-I agonists G3-YSD and 3p-RNA followed by measurement of IFN-I bioactivity with a reporter cell line. Transfection of PBMCs of LC patients with the cGAS and RIG-I agonists resulted in increased IFN-I bioactivity in comparison with HC. Unsupervised hierarchical clustering revealed two distinct clusters, each predominantly composed of either patients or HC. In addition, a moderate correlation between RIG-I stimulation with 3p-RNA and fatigue severity scores was found. These data show a hyperresponsive phenotype of immune cells of LC patients upon stimulation with viral mimics. The current availability of biologicals and small molecule inhibitors that interfere with aberrant IFN-I pathway activation underscores the importance of pursuing future investigations into this phenomenon.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a860b1f890cd6919e6ed4f49c16018a6906fcd8a" target='_blank'>
              Exaggerated IFN-I Response in Long COVID PBMCs Following Exposure to Viral Mimics
              </a>
            </td>
          <td>
            Bart Humer, J. Berentschot, C. V. van Helden-Meeuwsen, L. Bek, Maaike de Bie, Tobias M Defesche, Chantal A Boly, Manon Drost, M. Hellemons, W. Dik, M. Versnel
          </td>
          <td>2025-12-10</td>
          <td>Journal of Clinical Immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/679a7b822ce567d8ac2ac1c2ea01dd417c348cfe" target='_blank'>
              The SARS-CoV-2 nucleocapsid protein induces microglia senescence-mediated cognitive impairment via Glycolysis.
              </a>
            </td>
          <td>
            Nan-Shi-Yu Yang, Han-Xi Sha, Chen-Yu Zhang, Hui Chen, Yu-Biao Liu, Jian-Bing Xiong, J. Duan, Jun Zhang, Cha-Xiang Guan, Yong Zhou, Feng Su, W. Zhong
          </td>
          <td>2025-12-12</td>
          <td>Molecular medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="The upper respiratory epithelium protects the airway from microbial exposure, environmental irritants, and viral pathogens such as influenza A virus (IAV). Situated at the airway–gastrointestinal junction, the larynx must integrate this barrier function with fine neuromuscular control under constant immune stimulation. Clinical syndromes such as post-viral vagal neuropathy—marked by chronic cough, throat clearing, dysphonia, and vocal fatigue—highlight critical gaps in our understanding of how the larynx and upper airway remodel after viral injury. To address this, we employed mouse models integrating genetics, imaging, and single-cell transcriptomics to dissect IAV-induced injury and repair in the upper respiratory tract. IAV infection displayed regionally restricted tropism toward ciliated, secretory, neuroendocrine, and basal epithelial cells, eliciting rapid clearance, acute neutrophil invasion, and a sustained intraepithelial population of cytotoxic CD8+ natural killer T (NKT)-like cells. Single-cell analysis revealed injury-induced Myc expression in KRT5+ basal progenitors, which activated a proliferative repair program and an epithelial–immune communication circuit centered on a MYC-dependent CXCL10–CXCR3 axis. Basal-specific Myc deletion preserved viral replication and clearance but blunted injury-induced proliferation, skewed lineage differentiation, and impaired CD8+ NKT cell recruitment. These findings define a coordinated epithelial–immune program governing post-IAV mucosal restoration and offer mechanistic insight into persistent upper airway sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/561fc69832beac4c1e41655e3f435bfb03fefa41" target='_blank'>
              Oncogene c-Myc Regulates Upper Respiratory Epithelial Repair for Host Immunity During Acute Influenza Infection
              </a>
            </td>
          <td>
            Alexander G. Foote, Le Xu, J. Verheyden, Belle Pan, Nikita Katoch, Xin Sun
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="The clinical outcome of Mycobacterium tuberculosis (Mtb) infection ranges from latent/nonprogressive disease to active/progressive tuberculosis (TB), but the cellular events contributing to these variable outcomes remain unknown. Here, we report that progressive Mtb infection is associated with upregulation of guanylate‐binding protein‐1 (GBP1), hypoxia‐inducible factor‐1 alpha (HIF‐1α), and elevated NLR family pyrin domain‐containing (NLRP3) inflammasome activation pathways. Using rabbit lungs and primary rabbit and human macrophages, as well as human monocytic THP‐1‐derived macrophages for infection with Mtb strains (H37Rv, HN878, or CDC1551) that differ in virulence, we show that NLRP3 inflammasome activation by HIF‐1α and GBP1 leads to elevated mitochondrial stress, apoptosis, and necrosis during progressive infection by HN878. These biological functions and pathways are dampened during nonprogressive TB in rabbit lungs, and in primary rabbit and human macrophages infected by CDC1551. These findings are consistent with and confirmed by Mtb infection studies of macrophages knocked down for HIF‐1α or GBP1 expression. Our study indicates that differences in HIF‐1α‐ and GBP1‐mediated NLRP3 inflammasome activation influence the outcome of Mtb infection in the host.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/03a725a42954422089b5cdb821dd4c57f65d3e21" target='_blank'>
              Inflammasome Activation Differences Underpin Different Mycobacterium tuberculosis Infection Outcomes
              </a>
            </td>
          <td>
            Ranjeet Kumar, Afsal Kolloli, G. Bhargavi, Seema Husain, Theresa L. Chang, Saleena Ghanny, Patricia Soteropoulos, S. Subbian
          </td>
          <td>2025-11-23</td>
          <td>MedComm</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Since the onset of the COVID-19 pandemic, obesity has been consistently associated with worse clinical outcomes. In 2020, we hypothesized that adipose tissue (AT) might serve as a viral reservoir and amplifier of immune responses in SARS-CoV-2 infection. Five years on, accumulating evidence supports this hypothesis. Recent autopsy and in vitro studies support that SARS-CoV-2 disseminates to and may replicate within human adipocytes. While several studies have detected SARS-CoV-2 RNA and proteins in AT, the recovery of infectious virus from this tissue has not yet been demonstrated. This remains a critical gap in our understanding of SARS-CoV-2 viral tropism and replication within adipocytes. Viral entry is mediated via angiotensin-converting enzyme-2 and neuropilin-1 receptors. Infected AT exhibits immune cell infiltration and cytokine activation, implicating it in systemic inflammation. Persistent viral RNA in AT correlates with prolonged metabolic dysfunction. These findings highlight the dual role of AT as a potential viral reservoir and immunometabolic organ. Understanding these mechanisms is critical to mitigating the long-term impact of COVID-19 and guiding responses to future pandemics involving metabolically active tissues.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/77a113aee7203a484ecb443a20ff11990516bad4" target='_blank'>
              Adipose Tissue in SARS-CoV-2 Viral Tropism, Viral Replication, and the Concept of a Viral Reservoir: An Update.
              </a>
            </td>
          <td>
            Liam Charles Maher, Paul M. Ryan, Noel M. Caplice
          </td>
          <td>2025-11-24</td>
          <td>Obesity</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating but poorly-understood disease. ME/CFS symptoms include immune system effects alongside incapacitating fatigue and post-exertional disease exacerbation. Symptom severity can range from mild to severe and whilst symptoms can fluctuate, few people fully recover. Immunological profiles of people living with ME/CFS were analysed by flow cytometry, focusing on cytotoxic cells, to determine whether people with mild/moderate (n = 43) or severe ME/CFS (n = 53) expressed different immunological markers. Flow cytometry data were tested for normality and the two clinical groups were compared by t-test or Mann-Whitney U-test as appropriate. People with mild/moderate ME/CFS had increased expression of cytotoxic effector molecules alongside enhanced proportions of early-immunosenescence cells, determined by the CD28-CD57- phenotype, indicative of persistent viral infection. In contrast, people with severe ME/CFS had higher proportions of activated circulating lymphocytes, determined by CD69+ and CD38+ expression, and expressed more pro-inflammatory cytokines, including interferon-γ, tumour necrosis factor and interleukin-17, following stimulation in vitro, indicative of prolonged non-specific inflammation. These changes were consistent across different cell types including CD8+ T cells, mucosal associated invariant T cells and Natural Killer cells, indicating generalised altered cytotoxic responses across the innate and adaptive immune system. These immunological differences likely reflect different disease pathogenesis mechanisms occurring in the two clinical groups, opening up opportunities for the development of prognostic markers and stratified treatments.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1e6b2fa3ad265819948a6a86e70aa620144d602" target='_blank'>
              Abnormal T-Cell activation and cytotoxic T-Cell frequency discriminate symptom severity in myalgic encephalomyelitis/chronic fatigue syndrome
              </a>
            </td>
          <td>
            Ji-Sook Lee, E. Lacerda, Caroline C. Kingdon, Ella Abken, Giada Susannini, H. Dockrell, L. Nacul, J. Cliff
          </td>
          <td>2025-12-10</td>
          <td>Journal of Translational Medicine</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Influenza-associated bacterial super-infections in the lung lead to increased morbidity and mortality. Previous studies have investigated how preceding viral infection causes dysregulation of the innate and adaptive immune systems, leading to increased susceptibility of developing secondary bacterial pneumonia. However, these previous studies cannot account for the spatial context of immune cells in lung. In our study, we employ a spatial transcriptomics platform (10X Genomics Visium) to systematically characterize the coordination of immune cells during super-infection. We compare deconvoluted spatial transcriptomics data between super-infection and single influenza and methicillin-resistant Staphylococcus aureus infections. Consequently, we find that the recruitment of neutrophils and interstitial macrophages from lung parenchyma to the airways is inhibited in super-infection, likely impairing pathogen clearance. Additionally, by analyzing cell colocalization and signaling, we find that the interaction between CD4+ T cells, B cells, and dendritic cells is disrupted by secondary bacterial super-infection. These findings are confirmed by immunofluorescence staining. Our study constructs a spatial sequencing atlas of lung super-infection, highlighting how secondary bacterial challenge significantly impacts recruitment and signaling of immune cells. These findings provide insight into the aberrant inflammation in the super-infected lung and may aid development of therapeutics that target key immune cell recruitment pathways. The authors report a spatial transcriptomic analysis of mouse lungs following a super-infection of influenza and methicillin-resistant Staphylococcus aureus.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b9ce378b7762918ff506d637ca20c6cc75ef36ef" target='_blank'>
              Influenza virus and Staphylococcus aureus super-infection disrupts spatially coordinated cellular immunity in the mouse lung
              </a>
            </td>
          <td>
            Tianhao Liu, Leigh M Miller, B. P. Dresden, Chong Zhao, Yogesh Pillai, Angel Rangel-Garcia, ML Garcia-Hernandez, Javier Rangel-Moreno, Wei Chen, J.F. Alcorn
          </td>
          <td>2025-11-23</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="HIV-associated neurocognitive disorder (HAND) is characterized by glial activation and neuroinflammation emerging from HIV infection. Moreover, methamphetamine (METH) is a highly addictive psychostimulant whose use is linked to high HIV prevalence, significantly worsening clinical outcomes for people living with HIV and hastening onset of systemic illness. Overall, pathologies associated with HIV infection/METH use comorbidity include neuroinflammation, neurotoxicity, synaptodendritic damage, and resulting cognitive dysfunction. However, mechanisms underlying this neuropathogenesis remain elusive due to the scarcity of human brain-specific experimental model systems. Therefore, we created a next-generation three-dimensional (3D) human brain model derived from human induced pluripotent stem cells (hiPSCs). Specifically, this 3D in vitro cerebral assembloid model integrates functional microglia derived from hiPSCs with cerebral organoids. Microglia are key contributors to HAND symptoms associated with HIV/METH comorbidity. We show that the presence of microglia in this assembloid model allows productive infection with HIV, which is enhanced by METH exposure, resulting in increased glial activation, inflammatory responses (namely IL-1β and IL-6 release), and neurotoxicity marked by neuronal cell death and synaptic protein loss. Importantly, in this model, we observed markedly decreased levels of the microglial receptor TREM2, which is implicated in microglial functions including phagocytosis, apoptosis and inflammatory responses following HIV infection and METH treatment. Analysis of our model showed that decreased TREM2 function may lead to HIV- and METH-associated pathological changes. Overall, our assembloid model could be a valuable tool for future analyses of HIV/METH/CNS interactions and mechanisms underlying HAND, which could lead to novel therapeutic approaches to decreasing the CNS viral reservoir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ffac3d500bac8bf3422011ef75e52fe379d437e3" target='_blank'>
              Investigation of CNS damage following HIV infection and methamphetamine exposure using human iPSC-derived microglia and 3D cerebral assembloid models
              </a>
            </td>
          <td>
            S. Tiwari, Gulshanbir Baidwan, S. Trescott, Shweta Jakhmola, N. Coufal, Tariq M. Rana
          </td>
          <td>2025-12-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="A comprehensive understanding of host-virus interactions during persistent foot-and-mouth disease virus (FMDV) infection is essential for elucidating the mechanisms that underpin disease causation by this highly contagious pathogen. This understanding necessitates the development of stable in vitro models. In this study, we established a model of persistent FMDV serotype O infection in Madin-Darby bovine kidney epithelial cells followed by integrated multiomics analyses. These analyses revealed that host cells adapt to persistent viral infection by reprogramming mitochondrial metabolism. This reprogramming is accompanied by alterations in mitochondrial structure and function, as well as the suppression of the apoptotic response in host cells. In particular, bystander cells, which are devoid of active viral replication, display enhanced proliferative capacity and possess a distinct microenvironmental signature that potentially increases viral susceptibility, facilitating sustained virus persistence within the cell population. Moreover, persistent viruses have evolved enhanced replicative fitness. Our findings elucidate the biological characteristics of FMDV-infected cell populations that persistently harbour the virus, reveal host-virus coadaptation, and highlight the critical role of bystander cells in sustaining persistent FMDV infection. These discoveries establish the foundation for further mechanistic studies of FMDV persistence maintenance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f717c7343d691b2f665717d1011e75b567875353" target='_blank'>
              Integrated multiomics reveals host-virus coadaptation in persistent foot-and-mouth disease virus infection
              </a>
            </td>
          <td>
            Shuang Wang, Zhihui Zhang, Sumin Wei, Guoliang Huang, Shuanghui Yin, Suyu Mu, Hu Dong, Shiqi Sun, Huichen Guo
          </td>
          <td>2025-11-24</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ebd7c1c95a72fa42446be74525f1dfe8c58ae064" target='_blank'>
              Decoding acute neuroinflammatory states from the 3D architecture of in vitro microglia
              </a>
            </td>
          <td>
            Anthoula Chatzimpinou, Johanna Huber, Xenia Podlipensky, J. Cairns, Ayse Erozan, Jian-Hua Chen, V. Loconte, M. Le Gros, Carsten Hopf, Carolyn A. Larabell, V. Weinhardt
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ebef12370aba49b0c9a0e8c7f942ab6de71a9e9" target='_blank'>
              Pharmacological intervention targeting neuroimmune axis in the aging hypothalamus prevents age-associated physiological decline
              </a>
            </td>
          <td>
            Min-Jong Seok, Na-Kyung Lee, In-Seop Sim, Jumi Kim, Kelvin Pieknell, T. Stein, Jung-Hee Lee, Hoon Ryu, Seung-Hyup Song, J. Seong, Il-Yong Kim, Eun Ha Ko, Yanuar Alan Sulistio, Sang-Hun Lee
          </td>
          <td>2026-01-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="Background and Objectives Interleukin-9 (IL-9) is an immune molecule with multiple roles in a variety of cell types. IL-9–induced cell responses are mediated by the IL-9 receptor (IL-9R). Recent evidence demonstrates that expression of IL-9R in post mortem brain tissues of patients with multiple sclerosis (MS) is associated with a protective, anti-inflammatory role of IL-9 in MS. In this study, we investigated the expression of IL-9R in cells resident in the CNS of patients with MS. We found that astrocytes express IL-9R, indicating their expected responsiveness to IL-9. Astrocytes play a critical role in MS, where the inflammatory environment turns them into reactive cells, which actively contribute to the disease. The transcription factor nuclear factor-kB (NF-kB) regulates the response of reactive astrocytes and their potential pathogenic activities during CNS inflammation. Methods To address the role of IL-9 in proinflammatory astrocytes, we used 3 different human in vitro models: (1) human astrocytoma cell line (U-373 MG), (2) primary normal human astrocytes, and (3) induced pluripotent stem cell–derived astrocytes. We used interleukin-1β for their conversion into proinflammatory astrocytes. Results We found that IL-9 contributes to the switch of astrocytes from an inflammatory to an anti-inflammatory profile by downregulating NF-kB activation. Moreover, we demonstrated that IL-9 inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF) expression driven by NF-kB. Discussion Because GM-CSF production by astrocytes is linked to microglial activation and CNS inflammation, these results indicate that IL-9 regulates the astrocyte-microglia axis and has potential therapeutic anti-inflammatory implications in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68caea23e18c5a4cd499ee0619116e5884afc207" target='_blank'>
              Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain
              </a>
            </td>
          <td>
            Miriam Cinotti, Susanna Amadio, Daniele Tidei, Gloria Donninelli, Costanza Stacchiotti, Veronica De Paolis, Emanuela Colombo, Anthea De Angelis, F. Ruffini, Gianvito Martino, Cinthia Farina, Chiara Parisi, C. Volonté, Elisabetta Volpe
          </td>
          <td>2026-01-13</td>
          <td>Neurology® Neuroimmunology & Neuroinflammation</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) elicits a sustained innate immune response involving both resident microglia and infiltrating peripheral immune cells. However, the influence of peripheral immune-derived signals on microglial dynamics and functional recovery remains poorly understood. We previously identified the receptor tyrosine kinase EphA4 as a regulator of acute neuroinflammation following TBI. In this study, we employed bone marrow chimeric mice with hematopoietic-specific EphA4 knockout and subjected them to controlled cortical impact (CCI) to investigate the role of EphA4 in modulating acute and chronic microglial responses. Mice lacking EphA4 in hematopoietic cells exhibited reduced microglial apoptosis and proliferation at 3 days post-injury (dpi), accompanied by increased microglial sphericity at 3- and 60-days post-injury (dpi) within the injured cortex. These morphological changes coincided with enhanced spatial proximity to peripheral-derived macrophages. Behaviorally, EphA4-deficient chimeric mice demonstrated improved performance in the novel object recognition test at 3 dpi, and in the T-maze at both 60 and 90 dpi. Single-cell RNA sequencing of hippocampal tissue at 90 dpi revealed microglial subpopulations uniquely enriched in EphA4-deficient chimeric mice, with transcriptional profiles associated with leukocyte differentiation, immune regulation, hematopoiesis, and endothelial development. Together, these findings demonstrate that peripheral immune-derived EphA4 signaling influences microglial heterogeneity and negatively regulates long-term neuroimmune remodeling and functional recovery following TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/571ba0d671c4fd733e28edbbe9d041d16e80df8b" target='_blank'>
              Hematopoietic EphA4 deficiency alters microglial heterogeneity and improves chronic spatial memory after brain injury
              </a>
            </td>
          <td>
            Eman Soliman, Caroline de Jager, Kylee Smith, Jing Ju, Andrew Willison, Jatia Mills, M. Theus
          </td>
          <td>2025-12-05</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Apoptosis, a form of programmed cell death, is crucial for keeping homeostasis during and after infections. Cellular FLICE-inhibitory protein (c-FLIP) is an inhibitor of death receptor-mediated apoptosis, of which three isoforms have been characterized so far. While the isoforms c-FLIPlong and c-FLIPshort are well characterized, the function of c-FLIPR remains poorly understood. To study the role of c-FLIPR in influenza A virus (IAV) infection, we employed vavFLIPR transgenic mice that constitutively express murine c-FLIPR in all hematopoietic cells. Upon IAV challenge, vavFLIPR mice showed an altered viral dynamic with a higher viral load than wild-type mice, coinciding with a higher number of Natural Killer (NK) cells. IAV directly infected murine NK cells, but viral particles produced by NK cells did not infect other target cells. While NK cells from vavFLIPR and control mice were equally able to kill tumor cells in vitro, we detected reduced degranulation of c-FLIPR transgenic NK cells from infected mice compared to wild-type counterparts. Furthermore, TNFα and IFNg expression was reduced in c-FLIPR transgenic NK cells. We conclude that c-FLIPR impairs NK cell activity during IAV infection. Constitutive expression of the anti-apoptotic c-FLIPR in hematopoietic cells increases IAV titers. Accumulation of NK cells in vavFLIPR mice during IAV infection. IAV infects NK cells in a non-productive manner. IAV infection of NK cells impairs their function. Constitutive expression of the anti-apoptotic c-FLIPR in hematopoietic cells increases IAV titers. Accumulation of NK cells in vavFLIPR mice during IAV infection. IAV infects NK cells in a non-productive manner. IAV infection of NK cells impairs their function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2201ed3d7dca3eff038218bf0fd445634039c961" target='_blank'>
              The cell death regulator c-FLIPR impairs natural killer cell responses during influenza a virus infection
              </a>
            </td>
          <td>
            André Carmo-Fernandes, Neda Tafrishi, Clara Bessen, Konstantinos Katsoulis-Dimitriou, Marina C. Greweling-Pils, D. Bruder, C. Plaza-Sirvent, Ingo Schmitz
          </td>
          <td>2025-12-26</td>
          <td>Journal of Molecular Medicine (Berlin, Germany)</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="ABSTRACT Rift Valley fever virus (RVFV) is a Phlebovirus causing febrile and haemorrhagic illness in ruminants and humans. The viral protein NSs is a major virulence factor that suppresses the IFN-β response in various hosts. Hence, RVFV variants lacking functional NSs, such as Clone 13, are highly attenuated. It is speculated that from the sites of infection, the virus disseminates to the target organs via the bloodstream. We hypothesized that primary infection of circulating immune cells and their response to infection are critical factors determining systemic RVFV spread and pathogenesis. Human PBMC from healthy blood donors were exposed to both wild-type (WT) RVFV and Clone 13 strains. Flow cytometric analysis revealed that monocytes expressing LRP1, a known RVFV receptor, are target cells for RVFV. RNA-seq analysis of monocytes exposed to WT and Clone 13 strains showed a large number of differentially expressed genes compared to mock-exposed cells. Various genes involved in antiviral immune mechanisms were specifically modulated in monocytes either in response to WT or Clone 13 infection. Expression of genes encoding key inflammatory mediators, such as CCL2, CD40, and CD83, was only upregulated in Clone 13-infected monocytes, whereas IFNB1 and NFKB1 were downregulated specifically in WT-infected monocytes. Taken together, our findings suggest that RVFV NSs dampen the innate immune responses in monocytes which may be critical not only in RVFV pathogenesis but also in the induction of virus-specific immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9bbf32c5fcf87eba5101e9e1046f41aebb58c18c" target='_blank'>
              Differential innate immune activation by wild-type and NSs-deficient RVFV strains in human blood monocytes
              </a>
            </td>
          <td>
            Niranjana Nair, Julia Friese, P. J. Wichgers Schreur, A. Osterhaus, G. Rimmelzwaan, C. K. Prajeeth
          </td>
          <td>2025-12-29</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="Severe influenza is frequently associated with bacterial or viral co-infections. Although immune-mediated mechanisms have been extensively investigated, the cell-intrinsic responses of respiratory epithelial cells prior to immune engagement remain poorly characterized. To model co-infection in vitro, we pre-activated B16 melanoma cells using the TLR9 agonist CpG ODN, followed by infection with influenza A virus (IAV) strain FM1. Key molecular events, including STING expression and activation, were assessed by Western blotting and RT-qPCR. The in vivo relevance was assessed in a mouse model of intranasal CpG ODN pre-treatment and IAV challenge. RNA-seq was performed as a supplementary approach to explore possible cell death pathways. Pre-activation significantly enhanced IAV-induced cell death within a restricted vulnerability window (≤ 24 h), independent of viral replication or TLR9 signaling. This was associated with inflammatory priming and initial STING activation. However, IAV infection subsequently suppressed STING phosphorylation and elevated inflammatory cell death. Mice pre-treated with CpG ODN exhibited increased mortality and aggravated lung injury following IAV challenge. RNA-seq analysis suggested the potential involvement of pyroptosis. These findings demonstrate that cellular pre-stimulation exacerbates influenza severity by promoting inflammatory cell death, a process mechanistically linked to the subsequent suppression of STING activation. This study reveals a novel pathogenic cell-intrinsic mechanism in co-infection pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3439ff28ee00f2494a3463487f23bdd0ebdcd631" target='_blank'>
              Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition
              </a>
            </td>
          <td>
            Tong Zhu, Mengru Zhu, Feiyu Lu, Kuo Qu, Hong Wang, Shengnan Wang, Zhengyi Sun, Yongli Yu, Liying Wang, Chaoying Yan
          </td>
          <td>2025-12-01</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3378eff780a7c92d18b8963451699b80dce810eb" target='_blank'>
              Aging Converts Microglial Repopulation into Maladaptive Reprogramming that Exacerbates Cognitive Deficits
              </a>
            </td>
          <td>
            Rui Yamada, H. Nagai, Yunhui Zhu, Chisato Numa, M. Taniguchi, Tomoyuki Furuyashiki
          </td>
          <td>2026-01-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d82b0101e16002e72922cc003dc674661bb12d26" target='_blank'>
              Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology
              </a>
            </td>
          <td>
            Michael Candlish, Jan Hofmann, Desirée Brösamle, Annika Haessler, Murphy DeMeglio, Angelos A. Skodras, Georgi Tushev, Eloah S. De Biasi, Stefan Günther, R. Wiegandt, Heidi Theis, Elena De Domenico, Nina Hermann, K. P. R. Nilsson, Marc Beyer, Mario Looso, M. Windbergs, Sigrun Roeber, Jochen Herms, J. Neher, Andreas G. Chiocchetti, Jasmin K. Hefendehl
          </td>
          <td>2025-12-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Viruses, like influenza and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remain major causes of upper respiratory tract infections worldwide, with symptoms ranging from asymptomatic to lethal outcomes. While antivirals and vaccines have helped ameliorate disease morbidity and mortality, these infections still pose significant challenges. Probiotics, including Lactococcus lactis strain plasma (LC-Plasma), have recently shown antiviral effects by activating plasmacytoid dendritic cells (pDCs), though their detailed mechanism remains unclear. In this study, we stimulated peripheral blood mononuclear cells (PBMCs) collected from healthy participants with LC-Plasma and conducted immunological analyses to investigate the immunomodulatory mechanisms of LC-Plasma. The supernatant derived from LC-Plasma-stimulated PBMCs (LCP Sup) exhibited dose-dependent inhibition of replication in Influenza A virus subtype H1N1 (H1N1) and SARS-CoV-2. LCP Sup significantly reduced the SARS-CoV-2 viral load in Huh-7 cells. However, in the H1N1 antiviral assay using A549 cells, LCP Sup was required at a higher concentration against H1N1 in A549 cells compared with SARS-CoV-2 in Huh-7 cells. Treatment with LCP Sup significantly upregulated interferon-stimulated genes (ISG) expression, particularly MxA, in A549 cells. While MxA showed the most notable increase, other ISGs also exhibited elevated expression levels compared with the negative control. Other cytokines, chemokines, and growth factors were also induced by LC-Plasma and CpG-DNA stimulation, and the effects of LC-Plasma were much higher than those of CpG-DNA. These results provide in vitro evidence of the antiviral mechanisms of LC-Plasma via upregulation of interferon-α (IFN-α) and related ISGs for host defense against respiratory viruses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/54c1e93f06d05aceebdf2e0d94bd475aa2743cdf" target='_blank'>
              Stimulation of Peripheral Blood Mononuclear Cells with Lactococcus lactis Strain Plasma Elicits Antiviral Effects Against H1N1 and SARS-CoV-2
              </a>
            </td>
          <td>
            Zhao Xuan Low, Owen Woo, Osamu Kanauchi, P. Hassandarvish, V. Tiong, Sazaly AbuBakar
          </td>
          <td>2025-11-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f3f466a8b6bbef99c55e8bb31d40feefddd8931f" target='_blank'>
              Tuberculous meningitis alters the proteomic landscape of brain-derived extracellular vesicles
              </a>
            </td>
          <td>
            Blanca V. Rodriguez, Nerketa N. L. Damiba, Nicole Beaubien, Daisy Puca, D. B. Foster, Samarjit Das, Elizabeth W. Tucker
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Post-Acute Sequelae of COVID-19 (PASC), or “long COVID,” describes persistent symptoms following recovery from SARS-CoV-2 infection. Early identification of circulating biomarkers predictive of PASC is critical for prognosis and therapeutic development yet remains poorly defined. To address this gap, we conducted a longitudinal, multi-omics analysis of blood samples from COVID-19 patients (n = 75), stratified by acute disease severity and PASC status. We integrated targeted multiplex assays, untargeted proteomics (LC-MS), and whole blood flow cytometry to define immune and vascular signatures associated with PASC. We found that individuals who went on to develop PASC exhibited a distinct phenotypic signature between 1 and 35 days post-infection, such as significantly elevated plasma Factor-IX, Tissue factor, and tPA, which reflected hyperactivation of immunothrombotic pathways. Similarly, pathway enrichment analysis revealed ongoing neutrophil degranulation, platelet activation, and extracellular matrix remodeling—indicating unresolved inflammation and immunothrombosis which persisted beyond 77 days post-symptom onset. Unlike prior studies using single biomarkers or limited timepoints, our study offers a comprehensive longitudinal analysis combining proteomic and cellular data to define a durable immune-vascular signature specific to PASC. This integrative approach reveals insights into PASC pathogenesis and highlights candidate biomarkers with potential utility in early risk stratification. Our findings underscore the critical role of chronic immune and endothelial dysfunction in long COVID and point toward actionable targets for intervention. This investigation links biorepository human samples with clinical symptoms and lays the foundation for precision diagnostics and therapeutic strategies aimed at improving long-term outcomes in COVID-19 survivors (NCT04603677).">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c8423d9fefb3d644864a26f8dbc02503abeb9ee" target='_blank'>
              Blood pro-thrombotic analytes and platelet activation are associated with post-acute sequelae of COVID-19
              </a>
            </td>
          <td>
            Luke A Whitcomb, K. Berry, S. LaVergne, Nicole Natter, Bridget Baxter, Sangeeta Rao, M. Tipton, Marina A. Gritsenko, Karl K. Weitz, Vince Gerbasi, L. Bramer, P. Piehowski, Tracy L. Webb, Marcela Henao-Tamayo, Adam J. Chicco, J. Dunn, Taru S. Dutt, Elizabeth P. Ryan
          </td>
          <td>2025-12-10</td>
          <td>BMC Infectious Diseases</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Aim: Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) persist in effectively treated HIV-infected individuals, in part due to HIV reservoirs in brain microglia, which express low levels of viral proteins such as Nef. This study aimed to elucidate how microglia release Nef into the extracellular space, where it exerts its biological functions. Methods: Here, we systematically characterized extracellular particles released from immortalized human microglia (h-microglia) expressing Nef alone or after HIV infection. Importantly, we established a novel h-microglia model harboring a stably integrated Nef tagged with green fluorescent protein (Nef.GFP) transgene under an inducible promoter. Extracellular vesicles (EVs) were enriched from culture media and analyzed for morphology, size, concentration and molecular composition, including Nef content, by (super-resolution) fluorescence microscopy, (immunogold) transmission electron microscopy, asymmetric flow field-flow fractionation coupled to a multi-angle light-scattering detector, nanoparticle tracking analysis, and nano-flow cytometry and immunoblotting. Results: Nef.GFP expression increased particle release up to 11.7-fold compared with controls or known stimulants adenosine triphosphate (ATP) and ionomycin. Compared to the latter, the particles were also significantly smaller (root mean square radius, Rrms = 172 nm) and displayed unique protein and density profiles. All data support the EV nature of the released particles. Approximately half of the Nef.GFP-induced EVs contained Nef (45.5% ± 15.8%), with immunogold labeling confirming its intraluminal localization. Notably, infection with HIV isolates NL4-3 and YU-2 likewise produced Nef-positive EVs distinct from virions. Conclusion: Our findings importantly contribute to understanding the source and characteristics of extracellular Nef in the central nervous system of HIV infected individuals and offer new tools to study HIV Nef biology. Nef-laden EVs should be further investigated as potential therapeutic targets in HAND.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/408ae3961db964c668acc8086651a2999a517580" target='_blank'>
              HIV protein Nef expression in human microglia drives the release of distinct Nef-containing extracellular vesicles
              </a>
            </td>
          <td>
            Teja Lavrin, Jure Loboda, J. Ferdin, Valentina Levak, Simona Sitar, M. Holcar, Nataša Resnik, M. Stenovec, A. Trampuš Bakija, Peter Veranič, E. Žagar, Magda Tušek Žnidarič, Pia Pužar Dominkuš, Metka Lenassi
          </td>
          <td>2025-12-02</td>
          <td>Extracellular Vesicles and Circulating Nucleic Acids</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Microglia are unique damage sensors of the central nervous system, and their homeostatic roles are increasingly recognized. Purinergic signaling through the P2Y12 receptor (P2Y12R) is indispensable for directed process movement of microglia in response to danger‐related ATP release. P2Y12R has also been shown to modulate microglial communication with neurovascular elements in the brain and to profoundly influence outcomes in experimental models of brain injury. However, the exact role of P2Y12R in shaping microglial phenotypes and interactions under physiological conditions remains unresolved due to disagreements between ex vivo and in vivo observations. Using in vivo 3D two‐photon imaging and high‐resolution anatomy we show that P2Y12Rs are essential regulators of microglial physiology, fundamentally shaping homeostatic microglial surveillance activity and direct contacts with other cell types. Genetic deletion or acute pharmacological blockade of P2Y12R function leads to altered surveillance activity, microglial morphology and P2Y12R nanoclustering, resulting in changes of direct microglial contacts with neuronal cell bodies, smooth muscle‐bearing blood vessels and oligodendrocyte processes in the somatosensory cortex of mice. Furthermore, molecular anatomy of P2Y12R expression shows correlation with disease severity and altered microglia–neuron interactions in human epilepsy. Thus, our results identify P2Y12Rs as major participants in microglial physiology whose dysfunction could impact defined cell–cell interactions in different neurological states.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5c367e4d1c254d3a3956accbf9f2980fe68e3660" target='_blank'>
              P2Y12 Receptor Function Governs Microglial Surveillance and Cell–Cell Interactions in the Cerebral Cortex
              </a>
            </td>
          <td>
            Balázs Pósfai, Eszter Szabadits, C. Cserép, Sára Vida, A. D. Schwarcz, Rebeka Fekete, Krisztina Tóth, Orsolya Bánkövi, C. Szekeres-Paraczky, Zsófia Maglóczky, Katinka Lakatos-Ujvári, Anna Kellermayer, Ana-Rita Bras, Péter Gombás, L. Erőss, Á. Dénes
          </td>
          <td>2025-12-02</td>
          <td>Glia</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Although most SARS-CoV-2 infections result in mild or moderate symptoms not requiring hospitalization, many patients experience persistent symptoms after their initial recovery, a condition termed Post-Acute Sequelae of SARS-CoV-2 infection (PASC). The underlying pathogenesis behind infection associated chronic illnesses, such as PASC, are poorly understood, thus critically limiting the development of therapeutics to prevent or alleviate symptoms. The current study examined the neurocognitive impact of SARS-CoV-2 induced inflammation in a nonhuman primate model. Ten adult rhesus macaques (5 female, 5 male) were monitored before, during, and after recovery from a mild COVID-19 illness (SARS-CoV-2 strain 2019-noCoV/USA-WA1/2020). Macaques exhibited persistent alterations in taste and smell, as well as decreased cognitive flexibility up to 3 months post-infection. Female macaques experienced sleep disturbances, greater stress and poorer autonomic function months after SARS-CoV-2 infection. Importantly, the development of these neurocognitive changes were associated with acute cytokine response to infection and increased microglia activation in brain tissue at 4 months post-infection. These findings suggest a causative link between the inflammatory response to mild COVID-19 symptoms and persistent neurocognitive changes associated with PASC and provide rationale for therapeutic strategies aimed at reducing acute inflammatory responses to the virus.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e39b66a62b804a305ef8c1e9f417b8c7fa8e3e19" target='_blank'>
              Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaques
              </a>
            </td>
          <td>
            Tomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, Winni Weng, Muskan Ali, Alex van Schoor, Elise G. Viox, Kevin Nguyen, James Auger, Richard Ketan, M. Gagne, Breanna Picou, Nadia A Golden, Monica Vaccari, Sherri Jean, Jennifer S Wood, Joyce Cohen, R. P. Johnson, Daniel C Douek, Benoit A Niclou, Rebecca D. Levit, Ian N. Moore, Mirko Paiardini, J. Raper
          </td>
          <td>2025-12-02</td>
          <td>Research Square</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f06caba0f4cc503c8b0aa1aadbc7d5f878826110" target='_blank'>
              GPR34 regulation of disease-associated microglial states and responses to physiological stimuli
              </a>
            </td>
          <td>
            Ana Geller, Min Jee Kwon, Sean K Simmons, Qihong Xu, William E. Martenis, Jordan L. Doman, Sahana Natarajan, Katherine J. Stalnaker, Jixiang Zhang, Xian Adiconis, Trang Nguyen, Matthew Demers, Donovan L. Batzli, Antia Valle-Tojeiro, Christy Biji, Sameer Aryal, Horia Pribiag, Constanze Depp, Nader Morshed, Deeksha Misri, Diana Bohannon, Elena Longhi, Hasmik Keshishian, Steven A. Carr, D. McKinney, Alexandra E.Gould, Evan P Lebois, M. Weïwer, Matthew Johnson, Joshua Z. Levin, Yan-Ling Zhang, Morgan Sheng, Prabhat S. Kunwar
          </td>
          <td>2025-12-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Despite the global spread of mpox virus (MPXV), the durability and breadth of infection-induced immunity remain incompletely defined. Here, we comprehensively characterize MPXV-specific antibody and T cell responses up to 18 months after natural infection in male individuals. Neutralizing antibodies exhibit typical acute viral kinetics, with titers peaking early and declining over time, from a mean of 328 at 12 months to 180 at 18 months post-infection. Neutralization analyses against MPXV clade Ib, clade IIb and VACV WR strains demonstrate pronounced cross-neutralization among orthopoxviruses, but with lineage-specific reductions in neutralization, indicating incomplete cross-reactivity across different lineages. In parallel, MPXV-specific CD4⁺ and Tfh cell responses remain robust and polyfunctional throughout follow-up, and CD8⁺ T cells maintain sustained responses characterized by cytokine production, together supporting durable cellular immunity. These findings offer critical insights into the durability and breadth of post-infection immunity, with implications for reinfection risk and orthopoxvirus vaccine strategies. Despite the global spread of the mpox virus, the long-term durability and breadth of infection-induced immunity are not fully understood. Here, the authors analyze MPXV-specific immune responses up to 18 months post-infection, revealing robust cellular immunity and cross-neutralization among orthopoxviruses, which inform reinfection risks and vaccine development strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/34d60218895d1200ff9badae5115a1cadf0c8f9a" target='_blank'>
              Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses
              </a>
            </td>
          <td>
            Yanqun Wang, Ruoxi Cai, Airu Zhu, Jiantao Chen, Canjie Chen, Lijuan Zhou, Xindan Xing, Qier Zhong, Peilan Wei, Xinxin Li, Zhaoyong Zhang, Yuanyuan Zhang, Lei Chen, Jingjing Gao, Suxiang Li, Xinyi Xiong, Bin Qu, Shuxiang Huang, Zhiwei Lin, Haoshi Bai, Qingtao Hu, Jingxian Zhao, Yongxia Shi, Yang Yang, Pengzhe Qin, Lu Zhang, Jincun Zhao
          </td>
          <td>2025-12-04</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Precise control of cell–cell communication networks within brain neurovascular units (NVUs) promotes normal tissue physiology. Dysregulation of these networks can lead to pathologies including uncontrolled angiogenesis, endothelial barrier disruption, and intracerebral hemorrhage (ICH). The cellular and molecular mechanisms underlying ICH pathogenesis and subsequent tissue repair processes remain poorly understood. Here we employed fixed single cell RNA profiling coupled with spatial in situ gene expression profiling to characterize NVU signaling pathways associated with ICH in Itgb8/β8 integrin mutant mice. In this model, early neonatal stages of ICH were characterized by downregulation of extracellular matrix (ECM)-associated signaling factors (Adamtsl2, Htra3, and Lama4) linked to canonical TGFβ activation and signaling in endothelial cells. Conversely, the progressive resolution of ICH involved upregulation of neuroinflammatory signaling networks (Gas6 and Axl) alongside activation of iron metabolism pathway components (Hmox1, Cp, and Slc40a1) in microglia/macrophages. Integrated computational modeling identifies additional ligand-receptor signaling networks between perivascular glial cells and angiogenic endothelial cells. Collectively, these findings illuminate the molecular signaling networks that promote NVU maturation and provide novel mechanistic insights into the pathways controlling ICH pathogenesis and repair in Itgb8 mutant mice.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/196d46e68f6d694e757a27b2ec5e73dcd59d1a6b" target='_blank'>
              Integrative single cell RNA and spatial profiling identify mechanisms of neonatal brain hemorrhage pathophysiology and repair
              </a>
            </td>
          <td>
            Santiago A Forero, Zhihua Chen, Ali Pirani, Arpan De, Zachary Wise, Xiaofeng Zheng, John E. Morales, Joseph H. McCarty
          </td>
          <td>2025-12-07</td>
          <td>Angiogenesis</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b84dc896cebb5207c2d65cbbad2d3534e7e7ea9e" target='_blank'>
              Endothelial TLR4 signaling drives tissue inflammation, Claudin-5 internalization, and vascular barrier breakdown in a mouse model of neonatal meningitis
              </a>
            </td>
          <td>
            Philip V. Seegren, A. Rattner, P. Smallwood, J. Nathans
          </td>
          <td>2026-01-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>95</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d5581192995f28d24b781c1e7c2e69bf2aa53d8" target='_blank'>
              Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial
              </a>
            </td>
          <td>
            E. Maestri, W. J. Kwon, H. Zheng, T. Prestwood, H. Hedlin, J. W. Liang, H. McCann, B. Shaw, L. Tian, B. Jones, R. Lu, G. Wiley, E. Haraguchi, O. Wirz, J. Afaghani, B. Lam, D. F. D. Mahmood, N. A. Phillips, M. M. S. Sim, J. P. Wood, J. R. Heath, S. D. Boyd, J. Guthridge, U. Singh, H. Bonilla, P. Jagannathan, P. Utz, L. Geng, P. Khatri
          </td>
          <td>2025-12-05</td>
          <td>None</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects millions of people worldwide and often leads to fatal heart damage. The course of CD is influenced by how the immune system is tuned, which can protect the host and favor parasite persistence. Interleukin-33 (IL-33) is an alarmin released upon tissue injury that signals through the ST2 receptor, exerting context-dependent regulatory or pathogenic effects. However, the role of the IL-33/ST2 axis in T. cruzi-induced myocarditis remains unclear. Here, using ST2-deficient (ST2–/–) and wild-type (WT) female mice infected with the T. cruzi Y strain, we investigated its contribution to cardiac inflammation, tissue damage, and parasite burden. We found that ST2 signaling was not essential for controlling parasitemia, but its deficiency led to early onset myocarditis, disorganized fibrosis, and distinct electrical conduction. This severe immunopathology was driven by a remodeling of the cardiac immune landscape, with ST2–/– mice exhibiting an influx of IFN-γ-producing monocytes and a shift in resident and monocyte-derived macrophages toward a pathogenic, pro-inflammatory phenotype. Likewise, the cardiac T cell compartment, including both conventional and γδ T cells, was skewed toward an inflammatory, IFN-γ-driven profile. However, infected ST2-deficient mice also displayed higher cardiac parasite burden and impaired nitric oxide production, indicating a dysfunctional response in parasite control. Together, these findings demonstrate that the IL-33/ST2 axis limits early systemic inflammation, orchestrates cardiac immune response, and protects against immunopathology and electrical remodeling during T. cruzi experimental infection. Targeting this pathway may offer therapeutic potential for preventing cardiac damage in CD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c31dfa372eb0f6f0a367ba1d3efbe2085386b350" target='_blank'>
              IL-33/ST2 Signaling Protects the Heart by Restraining Inflammation and Parasite Burden during Trypanosoma cruzi Experimental Infection
              </a>
            </td>
          <td>
            M. E. Cardozo, T. M. Cirilo, Jorge Lucas Nascimento Souza, J. B. R. Rihs, Isabela de Brito Duval, Fernando Bento Rodrigues Oliveira, Mayra Ricci, Laura Lis de Oliveira Santos, Livia Fernanda Dias Santana, Luiza Pinheiro Silva, C. Amorim, Ana Rafaela Antunes-Porto, Izabela da Silva Oliveira, Ana Laura Grossi de Oliveira, Luisa Vitor Braga do Amaral, Gabriela Gomes Monteiro Lemos, Getúlio Mota E Silva Junior, Ivan Lobo Sousa Marques, M. P. Reys, G. Cassali, Artur Santos-Miranda, L. Magalhães, L.L. Bueno, F. S. Machado, R. Fujiwara
          </td>
          <td>2025-12-09</td>
          <td>ACS Infectious Diseases</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="Trisomy 21 increases the risk of severe outcomes and mortality in hospitalized individuals with Down syndrome (DS) following SARS-CoV-2 infection. Using data from the Brazilian Epidemiological Surveillance Information System Influenza (SIVEP-Gripe), we analyzed 102,767 hospitalized COVID-19 patients (1,115 DS and 101,652 non-DS, NDS). DS patients had a higher prevalence of comorbidities and required ventilatory support, ICU admission, and intubation more frequently than NDS patients (p < 0.001). Mortality was 4.5 times higher in DS patients aged 0–30 years (26.3% vs. 5.9%, p < 0.001) and remained 2.22 times higher after adjusting for comorbidities. DS patients over 30 years also exhibited a 22% increase in mortality (PR 1.22, p < 0.001). Gene expression analysis of pre-pandemic monocytes and T cells from DS individuals revealed upregulated pathways linked to SARS-CoV-2 infection, including interferon signaling and cytokine interactions. This baseline immune dysregulation may contribute to severe COVID-19 outcomes in DS patients. Identifying these altered pathways could inform targeted therapeutic strategies to improve immune homeostasis and clinical outcomes. To the best of our knowledge, this is the first study integrating nationwide clinical outcomes with pre-pandemic immune transcriptomic data to mechanistically explain the heightened COVID-19 severity in individuals with DS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f7075222f6b4bba193e24822c99a19b4d8bb480" target='_blank'>
              Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome
              </a>
            </td>
          <td>
            Daniella Balduino Victorino, J. Malheiros, Felipe ten-Caten, Victor Hugo Cardoso Betta, Felipe Farinha Saad Barbosa, K. Ghneim, Fernanda Caroline Coirada, Fernanda Romano Bruno, Giuliana Xavier de Medeiros, Cassia Silveira, Christina Gavegnano, Robert Balderas, Ana Claudia Brandao, Edward Yang, Helder Nakaya, Gabriela A. Wagner, L. Covolan, Susan Pereira Ribeiro
          </td>
          <td>2026-01-05</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Abstract Long COVID (LC) or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome represents a widespread health challenge that necessitates the development of novel diagnostic approaches and targeted therapies that can be readily deployed. Immune dysregulation has been reported as one of the hallmarks of LC, but the extent of LC immune dysregulation in patients over time remains unclear. We therefore assessed SARS-CoV-2-specific antibody responses, peripheral immune cell profiles, autoantibody profiles and circulating cytokines for up to 6 months in participants with a SARS-CoV-2 infection who either convalesced or developed LC. Compared to convalescent, LC participants with a broad range of LC phenotypes exhibited persistently elevated IgG titers for SARS-CoV-2 Envelope and Nucleocapsid proteins over the 6 months of study duration. In contrast, the IgG responses to Spike protein were significantly lower in the LC cohort with predominantly IgG1 and IgG3 class-switched bias. Using CyTOF analysis we show elevated numbers of circulating T follicular helper cells (cTFH) and mucosa- associated invariant T cells (MAIT), which also correlated with high anti-Envelope IgG titers. Persistent immune activation was accompanied by augmented serum cytokine profiles with LIF, IL-11, Eotaxin-3, and HMGB-1 in LC participants, who also demonstrated significantly higher rates of autoantibodies. These findings highlight the persistence of immune dysregulation in LC, underscoring the need to explore targeted therapies addressing viral persistence, dysregulated antibody production, and autoimmunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c4f9def96ecd7623891e3f4b4f5c72c22acebf31" target='_blank'>
              Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins
              </a>
            </td>
          <td>
            Jalees Rehman, Marcin Kwissa, Manikannan Mathayan, Satyajeet S. Salunkhe, Velavan Bakthavachalam, Zijing Ye, Mark A. Sanborn, Samantha Condo, Aditi Upadhye, Athulith Nemakal, Haoyang Wang, James Chan, Justin M. Richner, Sanjib Basu, Richard Novak, Jeffrey R. Jacobson, Balaji B Ganesh, Martha Cerda, Hassan Brim, Nathaniel Erdmann, Bruce Levy, Gailen Marshall, Grace McComsey, Torri Metz, Megumi Okumura, Michael Peluso, Tiffany Walker, Paul Utz, Jerry A. Krishnan, Bellur S. Prabhakar
          </td>
          <td>2026-01-08</td>
          <td>Research Square</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Cognitive dysfunction associated with type 1 diabetes (T1D) is closely linked to the accumulation of amyloid-beta (Aβ) oligomers. However, the role of microglia and their underlying molecular mechanisms in this process remain unclear. Triggering receptor expressed on myeloid cells 2 (TREM2), a microglial receptor critical for clearing neurotoxic Aβ and maintaining metabolic homeostasis, is dysfunctional in Alzheimer’s disease. Here, we investigated TREM2-mediated microglial dysfunction in diabetic neurodegeneration. To investigate the role of TREM2-mediated microglial dysfunction in Aβ clearance and cognitive impairment in T1D. A total of 204 male C57BL/6J mice, aged 6–8 weeks, were used in this study. We performed single-nucleus RNA sequencing (snRNA-seq) on 59,356 cells from the prefrontal cortex and hippocampus. Aβ pathology was evaluated by western blot, immunofluorescence and ELISA. TREM2 knockout mice and the murine microglial cell line BV2 were used to study the role of TREM2 in cognitive function and Aβ clearance. T1D mice exhibited progressive memory deficits and prefrontal Aβ oligomer accumulation (36–50 kDa), with region-specific microglial activation. SnRNA-seq identified ten microglial subpopulations, with Trem2-enriched clusters (M1/M2/M3/M5) showing impaired phagocytosis and metabolic dysregulation. TREM2 knockout exacerbated cognitive deficits and Aβ accumulation in T1D mice. Mechanistically, TREM2 regulated microglial migration, phagocytosis of Aβ oligomers, and mitochondrial integrity under high-glucose conditions, potentially via the mTOR signaling pathway. These findings establish TREM2 as a critical regulator of microglial Aβ clearance in T1D, operating mitochondrial and phagocytic programs via mTOR and highlighting its therapeutic potential for diabetic neurodegeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/504f67391ce0f3646645568c2d0f2a018f2f44cc" target='_blank'>
              Cognitive dysfunction in type 1 diabetes: role of TREM2 in microglial activation and Aβ pathology
              </a>
            </td>
          <td>
            Yue Wang, Ruyue Wang, Yimeng Liu, Zhaohui Wang, Hongyan Ding, Xinyi Wei, Aikeda Aihemaitijiang, Minghan Sun, Li Zhao
          </td>
          <td>2026-01-02</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Organ transplant recipients are at high risk of developing chronic infection when exposed to hepatitis E virus (HEV), which can rapidly progress to liver fibrosis and cirrhosis. Macrophages play a key role in the response to the infection and disease progression. However, the interactions amongst immunosuppressants, macrophages, the course of HEV infection and activation of inflammatory response remain unclear. In this study, we generated M0, M1 and M2 macrophages from the human THP‐1 cell line. These macrophages were then infected with HEV and treated with different immunosuppressants. We visualised viral infection using laser confocal microscopy, and quantitatively analysed viral replication and inflammatory responses by bulk sequencing, RT‐qPCR, ELISA and Western blotting. We found that the M1 inflammatory macrophages exhibited the highest, while M2 macrophages had the lowest levels of viral RNA. Genome‐wide transcriptome analysis indicated that viral, inflammation and immunity‐related pathways were predominantly upregulated by HEV infection. Dexamethasone exerted potent inhibitory effects on inflammatory response in macrophages. Mycophenolic acid (MPA) demonstrated inhibitory effects on viral replication, IL‐1β and TNF‐α expression, whereas mTOR inhibitors had the opposite effects, and tacrolimus showed no clear effect. In conclusion, immunosuppressants can differentially affect HEV replication and the subsequent inflammatory responses in macrophages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eac70274038702e260d9f4da11346625f1871599" target='_blank'>
              The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in Macrophages
              </a>
            </td>
          <td>
            Jiahua Zhou, Kuan Liu, P. Boor, Qiuwei Pan, I. Ayada
          </td>
          <td>2025-12-16</td>
          <td>Journal of Viral Hepatitis</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Inflammatory responses including glial activation, and upregulated inflammatory factors occurred after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected central nervous system. Blood-brain barrier (BBB) disruption has been implicated in coronavirus disease 2019 (COVID-19) pathogenesis and may predispose to the long-lasting neurological damage even after the epidemic ends. The BBB is a highly selective dynamic interface to protects the brain from neurotoxins and the elimination of byproducts of brain metabolism via efflux transporters. The COVID-19 pandemic has introduced new challenges in managing neurological conditions, and understanding SARS-CoV-2 journey through BBB and the interconnections between the members of BBB is crucial. This review aims to summarize and elucidate the damage to the main constituent cells of BBB, including brain microvascular endothelial cells, astrocytes, and microglia and its contribution to COVID-19. Further understanding of these interactions may facilitate the development of improved treatment options and preventative measures of central nervous system injury due to COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/85e1f8e6db59f325d648f88b5923eb205b1a3a64" target='_blank'>
              Exploring SARS-CoV-2 impact on blood-brain barrier and its composition: A review
              </a>
            </td>
          <td>
            Jin Li, Shangfu Xu, Sixu Guo
          </td>
          <td>2025-11-21</td>
          <td>Medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="In the context of neurodegeneration, activated microglia facilitate inflammation via secretion of TNF-α, IL-1α, and C1q. Astrocytes exposed to this signaling array polarize to a reactive inflammatory phenotype, termed A1 or A1-like. Astrocytes are essential for neuronal survival, synaptic support, and blood–brain barrier (BBB) function, but A1-like astrocytes upregulate inflammatory gene expression, downregulate neurotrophic factors, and secrete neurotoxic signals. The consequences of A1-like polarization on BBB function are unknown but may have etiological implications for some diseases. Frequently identified by upregulation of complement component 3 (C3), A1-like astrocytes have been characterized in neurodegenerative disorders like Alzheimer’s disease, with polarization correlated with disease progression and severity. However, the role of A1-like astrocytes in neurodegeneration associated with chronic viral infections, like HIV-1-associated neurocognitive disorder (HAND), remains unclear. An in vitro system using primary human astrocytes, as well as a BBB model featuring primary human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes, was used to elucidate cellular and molecular consequences of chronic astrocyte activation. As measured by whole transcriptome analysis and protein expression assays, repeated treatment with TNF-α, IL-1α, and C1q induced A1-like polarization of astrocytes both in monoculture and in a BBB model, resulting in increased secretion of pro-inflammatory signals. No substantial change to BBB permeability was observed. In contrast, exposure to HIV-1 viral protein Tat did not independently induce A1-like polarization. Ongoing investigations into the effect of astrocyte polarization on BBB integrity and treatment with pathogenic proteins may provide insights into the role of neurotoxic astrocytes in neurovirologic pathologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33a034aeaf82d86cd18ab74f1a0b8c466df7ff53" target='_blank'>
              Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat
              </a>
            </td>
          <td>
            Jill M. Lawrence, W. Dampier, J. Mell, Diehl R. De Souza, Kayla Schardien, Kyle Yeakle, R. J. Barnett, Bhaswati Sen, Azad Ahmed, Michael Bouchard, Brian Wigdahl, Micheal Nonnemacher
          </td>
          <td>2025-12-04</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="mRNA vaccines have shown high efficacy against SARS-CoV-2, yet orchestration of innate and adaptive responses in infection-naïve individuals remains incompletely characterized. Understanding these dynamics in people without prior infection is essential for defining baseline immune trajectories and providing a reference for future studies. We conducted a longitudinal study in SARS-CoV-2-naïve adults who received two doses of the BNT162b2 vaccine. Peripheral blood was analyzed by flow cytometry to quantify monocyte, NK, T, and B cell subpopulations, and serum cytokines were measured by multiplex assays. Data were evaluated with Z-score normalization and paired comparisons. Monocyte subsets segregated into two groups: one with progressive decline and another with transient activation. NK cells displayed multiphasic activation, particularly after booster. CD4+ and CD8+ T cells differentiated toward central and effector memory phenotypes, while B cells showed evidence of germinal center engagement followed by memory refinement. Cytokine fluctuations, including interferon-related signals, paralleled cellular dynamics. The booster was associated with re-engagement of innate components and amplification of adaptive responses. BNT162b2 vaccination in naïve individuals induces a coordinated sequence in innate and adaptive compartments, culminating in memory T and B cells. These findings align with current literature and provide trajectories to inform immune monitoring and optimization strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec63f2d70eca68584542e62e194ff95891698efb" target='_blank'>
              Primary immune trajectories following a single BNT162b2 vaccination scheme in SARS-CoV-2-naïve individuals.
              </a>
            </td>
          <td>
            Miguel Leonardo Méndez Rodríguez, A. Ponciano-Gómez, Myriam Campos-Aguilar, Wilfrido David Tapia-Sánchez, Carlos Leonardo Duarte-Martínez, Jesús Salvador Romero-Herrera, Sandra Olivas-Quintero, A. Saucedo-Campos, Jaciel Ivan Lopez-Sanchez, A. René Méndez-Cruz, Rafael Jiménez-Flores, Héctor Romero-Ramírez, Leopoldo Santos-Argumedo, V. Rosales-García, Vianney Ortiz-Navarrete
          </td>
          <td>2026-01-13</td>
          <td>European journal of microbiology & immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Immunocompromised hosts (ICHs) face elevated risks of severe respiratory infections and mortality. Glucocorticoids, commonly used to treat underlying conditions in ICHs, may further impair immune defenses, but the underlying mechanisms remain unclear. Retrospective analysis of peripheral blood immune cell profiles was conducted in pneumonia patients with ICHs. Prospective immunophenotyping of PBMCs by Cytek flow cytometry was performed to compare immune cell subsets in survivors versus deceased patients. To explore glucocorticoid effects on ICH immune mechanisms, we used a murine model of severe pneumonia (MRL/lpr mice) and an in vitro ICH infection mimic model. Glucocorticoid effects on immune cell populations and function were examined in these models. Focusing on key immune cells, we observed that ICH patients with severe pneumonia exhibit a reduction in classical monocyte subsets. Mechanistically, glucocorticoids downregulated CCL2 expression in the lung via GR/STAT3, thereby inhibiting the PA-LPS/TLR4/PI3K/AKT/STAT signaling pathway and diminishing pulmonary CCL2 and Ly6C+CCR2+ monocyte levels. Importantly, exogenous recombinant CCL2 administration restored monocyte function, reduced lung injury, and enhanced survival. These findings uncovered a critical immunosuppressive mechanism by which glucocorticoids, via GR/STAT3-mediated suppression of the CCL2-CCR2 axis, impair monocyte-driven antibacterial responses in severe pneumonia, highlighting the need for targeted immunomodulation in ICH patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d9b4bf1673b01f4644488331e3a225c1f792b5eb" target='_blank'>
              Glucocorticoid-mediated suppression of the CCL2-CCR2 axis drives monocyte dysfunction in severe pneumonia among immunocompromised hosts
              </a>
            </td>
          <td>
            Zhongshu Kuang, Yue Luo, Yao Chen, Yilin Yang, Chen Chen, Feixiang Xu, Yumei Chen, Yannan Zhou, Yongqi Shen, Li Yuan, Hua Su, Chaoyang Tong, Zhenju Song
          </td>
          <td>2025-11-26</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a80bbb3790bf37a49652e840f00b66c360bfe299" target='_blank'>
              Monomeric C-reactive Protein Exacerbates Neuronal Injury and Enhances Microglial Activation after Global Cerebral Ischemia in Mice
              </a>
            </td>
          <td>
            Gaowei Pan, Xiaoling Liu, Xiaoyue Zhang, Hao Gao, Ting Xu, Kemin Li, Lei Wang, Shangrong Ji, Ting Li, Shengxiang Zhang
          </td>
          <td>2025-12-29</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="The pathological basis underlying mild traumatic brain injury (mTBI)-induced long-term cognitive impairment is not fully understood. It is supposed that mTBI induces residential microglia activation rather than peripheral leukocyte infiltration to promote neuroinflammation, thus triggering myelin damage as well as cognitive impairment. The transformation of microglia towards a pro-inflammatory (M1 type) or anti-inflammatory (M2 type) state is critical for restraining the cerebral inflammatory response to acute or chronic insults. In addition to classical M1- and M2-like phenotypes, a specific subgroup of microglia, which is referred to as disease-associated microglia (DAM), the transition of which is regulated by triggering receptor expressed on myeloid cells 2 (Trem2), is also demonstrated to play a critical role in neurodegenerative diseases sharing similar pathological procedures to mTBI. The expression and function of p75 neurotrophin receptor (p75NTR) in microglia vary depending on the type and severity of the specific pathological stimuli. In the current study, we investigated whether peripheral leukocytes infiltrated the brain following mild traumatic brain injury (mTBI) using a CX3CR1- and CCR2-double transgenic reporter mouse model. We also examined whether M1- or M2-like microglia exhibited a disease-associated microglia (DAM) phenotype after mTBI, as indicated by their Trem2 expression. Then we explored the expression of p75NTR in M1- and M2-like phenotype microglia after mTBI and its modulating effects on the activation of Trem2 positive M1- and M2-like phenotype microglia, neuroinflammatory reaction, myelin damage, and cognitive performance. We found that most of the activated residential microglia after mTBI were Trem2 positive and p75NTR expression was significantly elevated in Trem2-positive M1-type microglia post-mTBI, correlating with increased pro-inflammatory cytokine release, demyelination, and cognitive deficits. Pharmacological blockade of p75NTR using the antagonist TAT-Pep5 suppressed M1 microglial activation, reduced neuroinflammation, and restored myelin integrity, leading to marked improvements in cognitive function. Mechanistically, p75NTR exhibited a cell-type-specific regulatory role in neuroinflammatory responses, potentially through interacting with Trem2 to modulate DAM-like microglia activation. These findings highlight p75NTR as a key mediator of mTBI-induced neuropathology and propose its inhibition as a novel therapeutic strategy to mitigate secondary neuroinflammation and cognitive decline.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16e198b3417a003759562d868d4c4717b845f885" target='_blank'>
              P75NTR blockading inhibits Trem2+ M1 phenotype microglia activation and myelin damage following mild traumatic brain injury
              </a>
            </td>
          <td>
            Xu Li, Zhen Xu, Jing Fang, Hua-Dong Huang
          </td>
          <td>2026-01-07</td>
          <td>Frontiers in Neuroscience</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="There are multiple reports of elevated inflammation in patients with major depression. It is, however, unclear whether these reported perturbations in immune functions in depression affect the general functionality of the peripheral immune system. Here, using single-cell RNAsequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) extracted from blood samples collected prior to a flu vaccination administration/immunization (at baseline), we found downregulated T cell and B-cell-associated gene expression repertoire coupled with a selectively upregulated plasmablast, CD14 classical monocytes, and natural killer (NK) proliferating cell-associated gene expression in 9 depressed patients (6 females) compared to 5 healthy controls (5 females), as well as in association with depression ratings. Our cell type proportion analysis revealed shifts in immune cell populations, specifically reduced numbers of CD4+ T and CD8+ T proliferating cells, plasmablasts, and NK cells in individuals with depression compared with controls. In contrast, we found increased numbers of CD14 classical and CD16 monocytes as well as doublet cells in depressed individuals compared with controls. Although our baseline and flu vaccine challenge did not show marked differences in peripheral immune markers measured by a multiplex cytokine assay, our results suggest impaired innate and adaptive immune responses at the transcriptomic and cellular population levels in depressed patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2cf073f7c3882ea32b466937ec788669b0a8b86" target='_blank'>
              Immune System Alterations in Depression across Baseline and Flu Vaccine Challenge
              </a>
            </td>
          <td>
            D. Arasappan, Alyssa Marron, Sina Sanei, Mbemba Jabbi
          </td>
          <td>2025-12-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="In the healthy brain, microglia maintain homeostasis by continuously surveying neuronal health through highly dynamic processes that form purinergic junctions with neuronal somas. These mechanisms are finely tuned for the rapid detection of acute injuries. However, during the transition to a chronically reactive state in neurodegenerative diseases, microglial ramification decreases even as the need for neuronal monitoring escalates. How reactive microglia adapt their surveillance strategies under these conditions remains poorly understood. Using time-lapse imaging of acute brain slices from prion-infected mice, we identified a previously unrecognized mode of neuronal surveillance employed by reactive microglia. Unlike homeostatic microglia, which exhibit low somatic mobility and high process motility, enabling broad, simultaneous monitoring, reactive microglia display high somatic mobility. These cells actively migrate through the brain parenchyma, pausing to form direct and extensive body-to-body contacts with individual neurons. Contact durations ranged from minutes to several hours, often involving partial or full somatic envelopment, with transitions between these states being both frequent and reversible. Notably, reactive microglia exhibited sustained intracellular calcium bursts correlated with their increased mobility. Pharmacological inhibition of the P2Y6 receptor partially reduced microglial migration without disrupting their ability to form neuronal contacts. Furthermore, this highly mobile behavior persisted in acutely isolated reactive microglia in vitro, even in the absence of external stimuli, indicating that dynamic mobility is an intrinsic feature of the reactive phenotype. These findings reveal a fundamental shift in microglial surveillance architecture during chronic neurodegeneration – transforming from static, multi-neuron monitoring to dynamic, neuron-by-neuron engagement. This work uncovers a novel, adaptive strategy of microglial behavior with critical implications for understanding microglia–neuron interaction under chronic neurodegeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/06292b0cfbd8784cd935c3bb3643c8eee123816d" target='_blank'>
              Dissecting surveying behavior of reactive microglia under chronic neurodegeneration
              </a>
            </td>
          <td>
            Sunitha Subhramanian, Olga Bocharova, N. Makarava, Tarek Safadi, I. Baskakov
          </td>
          <td>2026-01-08</td>
          <td>eLife</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d58d659e01646033f54b4d5e7e8ed88c2867fb7" target='_blank'>
              Microglia Mitochondrial Metabolism in Neurological Diseases
              </a>
            </td>
          <td>
            Jin Wang, Yikun Gao, Qing Chen, Xiaoxing Xiong, Sen Miao, Xuemei Chen, Youjia Tang, Lijuan Gu
          </td>
          <td>2026-01-01</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bd34010aa1ea1210d34d9e69c2b56f53fe420294" target='_blank'>
              TLR3 Activation of Microglia-Containing Cerebral Organoid Induces Antiviral Factors against HIV-1 Infection
              </a>
            </td>
          <td>
            Qianhao Xiao, Xu Wang, Priyanka Sarkar, Xiao-Long Wang, Li Song, Binhua Ling, Wenhui Hu, Wen-Zhe Ho
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) pneumonia is prevalent in the elderly infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, the mechanisms underlying its age-dependent pathogenesis remain unclear. In this study, we established a mouse-adapted SARS-CoV-2 strain infected Nr4a3-Tocky mouse model to examine T-cell dynamics associated with disease severity. Nr4a3-Tocky mice allow the analysis of the dynamics and induction of antigen-reactive T cells following antigen recognition in vivo using fluorescent Timer protein. SARS-CoV-2-infected adult mice exhibited transient body weight loss and recovery, whereas aged mice developed severe pneumonia. BALF viral RNA was comparable between 1-4 days post-infection (d.p.i.), but declined in adults at 5 d.p.i. Aged mice displayed stronger inflammation as indicated by scRNA-seq, and higher levels of inflammatory cytokines (TNF-α, CCL2, CXCL10 and IL-6) in BALF correlated with weight loss. Timer analysis revealed induction of antigen-reactive T cells in the adult lungs at 5 and 8 d.p.i., which inversely correlated with disease severity. Additionally, S-specific IFN-γ ⁺ CD8 ⁺ T cells were detected at 5 d.p.i. in adults, whereas detection of antigen-specific T cells was delayed in aged mice. These results suggest that the coexistence of age-related lung inflammation and delayed induction of antigen-specific T cells is linked to more severe pneumonia, while earlier T-cell responses are associated with improved viral control and milder disease. In this study, we utilized a novel mouse model enabling characterization of antigen-reactive T cells in the local tissue, and investigated inflammatory responses in the lung together with lung-infiltrating virus-specific T cells, finding the dynamics of these immunological parameters associated with the age of the mice. Our analysis provides new insights into understanding how age-related T-cell dysfunction is associated with the severity of SARS-CoV-2 pneumonia.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/26d80e657921afbee11ed57efcbb48ed233ef470" target='_blank'>
              Dynamics of lung-infiltrating virus-specific T cells associated with age-dependent SARS-CoV-2 pneumonia severity.
              </a>
            </td>
          <td>
            Rise Kurokawa, Chatherine Silas Mtali, Innocent John Daniel, Thorbjorg Einarsdottir, Omnia Reda, Nobuko Irie, Wajihah Sakhor, Koki Niimura, Mitsuyoshi Takatori, Kenji Sugata, C. A. Tye, Yorifumi Satou, Masahiro Ono, Takushi Nomura
          </td>
          <td>2026-01-14</td>
          <td>PLoS pathogens</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Microglial deformation and migration represent the final stages of inflammatory cytokines release, a key contributor to Alzheimer's disease (AD) pathology. However, the upstream regulators that initiate these morphological and functional changes in microglia remain unclear. In this study, we observed marked cytoskeletal reorganization in the hippocampal microglia of 2VO rats at 8 weeks, indicative of a shift from a homeostatic to a pro-inflammatory state. Notably, Tincr expression was significantly downregulated in both the microglia of 2VO rats and the hippocampi of AD patients. Tincr knockdown promoted microglial deformation and migration, accompanied by enhanced cytokines release and phagocytic capacity. These morphological changes correlated with redistribution of non-muscle myosin IIA ( NM IIA) and reduced expression of MYPT1, both in vitro and in vivo, effects that were reversed by Tincr overexpression. Genetic rescue of Mypt1 restored MYPT1 levels and attenuated Tincr-deficiency-induced microglial deformation in the hippocampi of 5xFAD mice. Mechanistically, Tincr enhanced MYPT1 protein expression through dual: functioning as a competing endogenous RNA (ceRNA) that sponged miR-153-3p, and serving as a direct protein-binding scaffold for MYPT1, thereby suppressing NM IIA phosphorylation and stabilizing microglial structure. These findings identify the Tincr-MYPT1-NM IIA axis as a critical regulatory pathway underlying chronic cerebral hypoperfusion (CCH)-induced microglial deformation and dysfunction, offering a novel mechanistic insight into the pathogenesis of neuroinflammation in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/735cc1335f6e27866e5b2fe126516d3341ff70fb" target='_blank'>
              Tincr protects against cognitive decline by upregulating MYPT1 mediated phosphorylation of structural protein NM IIA in microglia
              </a>
            </td>
          <td>
            Qin Wang, Liyang Sun, Jing Ma, Aiping Qiu, Guitian Cong, Xiaobin An, Y. Qu, Mingyou Zhang, Xuqiao Wang, Lu Zeng, Jinan Yang, Yan Wu, Haining Chen, Jiaqi Liu, Fucong Han, Dongyang Wang, Tao Wang, Jing Ai
          </td>
          <td>2025-12-01</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c515ee3e9e86703752ec072206a806bfdf0f76b3" target='_blank'>
              SLAMF1-peptide mediated epigenetic priming reprograms innate immune responses in sepsis
              </a>
            </td>
          <td>
            Sindre Ullmann, Birgitta Ehrnström, Jørgen Stenvik, S. Pinto, Yashwanth Subbannayya, Victor Boyartchuk, I. Mestvedt, Mahamaya Dhaware, Siddhesh S. Kamat, L. Ryan, Hilde Vagle, T. Dahl, B. Halvorsen, J. K. Damås, T. Espevik, Maria Yurchenko
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>71</td>
        </tr>

        <tr id="The long-term immunological effects of prior Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in people living with Human Immunodeficiency Virus (HIV) remain poorly understood. This study aimed to characterize plasma proteomic alterations associated with previous SARS-CoV-2 infection in HIV-infected individuals and to identify potential biomarkers and affected pathways. High-throughput liquid chromatography–tandem mass spectrometry (LC–MS/MS) was performed on plasma obtained from three groups: HIV-infected individuals with documented prior SARS-CoV-2 infection, HIV-monoinfected individuals, and healthy controls. A total of 13,675 proteins were identified. Hierarchical clustering and sparse partial least squares discriminant analysis revealed distinct proteomic profiles in the prior-SARS-CoV-2 group. Ten proteins with the highest discriminatory power—PRR11, TEX14, METTL9, NMD3, PXT1, CRISP2, MELK, SPF27, GCP6, and GTPBP8—were associated with cell cycle regulation, RNA processing, apoptosis, mitochondrial function, and cytoskeletal organization. Subcellular localization indicated predominant nuclear and cytoplasmic involvement, suggesting alterations in transcriptional regulation and intracellular structural dynamics. These signatures imply that preceding SARS-CoV-2 exposure may compound HIV-associated immune dysregulation and disrupt cellular homeostasis. The findings offer novel molecular insights into the persistent biological impact of SARS-CoV-2 in the context of HIV and identify candidate proteomic biomarkers with potential utility for risk stratification and targeted intervention in immunocompromised populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e603a3eec42ec77b104560dc9bb5835ed1851d4" target='_blank'>
              Plasma proteomic signatures in HIV-infected individuals post-SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Chayanin Chanthara, Janya Khattiya, S. Roytrakul, C. Akekawatchai, Narumon Phaonakrop, Nattamon Niyomdecha
          </td>
          <td>2025-12-09</td>
          <td>BMC Infectious Diseases</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="ABSTRACT In the context of COVID-19, macrophages are primarily responsible for sensing and responding to the virus, significantly influencing disease outcomes. They are involved in early pathogen recognition, immune activation, and tissue repair. Heterogeneity and phenotypic plasticity of macrophages are dynamically shaped by microenvironmental cues, including metabolites, hypoxia, and pathogen-derived signals. Notably, emerging evidence underscores that cellular metabolism, particularly in macrophages, dictates immune responses to viral infection. This metabolic-immune crosstalk critically determines COVID-19 severity, ranging from viral clearance to hyperinflammation or fibrosis. In this review, we systematically dissect how cell-intrinsic metabolic nodes and extrinsic factors modulate macrophage effector functions, while illustrating the complications associated with macrophage metabolic dysregulation in SARS-CoV-2 infection. These mechanistic insights provide a rational foundation for therapeutic strategies targeting macrophage metabolism to rebalance immune responses and mitigate COVID-19 complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a2e1bb8d0dab5824b185f810e0cd5ef78deac45" target='_blank'>
              Metabolic control of macrophages in coronavirus disease 2019
              </a>
            </td>
          <td>
            Li An, Houxi Xu, Qiaoling Fan, MengJiang Lu, Dongdong Sun
          </td>
          <td>2025-12-23</td>
          <td>Virulence</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="This review explores the interplay between SARS-CoV-2 and HIV-1 infections within the human brain, highlighting the significant neurological implications of these viral infections. SARS-CoV-2 can infect the central nervous system (CNS), with evidence of the virus detected in various brain regions, including the hypothalamus, cerebellum, and olfactory bulb. This infection is linked to microglial activation and neuroinflammation, which can lead to severe neurological outcomes in affected individuals. Autopsy studies revealed microglial changes, including downregulation of the P2RY12 receptor, indicating a shift from homeostatic to inflammatory phenotype. Similar changes in microglia are found in the brains of people with HIV-1 (PWH). In SARS-CoV-2, the correlation between inflammatory cytokines, such as IL-1, IL-6, and MCP-1, found in cerebrospinal fluid and brain tissues, indicates significant neurovascular inflammation. Astrogliosis and microglial nodules were observed, further emphasizing the inflammatory response triggered by the viral infections, again in parallel to those found in the brains of PWH. Epidemiologic data indicate that although SARS-CoV-2 infection rates in PWH mirror those in People without HIV (PWoH) populations, Long-COVID prevalence is markedly higher among PWH. Evidence of overlapping cognitive impairment, mental health burden, and persistent neuroinflammation highlights diagnostic complexity and therapeutic gaps. Despite plausible mechanistic synergy, direct neuropathological confirmation remains scarce, warranting longitudinal, biomarker-driven studies. Understanding these interactions is critical for developing targeted interventions to mitigate CNS injury and improve outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a0ebece59d92a56c77aa4f6d9df14d6fa82e5c4" target='_blank'>
              Synergy of SARS-CoV-2 and HIV-1 Infections in the Human Brain
              </a>
            </td>
          <td>
            Rajnish S. Dave, Howard S. Fox
          </td>
          <td>2026-01-13</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="AIMS
Patients with cardiovascular disease (CVD) have an increased risk of developing severe respiratory infections, including COVID-19. However, the underlying molecular mechanisms are not completely understood. It has been previously shown that cardiovascular disease predisposes to an altered responsiveness to subsequent inflammatory triggers by an imprinted epigenetic memory in innate immune cells. Therefore, we hypothesized that patients with preexisting atherosclerotic cardiovascular disease (ASCVD) and COVID-19 display a dysregulated inflammatory response compared to patients without ASCVD due to epigenetically altered immune cells leading to increased disease severity.


METHODS AND RESULTS
Single-cell RNA sequencing revealed a dysregulated myeloid immune response with hyperinflammatory and immunosuppressive features in patients with ASCVD and moderate COVID-19. Assay for Transposase-Accessible Chromatin sequencing and in-vitro experiments with isolated monocytes infected with SARS-CoV-2 showed epigenetic priming of monocytes from patients with ASCVD towards increased expression of inflammatory mediators and type I interferon signalling. In a German nationwide cohort (NAPKON), using multiplex cytokine assays, enzyme-linked immunosorbent assays, and bulk-RNA-sequencing, we confirmed that patients with ASCVD display an exaggerated inflammatory response during moderate COVID-19.


CONCLUSIONS
This study demonstrates that patients with ASCVD show a dysregulated myeloid immune response in moderate COVID-19 disease. Mechanistically, epigenetic imprinting sensitizes myeloid cells of patients with ASCVD to an exaggerated type I interferon-associated immune response.


TRANSLATIONAL PERSPECTIVE
This study evaluates the underlying molecular mechanisms of worse outcomes of patients with atherosclerotic cardiovascular disease during respiratory infections, specifically COVID-19. Patients with atherosclerotic cardiovascular disease present with a dysregulated hyperinflammatory, type I interferon-driven immune response already during moderate COVID-19. This not only explains a major risk factor for severe COVID-19 but might also enable targeted therapies for this specific risk group.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/417901a925ab6ef7f438ab3c6409b92a5127c60d" target='_blank'>
              Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
              </a>
            </td>
          <td>
            J. Leberzammer, W. Abplanalp, Katharina Grikscheit, Emmanouil G. Solomonidis, S. Glaser, B. Schuhmacher, Maximilian Merten, Gligorije Jeremijev, A. Wilken-Schmitz, Lara Korth, David John, S. Günther, C. Kuenne, Mario Looso, C. Valasarajan, V. Beneš, Ferris Jung, Vivianne Niehaus, Gabriele Anton, Christoph Stellbrink, C. Römmele, S. Göpel, Soni S Pullamsetti, J. Vehreschild, M. Vehreschild, S. Ciesek, David M. Leistner, Andreas M. Zeiher, S. Dimmeler, S. Cremer
          </td>
          <td>2025-12-13</td>
          <td>Cardiovascular research</td>
          <td>0</td>
          <td>159</td>
        </tr>

        <tr id="ABSTRACT After antigen encounter, long‐lived antibody‐secreting cells (ASC) secrete high‐affinity circulating antibodies. In addition, memory B cells (MBC) are quickly reactivated upon antigen re‐exposure and predominantly generate shorter‐lived ASCs. Studies have suggested that MBC can differentiate into ASCs without recognizing their cognate antigen, a process known as “bystander activation”. This antigen‐independent reactivation of MBC could help maintain circulating antibody levels, thereby protecting against future infections. To elucidate whether SARS‐CoV‐2 mRNA vaccination leads to bystander activation of B cells, the dynamics of antibody concentrations against six pathogen‐specific antigens not encountered during the sampling period were analyzed over time. Deep profiling of antigen‐specific B cell responses was simultaneously performed using multiparameter high‐dimensional spectral flow cytometry. Antibody concentrations against tetanus toxoid (TT), respiratory syncytial virus (RSV), and influenza hemagglutinin (HA) unexpectedly increased 6 weeks after the first SARS‐CoV‐2 vaccination. Deep profiling of B cell differentiation stages demonstrated a short‐term increase in influenza‐specific IgG+ DN3 B cells, RSV‐specific IgG+ CD11c+ activated B cells, and TT‐specific IgG+ MBC following vaccination. In this study, we demonstrated at both the antibody and cellular levels that SARS‐CoV‐2 mRNA vaccination transiently activates distinct early activated B cell compartments directed against influenza HA, RSV, and TT.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f900c073d1085623f61904044b055568f8e6e7fd" target='_blank'>
              SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults
              </a>
            </td>
          <td>
            Lisan H Kuijper, L. Kummer, Laura Fernandez Blanco, K. van der Straten, M. Claireaux, A. Bos, Miranda C Dieker-Meijer, T. Jorritsma, M. Duurland, M. Steenhuis, Juan J Garcia Vallejo, K. V. van Dam, E. Stalman, L. Wieske, S. Tas, L. Boekel, Gert-Jan Wolbink, T. Rispens, T. Kuijpers, F. Eftimov, M. van Gils, A. ten Brinke, S. V. van Ham
          </td>
          <td>2026-01-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="The mechanisms of the chronic inflammatory response in smoking-induced chronic obstructive pulmonary disease (COPD) remain unclear, with limited understanding of T cell responses to smoke exposure in lung tissue and circulation. We characterized the alterations in T cells associated with smoke exposure using single-cell RNA sequencing, TCR sequencing, and flow cytometry-based validation. Our experiments show significant recruitment of T cells within the airways, exhibiting a multifaceted immune profile, augmented TCR clonal diversity, and a prolonged CDR3 length. Notably, smoke-induced γδ T cells, particularly clonally expanded γ6δ4 T cells with high Il17a expression, accumulate in smoke-induced airway inflammation. Despite arising in inflammation, these cells function in a protective manner: γδT17 deficiency worsens smoke-induced lung injury, whereas adoptive transfer of γδT17 cells restores tissue protection in smoke-exposed lungs over time. Here, we show γδT17 cells as a potential target for addressing smoke-induced immune dysfunctions, providing alternative avenues for early prevention and treatment of COPD. T cells have been shown to have a function in chronic lung inflammation in COPD. Here the authors characterise the single cell transcriptional profile of T cells after smoke inhalation in mouse models showing changes in TCR repertoire and Il17a expression in γδ T cells, suggesting smoke-associated γδ T cells are involved in COPD inflammation and implicating γδT17 cells as a possible target for early prevention and treatment of COPD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c72bfc4278bed289c335fdcb150aff219f94dd9e" target='_blank'>
              Comprehensive profiling of smoke-induced T cells in mice implicates clonal γδT17 cells as a hallmark of COPD
              </a>
            </td>
          <td>
            Xinyue Mei, Junxiang Wang, Yuan Wang, Li Cheng, Xiaoyu Wang, Xinyuan Liu, Ge Bai, Jiaying Zhong, Mingzhu Huang, Suyin Huang, Peiyu Huang, Jieda Cui, Yu Liu, Qianmei Wen, Ruiting Sun, Erkang Yi, Fan Wu, Xiaohui Wu, Ziqing Yuan, Q. Wan, Xiaoyang Zheng, Yujie Zuo, Jingwei Zhang, Leqing Zhu, Yumin Zhou, Zhongfang Wang, Pixin Ran
          </td>
          <td>2025-12-08</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="


 Microglia are the primary immune cells in the central nervous system (CNS); however, their temporal and spatial responses to traumatic brain injury (TBI) at the single-cell level remain poorly defined. This study aimed to map the dynamic microglial responses to TBI using single-cell transcriptomics and validate key signaling pathways
 in vitro
 .





 A single-cell transcriptomic atlas was reconstructed from publicly available datasets comprising cortical, hippocampal, and blood samples from 35 mice (11 blood, 12 cortex, and 12 hippocampus) subjected to TBI or sham treatment at 24 h and after 7 days. Comparative analyses were conducted to investigate the heterogeneity of myeloid cells, including monocytes, macrophages, and microglia, with a particular focus on activated microglia. The key findings were further validated using quantitative PCR (qPCR) in an
 in vitro
 TBI-mimicking model, employing lipopolysaccharide (LPS)-stimulated microglial cell lines to assess changes in gene expression.




 TBI induced rapid immune remodeling, including an increase in activated microglia in the cortex, enriched in leukocyte differentiation pathways, and elevated macrophage populations in the cortex and hippocampus, enriched in chemotaxis functions at 24 h. Ligand–receptor (LR) analysis revealed three major signaling axes—Ccl2/Ccl7–Ccr2, Tnf–Tnfrsf1b, and Grn–Flna—associated with monocyte recruitment, M1 polarization, and macrophage differentiation. Validation using qPCR confirmed significant upregulation of Ccl2, Tnf, and Grn in LPS-stimulated microglia, which is consistent with single-cell findings.



 This study provides the first integrative single-cell transcriptomic map of microglial–myeloid interactions after TBI across multiple tissues and time points, linking microglial signaling to mitochondrial dysfunction and neuroinflammation. These findings lay the foundation for therapeutic strategies targeting myeloid-driven immune regulation in TBI.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c5a17b04f4ec332fbc1802bd8c1e298ce5e68fd6" target='_blank'>
              Single-cell analysis of microglial activation after traumatic brain injury reveals immune signaling pathways linked to mitochondrial dysfunction and brain aging
              </a>
            </td>
          <td>
            Ming Sun, Chao Wu, Jingjing Wu, Lixin Liu, Liang Gu, Zihao Wang, Xue Yang, Feng Xu
          </td>
          <td>2026-01-09</td>
          <td>Frontiers in Aging Neuroscience</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis (Mtb) co-infection remains a major cause of mortality in AIDS patients, yet the mechanisms of pathogen interplay and host immune remodeling remain poorly understood. Methods To capture early untreated states, we applied single-cell RNA sequencing (scRNA-seq) to peripheral blood mononuclear cells from healthy controls, and from participants newly diagnosed with HIV mono-infection or HIV-Mtb co-infection, before therapy initiation. Integration guided by a Directed Acyclic Graph (DAG) inferred a pseudo-temporal trajectory from health to HIV infection to co-infection. Results Along this continuum, TNF-α and TGF-β signaling progressively declined in CD8+ T cells and monocytes. Th1 cells emerged as the dominant anti-tuberculosis effectors, whereas Th17 cells exhibited transcriptional exhaustion and ribosomal stress signatures consistent with a non-responsive state. Cell communication analysis revealed fewer overall interactions but increased signaling strength within pathways during co-infection. Notably, we observed a transition in T cell from MHC class II to class I, a shift that was most pronounced in the CD4+ effector memory subset. These rewired interactions featured selective upregulation of inhibitory checkpoint molecules (PGE2–PTGES3–PTGER2/4, PPIA-BSG, PECAM1) and loss of stimulatory signals (CD6-ALCAM, CLEC2B/C/D-KLRB1). Discussion Our study provides a single-cell roadmap of HIV-Mtb co-infection and identifies Th1/Th17 imbalance and MHC-I-biased T-cell signaling reconfiguration as candidate targets for restoring immune homeostasis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3079e80670107d8df959c9a9373c58fb84ac742d" target='_blank'>
              Single‐cell transcriptomics reveals pathogen interactions and T cell reprogramming in HIV and Mycobacterium tuberculosis co‐infection
              </a>
            </td>
          <td>
            Zihui Zhao, Suyue Huang, Wei Huang, Wei Song, Li Liu, Jun Chen, Ren-fang Zhang, Yinzhong Shen
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e66ca3285aa3fb2f5b1301f35111f35086a256eb" target='_blank'>
              Zika virus inhibits mitophagy to facilitate its replication
              </a>
            </td>
          <td>
            Qi Li, Xiaoxue Ding, Yong Yin, Xingchi Nie, Shengbo Cao, Jing Ye
          </td>
          <td>2025-11-28</td>
          <td>Animal Diseases</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a49c865b1c705b9bfe6bc7d206d36d45188ef570" target='_blank'>
              Neural CXCR4 contributes to neuroimmune modulation of atherosclerosis in a cardio-metabolic Ldlr⁻/⁻ mouse model
              </a>
            </td>
          <td>
            Yaqi Sun, R. Tom, Anna Götz, Sebastian Cucuruz, Annette Feuchtinger, Dominik Lutter, Y. Jansen, C. Weber, Yvonne Döring, Cristina García Cáceres, A. Kapurniotu, J. Bernhagen, T. Müller, Susanna M. Hofmann
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="African swine fever (ASF) is a highly contagious hemorrhagic disease caused by African swine fever virus (ASFV), which has inflicted devastating impacts on the global swine industry. Currently, no commercially available vaccines exist. A major obstacle in ASF research of mechanistic exploration and vaccine studies is the virus’s strict tropism for primary cells like porcine alveolar macrophages (PAMs), while exhibiting poor susceptibility to most immortalized cell lines. This study compared the replication and host response of the ASFV SY-1 strain in PAMs versus immortalized porcine macrophage cell lines (iPAMs) using qPCR, western blot, and early infection transcriptome data. Results revealed that the SY-1 strain replicates only minimally in iPAMs, with significantly lower replication capacity than in PAMs. Transcriptomic data demonstrated divergent host responses: iPAMs predominantly involved in in the regulation of lipid metabolism and response to oxidative stress, whereas PAMs preferentially activate cytokine signaling and immune responses. Furthermore, Functional validation indicated JPH4 and CYP1A1 (selected from differentially expressed genes list) as potential host factors influencing viral replication. This study delineates early host–virus dynamics in ASFV susceptible cells (PAMs) and restricted replicating cells (iPAMs), which not only provides an insight into the replication of ASFV but also improved rational design of antiviral strategies in ASF research.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43327ef974ead7f5fb634f703f8e597b4b8095fa" target='_blank'>
              Transcriptome analysis of differences in the infection of African swine fever virus (SY-1 strain) in iPAMs and PAMs
              </a>
            </td>
          <td>
            Haiying Mao, Chuxing Cheng, Yong Wang, Wenhui Zhou, Ke Zhang, Yongqi Wang, Lihao Wang, Zhenrui Song, Xiaomei Sun, Yuanfeng Zhang, Xiaotong Hu, Yumei Zhang, Zong Zou, Ya Zhao, Qiang Zhang, Meilin Jin
          </td>
          <td>2025-12-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="
 Since the emergence of SARS-CoV-2 in late 2019, substantial efforts have been made to understand its mechanisms of pathogenicity. Although angiotensin-converting enzyme 2 (ACE2) has been identified as the main receptor for viral entry, the complexity of the host immune response to different Spike protein conformations and variants remains poorly understood. Using zebrafish larvae as an
 in vivo
 model, we show that the monomeric S1 domain of the Omicron variant triggers a potent proinflammatory response characterized by elevated Nfkb activity and increased expression of key cytokines, despite reduced recruitment and expansion of neutrophils and macrophages. Notably, monomeric S1 Omicron also promotes neutrophil cell death, suggesting an alternative mechanism of immune modulation. In contrast, the trimeric form of the Spike protein fails to induce significant inflammation or emergency hematopoiesis, likely due to its efficient neutralization by endogenous Ace2. Our results revealed that both zebrafish and human ACE2 exert a dual anti-inflammatory role: indirectly through the production of angiotensin-(1-7), and directly by binding and neutralizing the trimeric Spike. These results provide new insights into variant-specific immune responses and the multifaceted role of ACE2 in modulating SARS-CoV-2-induced cytokine storm syndrome.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0ca72bd55ea95e6ec10136fbdf6de706bf156d6" target='_blank'>
              Dual role of ACE2 in regulating inflammation triggered by Omicron S1 and other SARS-CoV-2 Spike variants
              </a>
            </td>
          <td>
            Annamaria Pedoto, Juan M Lozano-Gil, María Ocaña-Esparza, Ana M Conesa-Hernández, S. Candel, M. Cayuela, Victoriano Mulero, S. D. Tyrkalska
          </td>
          <td>2026-01-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="The COVID-19 pandemic has profoundly affected societies around the world. Although the emergency phase of coronavirus disease 2019 (COVID-19) has ended, the threat it poses remains persistent. This review aims to clarify the mechanisms of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection to support effective management of the disease. A central focus is the host cellular response to the viral infection, with particular emphasis on the role of cytokines. Cytokines play a dual role in antiviral defense: they contribute to the inhibition of viral replication and facilitate the clearance of pathogens, yet dysregulated cytokine responses can result in severe immunopathology. Interferons (type I, type II, and type III) and other cytokines are pivotal in activating intracellular antiviral mechanisms and in orchestrating the recruitment of immune cells through extracellular signaling. Effective immune responses to viral infections are governed not only by primary immune cells—such as dendritic cells, T lymphocytes, and B lymphocytes—but also by the local cytokine milieu shaped by infected and neighboring cells. Given the presence of endogenous inhibitors and autoantibodies in vivo, it is essential to evaluate the functional activity of cytokines in clinical samples. We propose a novel approach to quantify biologically active cytokine levels.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/549a84778c011cc8c3e8f33bdfcaf598bd26756a" target='_blank'>
              Host Responses to SARS-CoV-2 with an Emphasis on Cytokines
              </a>
            </td>
          <td>
            Hideki Hayashi, Yoshinao Kubo, Yoshimasa Tanaka
          </td>
          <td>2026-01-09</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="ZIKA virus (ZIKV) infections in human neonates and adults are associated with deleterious effects on brain cognition and neurological disorders. The mechanism(s) of ZIKV infection in neurons and associated neuronal antiviral responses are not fully understood. In this study, we determined the effects of ZIKV infectivity in human neuronal (SH-SY5Y) cells and mouse N2a cells/primary cultures of murine cortical neurons at early and late tested timepoints of infection. The human neuronal cells had higher ZIKV loads compared to the mouse N2a cells, but the viral loads in the murine cortical neurons were between the loads in these two in vitro cell lines. The murine cortical neurons were thought to be more permissive to ZIKV infection, but viral infection kinetics showed a declining trend like that observed in the mouse N2a cells. We noted that infectious extracellular vesicle (EV)-mediated ZIKV infection showed higher viral loads in the SH-SY5Y cells compared to direct infection with laboratory virus stocks. Similar results were obtained with ZIKV infectious EVs in the mouse N2a cells and cortical neurons. In addition, we noted that ZIKV infection significantly induced EV secretion from all three neuronal cells. Also, we found that ZIKV infection modulates the expression of type 1 interferons (IFNs) and entry receptors such as Tyro3, Axl, and MER-TK (TAM). Alongside the increased ZIKV loads in the SH-SY5Y cells, IFN-beta transcript levels and receptors Tyro3/MER-TK were upregulated at early timepoints of infection. Overall, the reduced ZIKV loads and decreasing IFN expression in the mouse neuronal cells suggested a unique murine cellular ability to restrict and limit viral replication. This could be one of the reasons for the unavailability of wild-type mouse models for ZIKV infection. Our data further shows that ZIKV may preferentially infect human rather than murine neuronal cells, and this could be the potential reason for microcephaly in newborns.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d2bbcba835793ffe7fbf7dbdc95e5db77870ad93" target='_blank'>
              Zika Virus Infection Is More Highly Replicative and Transmissible by Extracellular Vesicles in Human than in Mouse Neuronal Cells
              </a>
            </td>
          <td>
            Kehinde D. Fasae, Md Bayzid, Girish Neelakanta, Hameeda Sultana
          </td>
          <td>2025-11-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1babe6054c4059128d610e6cfbc8906c8e8c1b18" target='_blank'>
              IFNγ-Driven Inflammatory Responses in the Nasal Mucosa Drive Influenza Virus Shedding and Transmission
              </a>
            </td>
          <td>
            Stacey Bartlett, Hedy L. Rocha, Leon L. Hsieh, Stephen T. Yeung, Chan Wang, Grace O. Ciabattoni, Cynthia A. Loomis, Huilin Li, B. tenOever, M. Ortigoza
          </td>
          <td>2026-01-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/077d61a2f5398bd9d9325e4f8f0c44e0a25878aa" target='_blank'>
              Flu Virus Infection in Juvenile Mice Leads to Lifelong Multi-Organ Damage and Parkinsonian Pathological Changes in Aging
              </a>
            </td>
          <td>
            Ruina You, Cuicui Liu, Xun Liu, Xinglian Wang, Zhuoya Xu, Qian Huang, Guolin Dong, Chaoqun Liang, Na Wang, Zhichao Miao, Taijiao Jiang, Dayan Wang, Lei Deng, Yousong Peng
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), remains a major public health threat, particularly in vulnerable populations. SARS-CoV-2 spike proteins interact with the human angiotensin-converting enzyme 2 (ACE2) receptor, together with accessory molecules that facilitate viral entry, through its spike receptor-binding domain (RBD). Although ACE2 is the primary receptor required for viral replication, its expression patterns do not fully correlate with viral distribution or tissue pathology. Moreover, SARS-CoV-2 has been shown to infect cells and tissues lacking detectable ACE2 expression. Viral entry via ACE2-independent pathways may also confer resistance to some monoclonal antibodies (Abs) targeting the spike RBD that block ACE2-mediated binding. These observations highlight the potential significance of ACE2-independent entry factors in SARS-CoV-2 infection, particularly in vaccinated individuals with Abs directed against ACE2-dependent viral entry. In this review, we discuss the emerging roles of ACE2-independent entry factors in SARS-CoV-2 infection and the immune responses. These factors include CD147, AXL, CD169/Siglec-1, CD209L, CD209, CLEC4G, ASGR1, LDLRAD3, TMEM30A, TMEM106B, transferrin receptor 1, GPR78, integrin α5β1, KREMEN1, LFA-1, and CD4. While ACE2 remains central to viral replication, ACE2-independent entry appears sufficient to elicit immune responses. Therefore, future investigations are warranted to elucidate the roles of ACE2-independent mechanisms in immune-mediated pathology and viral evolution, independent of immune pressure targeting ACE2-mediated entry in previously infected or vaccinated individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/416f126df60ac30115fcfb6b97329efa70fd8c23" target='_blank'>
              ACE2-independent entry factors for SARS-CoV-2 infection and immune activation
              </a>
            </td>
          <td>
            Yiyu Sun, L. Wong, Theresa L. Chang
          </td>
          <td>2025-12-22</td>
          <td>mBio</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Post-COVID cardiac complications have emerged as a significant and persistent clinical concern, yet their underlying mechanisms remain poorly understood. Animal models can act as proxies to investigate the pathophysiology of the human, post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this experimental study was to evaluate the expression of inflammatory biomarkers in cardiac tissue 28 days after SARS-CoV-2 infection in a female hACE2 mouse model, with a focus on chemokine-mediated immune activation. Twelve female C57BL/6 hACE2 mice were infected with the Omicron variant (BA.1.17 lineage) of SARS-CoV-2, and eleven non-infected mice served as controls. Cardiac tissue was analyzed via Western blot for markers of innate immune activation (TLR4, MyD88, NF-κB) and pro-inflammatory cytokines (IL-6, IL-18, IL-1β, TNF-α, CD11d). Cardiac tissue injury markers (iNOS, PAI-1 and Connexin43) were also analyzed. Compared to non-infected mice, cardiac tissue from infected mice showed significantly higher expression of IL-6 (p = 0.028), indicating an inflammatory state, and CD11d (p = 0.016), suggesting an inflammatory stage accompanied by sustained activation of chemokine-mediated inflammatory signaling. No significant differences in TLR4 (p = 0.340), MyD88 (p = 0.410), NF-κB p65 (p = 0.780), IL-18 (p = 0.548), IL-1β (p = 0.455), and TNF-α (p = 0.125) expressions were observed Similarly, no changes in cardiac damage markers (iNOS: p = 0.4684; PAI-1: p = 0.5345; Connexin 43: p = 0.2879) were found. The results of this experimental study would support the hypothesis of persistent low-grade inflammation as a contributor to post-COVID cardiac sequelae in females that is not accompanied by severe tissue damage, as also observed in clinical studies. This study also reinforces the need for studies evaluating the functional and structural evolution of the myocardium after an acute SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8c71f525771ab829c5b8bbcdcdb88fac1b05cc46" target='_blank'>
              Cardiac Tissue Damage in a Female Animal Post-COVID Model: Relevance of Chemokine-Mediated Inflammation
              </a>
            </td>
          <td>
            Silvia Flaj-Prados, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Eva M. Sánchez-Robles, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="Persistent, unresolved inflammatory processes disrupt the complex homeostatic state and lead to severe disease, ultimately resulting in organ failure, shock, and death. The mediators that monitor and control the programmed mechanisms in tissue homeostasis and repair remain elusive. A recently discovered group of endogenous proteins, termed neuronal guidance proteins (NGPs), has gained attention as important mediators of immunoregulation and tissue homeostasis through their role in the complex interplay between metabolic reprogramming and immunity. In murine peritonitis, the deficiency of the NGP Plexin C1 (PLXC1−/−) led to an increase in neutrophil and Ly6Chi monocyte recruitment to the injury site and a decrease in the phagocytosis rate. This was accompanied by a decrease in the endogenous biosynthesis of specialized proresolving lipid mediators (SPMs) such as Maresin-1 and Protectin DX and finally by a lengthening of the resolution interval. Peritoneal macrophages (MΦs)PLXC1−/− followed specific strategies to adapt their metabolism to catabolic conditions, by reducing fatty acid oxidation and oxidative phosphorylation, increasing aerobic glycolysis and activation of the pentose phosphate pathway, and disrupting the tricarboxylic acid cycle. The decreased MΦsPLXC1−/− citrate levels corresponded with a lipid mediator profile in which PGD2 and PGE2 were greatly decreased in murine PLXC1−/− peritoneal exudates, indicating a lesser effect on lipid mediator class switching and ultimately the formation of SPMs. Analysis of the related signaling networks indicated mTOR and AKT2 phosphorylation pathways are critical determinants of metabolic reprogramming in activated MΦsPLXC1−/−. These findings highlight a novel role for PLXC1 in regulating the crosstalk between immunometabolism and inflammation resolution programs in severe inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142901da389dc4e201c184a92df6289f59bd6377" target='_blank'>
              Plexin C1 modulates metabolic programming for resolution of severe inflammation
              </a>
            </td>
          <td>
            Andreas Körner, Michael Koeppen, Jasvir Kaur, Julia C Fitzgerald, S. Kostidis, Torsten Kaussen, Christoph Trautwein, M. Giera, Tamam Bakchoul, Alice Bernard, V. Mirakaj
          </td>
          <td>2025-11-25</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="ABSTRACT Chikungunya virus (CHIKV) is an emerging, mosquito-borne alphavirus responsible for debilitating, long-lasting arthralgia and myalgia. In light of recent findings of prolonged CHIKV RNA shedding in human semen and testicular tropism in animals infected with related alphaviruses, it is imperative to investigate CHIKV's capacity to infect the human testis, an established reservoir for arboviruses like Zika, and to delineate its implications for testicular function. Using an ex vivo human testicular tissue model, we demonstrate that CHIKV rapidly infects peritubular myoid cells (PMCs) and a range of interstitial cells, with robust viral production peaking at day 3 before declining. Importantly, seminiferous tubule cells and isolated testicular germ cells proved nonpermissive to CHIKV infection, indicating a potential limitation for seminal shedding of virions. Infected testicular explants exhibited a broad antiviral response but limited pro-inflammatory cytokines upregulation. CHIKV replication in the testis induced apoptosis and cell death, with a marked impact on PMC markers including decreased transcriptional expression of genes crucial for PMC contractile properties and extracellular matrix production. In summary, our study highlights the susceptibility of human testicular tissue to CHIKV infection, marked by robust viral replication that primarily compromises PMC function. The observed cellular impairment and damage suggest that CHIKV infection might negatively affect key testicular functions, such as tubular contractility and sperm release. These findings warrant further investigation into semen parameters and viral shedding in CHIKV-infected men.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/db2223232e271cfdf9d6135d60998d17a29caaad" target='_blank'>
              Chikungunya virus replicates in the human testis ex vivo and impacts peritubular myoid cells functional markers
              </a>
            </td>
          <td>
            Matéo Cartron, Vincent Ciesielski, Laurent Houzet, Krishani Dinali Perera, Hervé Abiven, María José Lista Brotos, Ingrid Plotton, Romain Mathieu, Julien Branchereau, Laurent Martin-Lefevre, Pierre Roques, Dominique Mahé, Nathalie Dejucq-Rainsford
          </td>
          <td>2025-12-01</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/291cd1612c50d00cdb88e4ebcedd78749a7bb740" target='_blank'>
              Pathology and viral evolutionary dynamics in a hamster model of persistent SARS-CoV-2 infection.
              </a>
            </td>
          <td>
            Wanting Wei, M. Kuroda, Yanan Liu, S. Iida, Sangam Kandel, Heather Machovech, Yuichiro Hirata, Tadaki Suzuki, K. Koelle, Zhongde Wang, T. C. Friedrich, Yoshihiro Kawaoka, P. Halfmann
          </td>
          <td>2026-01-08</td>
          <td>Communications biology</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="The Flaviviridae are a family of viruses that include the important arthropod-borne human pathogens dengue virus, West Nile virus, Zika virus, Japanese encephalitis virus, and yellow fever virus. Flavivirus nonstructural protein 1 (NS1) is essential for virus replication but is also secreted from virus-infected cells. Extracellular NS1 acts as a virulence factor during flavivirus infection in multiple ways, including triggering endothelial dysfunction and vascular leak via interaction with endothelial cells. While the role of NS1 in inducing vascular leak and exacerbating pathogenesis is well appreciated, if and how NS1-triggered endothelial dysfunction promotes virus infection remains obscure. Flaviviruses have a common need to disseminate from circulation into specific tissues where virus-permissive cells reside. Tissue-specific dissemination is associated with disease manifestations of a given flavivirus, but mechanisms dictating virus dissemination are unclear. Here we show that NS1-mediated endothelial dysfunction promotes virus dissemination in vitro and in vivo. In mouse models of dengue virus infection, we show that anti-NS1 antibodies decrease virus dissemination, while the addition of exogenous NS1 promotes virus dissemination. Using an in vitro system, we show that NS1 promotes virus dissemination in two distinct ways: (1) promoting crossing of barriers and (2) increasing infectivity of target cells in a tissue- and virus-specific manner. The capacity of NS1 to modulate infectivity correlates with a physical association between virions and NS1, suggesting a potential NS1-virion interaction. Taken together, our study indicates that flavivirus NS1 acts as a viral toxin and promotes virus dissemination across endothelial barriers, providing an evolutionary basis for virus-triggered vascular leak.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2023654a8ed35317fc7298a2a03aeb81d2d210b7" target='_blank'>
              Flavivirus NS1-triggered endothelial dysfunction promotes virus dissemination
              </a>
            </td>
          <td>
            Henry Puerta-Guardo, Scott B Biering, Bryan Castillo-Rojas, Michael Dibiasio-White, Nicholas T. N. Lo, Diego A Espinosa, C. Warnes, Chunling Wang, Thu Cao, Dustin R. Glasner, P. Beatty, Richard J Kuhn, Eva Harris
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Myopia is a leading cause of visual impairment, with its prevalence rising rapidly worldwide. Our prior investigations suggest that cross-organ communication, involving the eye, brain, and gut, may play a role in myopia. However, the extent of this cross-organ communication in myopia remains unclear. To elucidate the underlying mechanisms, this study generates a comprehensive pan-tissue transcriptome profile of myopic mice covering eye, brain, blood, bone marrow, spleen, thymus, intestines, liver, kidney, lung, and adrenal gland using single-cell RNA sequencing (scRNA-seq). Widespread immunologic alterations in myopia are identified, characterized by a significant increase in macrophage abundance and macrophage-mediated cell communications across multiple tissues. Notably, these macrophages exhibit a cross-tissue proinflammatory phenotype, which is marked by significant activation of the hypoxia pathway, with upregulation of key markers, including Car1, HIF-1α, and reactive oxygen species, a pattern also observed in the blood of myopic patients. Further analysis suggested that hypoxia stress likely regulates the energy metabolism of proinflammatory macrophages. Inhibition of the hypoxia pathway suppressed the proinflammatory phenotype of macrophages and their hypoxia-related gene expression in myopic mice, reducing the degree of myopia. More importantly, analysis of a large cohort of 114,661 patients reveals 16 extraocular diseases with a myopia-biased prevalence. Our findings underscore the link between myopia and extraocular diseases and suggest that proinflammatory macrophages may potentially serve as the shared mechanism across organs.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/417fa333c4f559313a9d16dbd20856dc09f74c20" target='_blank'>
              Single-cell profiling reveals a shared proinflammatory macrophage signature across multiple organs in myopia
              </a>
            </td>
          <td>
            J. Meng, Ye Zhang, Mengchao Zhu, Yu Du, Yunqian Yao, Shuyu Liu, Wenwen He, Xiangjia Zhu
          </td>
          <td>2025-12-01</td>
          <td>Cell Discovery</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="

 Multisystem inflammatory syndrome in children (MIS-C) is a severe condition that arises 4–6 weeks after SARS-CoV-2 exposure, marked by persistent fever, mucocutaneous symptoms, cardiac involvement, and shock. Natural killer (NK) cells are thought to contribute during the acute phase due to their antiviral and immunoregulatory roles, but their phenotype during recovery is not well defined. An expansion of TCR Vβ21.3+ T cells has been observed during acute MIS-C, though their long-term presence and significance remain unclear.



 Peripheral blood mononuclear cells (PBMCs) were collected from 4 healthy pediatric controls, 4 febrile (non-COVID) controls, 4 children with acute COVID-19, 9 with acute MIS-C, 8 MIS-C convalescents (6–12 months), and 6 long-term MIS-C convalescents (4 years). TCR Vβ21.3 expression was analyzed using a T cell panel (CD3, CD4, CD8, CD27, CD45RA, TCR Vβ21.3). NK cell phenotype was assessed after co-culture with K562 cells using markers including CD56, CD3, CD16, CXCR6, Ki67, NKG2D, NKG2C, and CD158.



 NK cells from acute MIS-C patients showed decreased CD57, CD158, and CD107a, along with increased NKG2D expression. Clustering analysis revealed a unique NK cell population exclusive to acute MIS-C, defined by absent CD107a and elevated CXCR6 and Ki67. Most alterations resolved within 6–12 months, except CD158, which remained low even after 4 years. TCR Vβ21.3+ T cells persisted for up to a year but were undetectable at 4 years.



 MIS-C triggers a transient NK phenotype marked by reduced cytotoxicity and increased activation, suggesting a hyperactivated or dysregulated immune profile. Persistent downregulation of the inhibitory receptor CD158 may indicate prolonged NK activation. TCR Vβ21.3+ T cells appear to be short lived. Further long-term studies with larger cohorts are needed to validate these findings.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c63e6c5c161a67863c64ce2aea0e118e09c3073" target='_blank'>
              Tracking NK and Memory T Cell Dynamics in Children Affected by Multisystem Inflammatory Syndrome (MIS-C)
              </a>
            </td>
          <td>
            Natalia González, Camila Astudillo, Yazmin Espinosa, Paz Cerda-Castro, Juan Pablo Araya, Grace Ayleen Silva, Martín Felipe Hernández, M. C. Poli, Emma Rey-Jurado
          </td>
          <td>2025-12-22</td>
          <td>Journal of Human Immunity</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="The coronavirus disease 2019 (COVID-19) pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a profound impact on global public health. The complexity of its pathogenic mechanisms and host interactions urgently requires high-fidelity animal models to support research. Humanized mouse models break the species barrier through gene editing and immune reconstitution technologies, providing a key tool to simulate human infection characteristics and pathological processes. A number of studies have reported the application of humanized mouse models in the fields of COVID-19 research, such as SARS-CoV-2 pathogenesis, anti-SARS-CoV-2 drug discovery and vaccine development, etc. The present review aimed to systematically document the latest advances in the application of humanized mouse models based on different construction strategies, such as receptor humanization, immune system humanization and composite humanization. These models have not only elucidated the pathogenicity differences and immune escape mechanisms of SARS-CoV-2 variants, but have also validated the efficacy of broad-spectrum anti-SARS-CoV-2 strategies, including angiotensin-converting enzyme 2-targeted therapies, antibody cocktail regimens and mucosal vaccines. Additionally, humanized mouse models have played a pivotal role in investigating the mechanisms underlying long COVID. By revealing the multi-system pathogenic mechanisms of pulmonary fibrosis, neurodegeneration and intestinal microbiota dysregulation, these models provide a theoretical foundation for the development of targeted intervention strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/399fe2d5446f40067840cb324855582d1f670591" target='_blank'>
              Application of the humanized mouse model in research into SARS-CoV-2 infection (Review)
              </a>
            </td>
          <td>
            Xiaoyue Feng, Yadong Wang, Yuan Li, J. Long, Fang Liu, Haiyan Yang
          </td>
          <td>2025-12-29</td>
          <td>Medicine International</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/275812dc3294ac678dbefad1e9f5e6d112d20c5e" target='_blank'>
              SP140 limits type I interferon–driven pathology, preserving T cell motility and promoting resistance in tuberculosis
              </a>
            </td>
          <td>
            Maxime Caouaille, Léa Fromont, Tomoyo Shinkawa, Marion Faucher, Aizat Iman Abdul Hamid, Serge Mazères, Yaël Duvergé, Yohan Lorreyte, Emmanuelle Näser, S. Behar, Emma Lefrançais, O. Neyrolles, Denis Hudrisier
          </td>
          <td>2025-12-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="ABSTRACT Chronic persistent viral infections can lead to significant spleen damage, thus disrupting the host humoral immune response; however, the underlying mechanisms remain unclear. In this study, we employed a Lymphocytic choriomeningitis virus (LCMV) chronic infection model to investigate the effects of virus infection on spleen damage. Mice infected with Lymphocytic choriomeningitis virus clone 13 (LCMV-CL13) presented a series of pathological features, such as white pulp atrophy and reduced germinal center diameter, length, and area in the spleen. More importantly, we observed a diminished GC response alongside a weak antibody response in the chronic infection model. Single-cell RNA sequencing (scRNA-seq) further revealed the dysregulation of gene expression, including Bbc3, Atf3, and Ptpn6, which inhibit B-cell differentiation during chronic viral infection. We verify that the upregulation of Bbc3 or Atf3, respectively, can promote apoptosis in BaF3 cells. Immune repertoire (IR) analysis revealed that the molecular diversity of the BCR repertoire after LCMV-CL13 infection, specifically manifested in BCR clonal diversity, IGHV gene segment usage preference, and CDR3 sequence changes. In conclusion, this study demonstrated that chronic LCMV-CL13 infection interrupted the development of splenic B cells by increasing the expression of apoptosis genes, thus enhancing our understanding of the underlying mechanisms of B-cell development interruption during chronic viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b7874d18fa09f3125fcaf4e38c682df442d0201" target='_blank'>
              Chronic viral infections impaired the growth process of splenic B cells by upregulating Bbc3 and Atf3 in LCMV-CL13 infected mouse model
              </a>
            </td>
          <td>
            Zhe Li, Wei Yang, Fangzhou Cai, Dan-ping Li, Qian Chen, Yiteng Zhang, Jiarui Cui, Wei Wang
          </td>
          <td>2025-12-02</td>
          <td>Virulence</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Salivary gland dysfunction and inflammation are common following SARS-CoV-2 infection. This study aimed to investigate the effects of SARS-CoV-2 spike and envelope proteins on glandular function in healthy C57BL/6 mice through direct intra-glandular injection into the submandibular glands. Local administration of spike protein significantly reduced salivary secretion, while the envelope protein had no measurable impact. Histological analysis revealed the presence of leukocyte foci in two-thirds of spike protein-treated mice, while none were detected in the vehicle- or envelope protein-treated groups. Furthermore, spike protein treatment led to a significant increase in total immune cells and B cells, and an expansion of the CD44high CD62Llow effector/effector memory subsets within CD4 T cells and B cells in the submandibular glands. Notably, serum antinuclear antibodies developed in one-third of spike-treated mice, consistent with the reported salivary gland pathology in COVID-19 patients that resemble autoimmune Sjögren’s disease. Moreover, spike protein treatment increased phospho-STAT3 levels and induced transcriptomic changes indicating impaired acinar compartment, heightened adaptive immune responses, and altered tissue remodeling activity. These findings show that SARS-CoV-2 spike protein alone is sufficient to initiate significant salivary gland pathology in the absence of intact virus or ACE2 interaction, providing evidence for a novel mechanism by which SARS-CoV-2 induces salivary gland dysfunction and pathology with autoimmune features.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0ed181b81ada91ccc763c713a424a697626f932b" target='_blank'>
              SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice
              </a>
            </td>
          <td>
            Fernanda Aragão Felix, Yuqiao Jiang, Jing Zhou, Dongfang Li, Victoria Zhou, Sílvia Ferreira de Sousa, Kevin Matthew Byrd, Qing Yu
          </td>
          <td>2025-11-21</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d70a7f410d7273941b555f5d38eb406c7358fb4" target='_blank'>
              Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus
              </a>
            </td>
          <td>
            D. Marín-Moraleda, A. Tort-Miró, E. Ezcurra, S. Montaner-Tarbes, J. Muñoz-Basagoiti, E. Coatu, M. J. Navas, M. Muñoz, P. Monleón, J. González-Oliver, L. Pailler-García, S. Pina-Pedrero, F. Accensi, F. Rodríguez, J. Argilaguet
          </td>
          <td>2025-12-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="This review article attempts to provide a unifying hypothesis to explain the myriad of symptoms and predispositions underlying the development of PASC (Postacute Sequelae of COVID), often referred to as Long COVID. The hypothesis described here proposes that Long COVID is best understood as a disorder of persistent immune dysregulation, with chronic macrophage activation representing the fundamental underlying pathophysiology. Unlike transient post-viral syndromes, Long COVID involves a sustained innate immune response, particularly within monocyte-derived macrophages, driven by persistent spike protein (peripherally in MAIT cells and centrally in Microglial cells), epigenetic imprinting, and gut-related viral reservoirs. These macrophages are not merely activated temporarily but also become epigenetically “trained” into a prolonged inflammatory state, as demonstrated by enduring histone acetylation markers such as H3K27acDNA Reprogramming. It is proposed that recognizing macrophage activation as the central axis of Long COVID pathology offers a framework for personalized risk assessment, targeted intervention, and therapeutic recalibration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b5f2903ed6d3bcbf8e560a451808bb27c9205bb" target='_blank'>
              The Central Role of Macrophages in Long COVID Pathophysiology
              </a>
            </td>
          <td>
            Philip Mcmillan, Anthony J Turner, B. Uhal
          </td>
          <td>2025-12-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="This study investigated how prolonged aggression in male CD1 mice alters responses to chronic LPS (lipopolysaccharide)-induced inflammation. Experience of aggression induced pathological aggression in 36% of mice. Following LPS, aggressors resolved systemic inflammation within five days—evidenced by normalized locomotor activity, WBC (white blood cells), and lymphocyte counts—while controls remained inflamed. LPS did not alter established aggression or anxiety. Furthermore, aggressors demonstrated accelerated inflammation resolution in the brain, showing a higher proportion of resting microglia and a lower percentage of activated microglia following LPS-induced inflammation compared to control animals. Gene expression analysis revealed a more pronounced inflammatory response in the hypothalamus than in the nucleus accumbens. Aggressive mice exhibited a profile associated with inflammation resolution, indicated by increased expression of the Trem2 gene. These differential immune responses may be modulated by the dopaminergic system. Elevated Drd1 gene expression in the hypothalamus could possibly contribute to the anti-inflammatory signaling, while changes in nucleus accumbens dopaminergic activity, involving D2 receptor activation, appear linked to the development of pathological aggression. Thus, this study demonstrates that prolonged aggression induces persistent changes in behavioral, neuroimmune, and neuroendocrine systems in male CD1 mice. Aggressive animals develop a distinct neuroimmune phenotype characterized by accelerated resolution of both systemic and brain inflammation following LPS challenge.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e8af717818ae65429c337dd3a00e34367f6925bd" target='_blank'>
              Prolonged Aggressive Experience Accelerates Resolution of Inflammation in Blood and Microglia After Repeated LPS Treatment
              </a>
            </td>
          <td>
            Anastasia Mutovina, A. Sapronova, Kseniya Ayriyants, Yulia Ryabushkina, Julia Khantakova, Polina Mezhevalova, Polina Ritter, Natalya Bondar
          </td>
          <td>2025-12-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Considerable attention has been recently devoted to the involvement of immune cells in the central nervous system (CNS) during infections with neurotropic viruses, such as SARS-CoV-2, HIV-1, and ZIKV. These viruses are capable of infecting astrocytes and microglia, the main glial cells in the CNS, responsible for regulating neuronal activity. Here, we discuss how viral infections lead to metabolic reprogramming toward aerobic glycolysis in these cells, enhancing pro-inflammatory pathways, such as inflammasome activation, resulting in the secretion of inflammatory cytokines that favor the development of neuroinflammation. In this mini review, we discuss the pivotal interplay between metabolism and immunity towards viral pathogenesis in the CNS, pointing out the relevance of therapeutic strategies targeting both metabolic and immunological pathways to enhance antiviral and neuroprotective responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c603076d92448698be2b3b34d399b974e9d4c131" target='_blank'>
              Viral reprogramming of glial metabolism as a driver of neuroinflammation
              </a>
            </td>
          <td>
            Tamara Rodrigues, Gabriel Salles Beltrão, Heloísa Girardi, Aguinaldo R. Pinto
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease worldwide. However, the inflammatory mediators that causally drive disease progression remain incompletely defined. In this study, we used a multi-omics approach that combined single-cell RNA sequencing, spatial transcriptomics, pseudotime trajectory analysis, cell-to-cell communication analysis, and Mendelian randomization (MR) to investigate the role of tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) in DKD development. Findings were further validated in zebrafish embryos depleted of pdx1, an established model of DKD. Spatial transcriptomic analysis showed that TNFRSF1A is enriched in cortical kidney regions. Pseudotime analysis revealed progressive immune reprogramming, with an early predominance of T and NK cells and gradual shift to myeloid infiltration and B-cell expansion. Cell-to-cell communication analysis highlighted IL-1β and related signaling pathways that increase NF-κB activity. Mendelian Randomization analysis, complemented by PPI network mapping, identified TNFRSF1A (OR = 1.78, 95% CI: 1.17–2.71, p = 0.007) as a gene with genetic evidence supporting a causal association. Consistent with the human data, experiments in zebrafish showed that TNFRSF1A expression increases significantly following pdx1 knockdown (p = 0.0025). Together, these findings support a role for TNFRSF1A in immune microenvironment reprogramming in DKD, while not excluding the involvement of additional regulatory pathways.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f04fb1ac2e99274019a86698b1c5527ad53e0b0" target='_blank'>
              Multi-Omics Integration Identifies TNFRSF1A as a Causal Mediator of Immune Microenvironment Reprogramming in Diabetic Kidney Disease
              </a>
            </td>
          <td>
            Wanqiu Xie, Dongfang Zhao, Henriette Franz, Annette Schmitt, Gerd Walz, T. Yakulov
          </td>
          <td>2025-12-26</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="The SARS-CoV-2 virus has shown incredible finesse in using the cellular machinery of its hosts to replicate itself while in addition escaping the host's immune system. This pivotal review covers the detailed and complex cellular mechanisms that SARS-CoV-2 employs to subvert various cellular processes within the host and focuses on some aspects of the virus cellular entry and replication processes and immune system evasion. After carefully collating the data that has been recently published, we have identified and described the virus mediated cellular subversion of the endoplasmic reticulum stress response, autophagy, innate immune system and its signalling, and cellular metabolism. Our thorough understanding of these processes cellular subverted by SARS-CoV-2 will guide future therapeutic interventions, and will illuminate some of the complex and devious host–pathogen interactions that drive the pathology of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac0103346ce84b0faadf6332e3a522b2fc6c2248" target='_blank'>
              Cellular pathways exploited by SARS-CoV-2 for replication and immune evasion: a comprehensive analysis of viral hijacking mechanisms
              </a>
            </td>
          <td>
            Shanmukha Madras
          </td>
          <td>2025-12-30</td>
          <td>International Journal of Therapeutic Innovation</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Parkinson’s disease (PD) is increasingly recognized as a multisystem disorder involving pathological α-synuclein (α-syn) accumulation and widespread neuroimmune dysregulation. Microglia, the resident immune cells in the central nervous system (CNS), are pivotal mediators of the bidirectional communication between the CNS and peripheral systems. In addition to sensing neuronal injury and α-syn pathology, microglia dynamically respond to peripheral immune signals, including circulating cytokines, immune cell infiltration, and microbial metabolites, through pattern recognition receptors such as Toll-like and NOD-like receptors. Furthermore, microglia regulate blood–brain barrier integrity, modulate peripheral immune cell recruitment, interact with meningeal lymphatic vessels, and contribute to the propagation of α-syn within the CNS and along the gut–brain axis. However, a comprehensive framework encompassing their diverse roles in peripheral–central immune crosstalk remains underdeveloped. This review synthesizes recent advances elucidating how microglia link the CNS to peripheral immune and metabolic signals in PD. We further highlight microglial contributions to α-syn propagation along the gut–brain axis and discuss how their functional states influence disease progression. A deeper understanding of microglial involvement in this complex neuroimmune interface may inform the development of effective and system-level therapeutic strategies for PD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40b4787f9c236f2822ea4097343456b74122cbca" target='_blank'>
              Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
              </a>
            </td>
          <td>
            Tianbai Li, Tao Qiu, Fei Jiang, Huaibin Cai, Weidong Le
          </td>
          <td>2025-12-01</td>
          <td>Translational Neurodegeneration</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Post-stroke T lymphocytes exert differential effects both at the infarction site and systemically; these are pro-inflammatory cascades, subsequent T cell infiltration into the brain, and persisting interaction of infiltrating T lymphocytes (more specifically a subset of CD4- CD8-double-negative T cells (DNTs)). Moreover, brain-resident microglia cells exacerbate the parenchymal damage. The acute peripheral immune response is characterized by lymphopenia and persisting activation of circulating T lymphocytes. In the temporal course, it is supposed that anti-inflammatory mechanisms in general and especially the anti-inflammatory M2 phenotype of microglia cells help to recover the functionality of brain parenchyma. We assessed the long-term temporal course of peripheral blood T cell activation post stroke as well as the interaction of pan-T cells or DNTs with microglia cells ex vivo. T cell subpopulations (CD4+, CD8+, DNT) and their activation (CD25, CD57, CTLA-4 (CD152) and PD-L1 (CD274)) were analysed in peripheral blood from stroke patients and controls by flow cytometry. Pan-T cells and DNTs were isolated by magnetic beads from stroke patients’ blood 3 days (t1), 1 month (t2), and 3 months (t3) post stroke or once from controls, and they were incubated with or without healthy donor human microglia cells ex vivo. Upon interaction, T cell (HLA-DR) and microglia activation (HLA-DR, CX3CR1, CD32, CD86, CD206 and CD209) was assessed by flow cytometry. Moreover, IL-1β in cell culture supernatants was quantified by ELISA. Post-stroke CD4+ and CD8+ T cell activation (CD25) persisted for 1 month and declined only after 3 months. Inhibitory activation markers CTLA-4 and PD-L1 were upregulated only 3 months after stroke. Co-culture of pan-T cells and microglia had little effect on microglial activation but a strong effect on T cell activation (HLA-DR). Co-culture of DNTs with microglia cells inhibited the M2 phenotype of microglia. Stroke acutely leads to a strong activation (CD25 upregulation) of both CD4+ and CD8+ T cells. This activation persisted in the subacute post-stroke phase and declined at 3 months post stroke, being accompanied by upregulation of PD-L1 and CTLA-4. Both might be involved in terminating chronic T cell activation. DNTs might influence microglia through CX3CR1 and inhibit an M2 state ex vivo, which might contribute to cerebral inflammation post stroke.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a6eeee342578d5c85114ed9491dbdbb4d5e9207f" target='_blank'>
              Lack of Negative Feedback Loops of CTLA-4 and PD-L1 as Key Mechanisms for Post-Acute T Cell Activation Until 3 Months After Ischemic Stroke
              </a>
            </td>
          <td>
            Lars Peglau, J. Ruhnau, Mara Winkelmann, Thomas Krüger, Alexander Dressel, J. Schulze, A. Vogelgesang
          </td>
          <td>2025-11-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Hemolytic uremic syndrome (HUS), a fatal complication of Shiga toxin-producing Escherichia coli (STEC) infection, is classically characterized by acute renal failure, but frequently accompanied by central nervous system (CNS) dysfunction. Because the CNS is normally protected by the blood-brain barrier (BBB), the toxin-mediated BBB injury is considered to be a major cause of neurologic sequelae in STEC infection. Here, we delineate how Shiga toxin type 1a (Stx1a) and Shiga toxin type 2a (Stx2a) compromise BBB-like endothelial barrier integrity with the human brain microvascular endothelial cell line hCMEC/D3 as an in vitro model, complemented by an endothelial–astroglial co-culture system. Stx1a/Stx2a exposure induced the MAPK pathway and ER stress, triggering caspase-mediated apoptosis and pro-inflammatory cytokines expression. Coincidentally, permeability across tight junctions was impaired, with junctional protein loss and increased paracellular permeability. Pharmacologic inhibition of caspases prevented cytotoxicity and tight junction loss, indicating a role for the apoptotic process in barrier breach. In co-cultures with transwell, human astrocytes (A172) demonstrated caspase activity and cytokine induction even without direct exposure to toxins, indicating endothelial injury–release paracrine activity in the propagation of BBB injury. Reactive oxygen species (ROS) also accumulated distal to toxin exposure and aligned with apoptotic and barrier phenotypes, indicating a ROS–caspase pathway in endothelial cell injury. Collectively, our findings show that Stx may impair BBB integrity through ROS accumulation and caspase-dependent apoptosis. This is the first study establishing hCMEC/D3 cells as a model for elucidating Stx-induced BBB disruption, providing mechanistic insights for the therapeutic development against CNS complications in HUS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9f406cffc93a41dc830f2322c958f0ea8d919c67" target='_blank'>
              Shiga Toxin Induces Apoptosis via ROS–Caspase Activation in Human Cerebral Endothelial Cell Line hCMEC/D3 and Astrocyte Co-Culture
              </a>
            </td>
          <td>
            Mirim Kim, Kyung-Soo Lee, Jun Young Park, Chang-Ung Kim, Yu-Jin Jeong, Moo-Seung Lee
          </td>
          <td>2026-01-08</td>
          <td>Journal of Microbiology and Biotechnology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background Severe COVID-19 is frequently associated with acute respiratory distress syndrome (ARDS) and prolonged pulmonary sequelae. Persistent immune activation, including dysregulated B cell responses and increased proinflammatory chemokines, has been linked to the post-acute sequelae of SARS-CoV-2 infection. However, the mechanisms linking these factors remain poorly defined. Methods Sixty patients were studied four months after acute COVID-19, including 34 who developed ARDS, 26 who did not develop ARDS, and 12 healthy controls. Clinical, computed tomography scan (CT), and diffusion capacity of the lungs for carbon monoxide (DLCOc) assessments were performed. Anti-SARS-CoV-2 IgM/IgG levels were quantified, circulating B cell subsets were characterized, and circulating cytokines and chemokines were measured. CXCR3 expression on B cells was analyzed by spectral flow cytometry. In vitro assays were performed to evaluate the effects of CXCL9 and CXCL10 on B cell activation, plasma cell differentiation, IgG production, and CD40L expression on CD4+ T cells. Associations between immunological markers and pulmonary sequelae were assessed. Results IgG, but not IgM, levels were significantly higher in patients with ARDS than in patients without ARDS. Both COVID-19 groups showed a reduction in CD19+CD20+ B cells and an increase in plasmablasts compared to controls. Serum levels of CXCL9 and CXCL10, but not other cytokines, positively correlated with IgG levels. In vitro, CXCL9 increased CD86 expression on B cells, while both chemokines promoted plasma cell differentiation (CD27+CD38+, CD138+) and increased total IgG secretion. CXCL9 also increased the expression of CXCR3 and CD40L on activated CD4+ T cells. Clinically, patients with combined CT abnormalities and reduced DLCO had the highest levels of IgG, CXCL9, and CXCL10. Conclusion Four months after COVID-19, patients with prior ARDS and persistent pulmonary sequelae exhibit sustained elevations of anti-SARS-CoV-2 IgG and chemokines CXCL9 and CXCL10. Both chemokines directly enhance B cell differentiation into IgG-secreting plasma cells in vitro, while CXCL9 also increases CD4+ T cell help, suggesting a mechanistic link between chronic inflammation, increased humoral responses, and long-term lung impairment. Targeting CXCL9/CXCL10–CXCR3 signaling could offer therapeutic potential to mitigate post-COVID pulmonary complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f87e4a08188abb1875547220225dd7d5712072b" target='_blank'>
              CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells
              </a>
            </td>
          <td>
            R. Quiroga, Sergio Sanhueza, Catalina Sepúlveda, Bárbara Antilef, C. Munoz, Camilo Cabrera, M. Fraga, Faryd Llerena, L. Lamperti, M. I. Barria, Alicia Colombo, Gonzalo Labarca, Mario Henriquez-beltran, Luciano Ferrada, Estefanía Nova-Lamperti
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Complement factor C3 is one of the most abundant proteins in the bloodstream and a central part of the complement system. Upon activation, C3 facilitates bacterial recognition and clearance in the extracellular environment. Initially regarded as a serum effector component, C3 is also emerging as an intracellular protein regulating basic cellular processes. Previously, we reported that intracellular, cytosolic C3 can opsonize bacteria and impact their virulence. In this study, we show that cells lacking C3 exhibit altered gene expression that influences immune responses to infection and inflammation. We observed decreased cytokine secretion in C3-deficient cells, which was rescued by expression of non-canonical, cytosolic C3. Further investigation revealed that C3 deficiency impairs signal transduction within the NF-κB signaling pathway, which is attributed to decreased expression of Toll-like receptors. This effect is reversed in cells expressing cytosolic C3, where receptor expression and pathway activation are restored. Therefore, we propose a novel role of intracellular, cytosolic C3 in shaping immune responses by modulating the expression of receptors critical to pathogen recognition.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b501f4da933dec11bc06aa3c18c3ca8eba59f601" target='_blank'>
              Intracellular C3 regulates the immune response to infection via NF-κB signaling
              </a>
            </td>
          <td>
            Katarzyna Kuska, Serena Bettoni, F. Mohlin, Maja Chrobak, Vaishnavi Dandavate, Saleh Moradi, B. King, K. Riesbeck, A. Blom
          </td>
          <td>2025-12-24</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Introduction Long COVID (LC), a clinical condition marked by persistent and new symptoms after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affects up to 10-20% of infected individuals. Although autoimmunity has been proposed as a key mechanism, the specific role of circulating autoantibodies in LC remains unclear. We characterized the autoantibody profiles in individuals with LC and assessed their association with persistent post-COVID symptoms, in comparison to recovered patients and pre-pandemic healthy controls (PPHC). Methods We analyzed 17 autoantibodies in a cohort of 220 pre-pandemic controls and 291 COVID-19 patients, targeting self-antigens. Of those, 237 patients presented symptoms for a month or more after the onset of SARS-CoV-2 infection (long COVID patients), and 54 individuals recovered from the initial infection without chronic symptoms. Autoantibody frequencies and associations with clinical variables were assessed using logistic regression and subgroup analyses. Results Autoantibody prevalence was higher in recovered individuals (37%) than in LC patients (24%) or PPHC (19%). While certain autoantibodies such as a-cardiolipin (a-CL) IgM, a-AML IgG, a-SSA IgG and a-SSB IgG were elevated in some COVID-19 patients, they were not significantly different in LC. The most frequently detected autoantibody was a-CL IgM, found across all groups and especially in individuals that fully recovered from COVID-19. However, a-CL did not differentiate individuals with long COVID or correlate with symptom persistence but was associated with the occurrence of dysphagia and anorexia as symptoms. No correlation was observed between autoantibody presence and disease severity. Discussion These findings do not support a primary pathogenic role for the evaluated autoantibodies in LC and emphasize the need for longitudinal studies to explore their temporal dynamics and interaction with other immunological or clinical factors involved in post-COVID-19 conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3eda56950809fc6d0fbb43c3e1d9ce4d782eb02d" target='_blank'>
              Autoantibodies in long COVID in a black/mixed population compared with recovered and pre-pandemic controls
              </a>
            </td>
          <td>
            Jéssica de Jesus Silva, Laila Sampaio Horta, Sayonara Melo Viana, A. B. Cazé, I. S. Oliveira, Mariana M. Pereira, Natalie Antas Nascimento, Blenda de Jesus Pereira, Ícaro Bonyek-Silva, Sara Nunes de Oliveira Araújo, Ananda Isis Lima de Marinho, Juqueline Rocha Cristal, Vishal Rao, Camila Coelho, T. Cerqueira-Silva, K. Malmegrim, A. Camelier, C. R. Cardoso, N. Tavares, Manoel Barral-Netto, Aldina Barral, C. Barbosa, V. Boaventura
          </td>
          <td>2025-12-11</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Respiratory infectious pathogens such as influenza, respiratory syncytial virus (RSV), and SARS-CoV-2 persist as significant threats to global health. Most of the pathogens come in through the respiratory mucosa, with the local immune mechanisms as the first line of defense. Here, we explore the role of mucosal immunity, such as secretory immunoglobulin A (sIgA), tissue-resident memory T cells (TRM), and inducible bronchus-associated lymphoid tissue (iBALT), in the management of respiratory infections in this research. The mechanistic part illustrates how mucosal vaccination achieves these reactions by protecting within the zone of pathogen entry. There is now experimental data on live attenuated influenza vaccination (LAIV), studies on preclinical SARS-CoV-2 mucosal vaccine, and early human trials that demonstrate the possible role of mucosal vaccination in limiting viral replication and transmission. But the translational challenge is still with various aspects, such as uniform mucosal immune correlates, heterogeneity in formulation and delivery, and regulatory obstacles. Mucosal vaccines provide a compelling complement to systemic immunization but remain challenging to implement. By acting via both systemic and local immunity, these vaccines are likely to play a role in comprehensive respiratory disease control as well as preparing populations for pandemics. These results highlight the necessity for mucosal immunity to be considered as a pillar of future vaccine development and public health policy framework.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/389cc307d6027991211242f633790eb7033667cb" target='_blank'>
              The Role of Mucosal Immunity in the Control of Respiratory Infectious Diseases
              </a>
            </td>
          <td>
            Yue Zhang
          </td>
          <td>2025-12-19</td>
          <td>MedScien</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/436bf9880456701390ff5d79fb01556ece3f12f3" target='_blank'>
              Single-cell characterization of skin response to a bite by West Nile virus-infected mosquito reveals fibroblast-mediated barrier to transmission
              </a>
            </td>
          <td>
            Hacène Medkour, Federico Bocci, Norman Schneider, Idalba M Serrato-Pomar, Félix Rey-Cadilhac, Elliott F. Miot, Wilfried A. A. Saron, A. S. St. John, G. Maarifi, Yingzi Liu, D. Missé, Qing Nie, Duncan R. Smith, Sébastien Nisole, M. Plikus, J. Pompon
          </td>
          <td>2026-01-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Dengue virus (DENV) is the causative agent of dengue, a mosquito-borne disease that represents a significant and growing public health burden around the world. A unique pathophysiological feature of dengue is immune-mediated enhancement, wherein preexisting immunity elicited by a primary infection can enhance the severity of a subsequent infection by a heterologous DENV serotype. A leading mechanistic explanation for this phenomenon is antibody dependent enhancement (ADE), where sub-neutralizing concentrations of DENV-specific IgG antibodies facilitate entry of DENV into FcγR expressing cells. Accordingly, this model posits that phagocytic mononuclear cells are the primary reservoir of DENV. However, multiple independent groups have shown that B cells are the largest reservoir of virally infected cells in circulation during acute dengue, representing a disconnect in our understanding of immune-mediated DENV tropism. In response to this persistent knowledge gap, our team has previously identified a novel mechanism of immune-mediated enhancement we have termed BCR-dependent enhancement (BDE) of DENV infection. In this study, we show that DENV infection of DENV-reactive B cells is highly sensitive to BCR/DENV envelope (E) protein interactions. DENV entry into this subset of B cells is dynamin-mediated and requires proximal BCR signaling. Finally, we show that DENV-reactive B cells are productively infected by live DENV, capable of supporting active viral replication and dissemination. We propose that BDE provides an additional layer of pathogen-specific immune-mediated infection risk that complements existing models of ADE and offers additional insight into potential mechanisms of DENV immunopathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6e623512c4d44d160e5f7f9707687b24d41d2ed8" target='_blank'>
              Molecular and biophysical requirements for B cell receptor dependent enhancement of dengue virus infection
              </a>
            </td>
          <td>
            Gaby Madrigal, Chad Gebo, Benjamin D McElvany, Sean A. Diehl, A. Waickman
          </td>
          <td>2026-01-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Background and Objectives In multiple sclerosis (MS), a variety of immunosuppressive treatments are available. While effective, these approaches often lead to sustained impairment of essential components of the immune system, posing long-term safety concerns. Consequently, there is a growing interest in alternative therapeutic approaches that selectively limit pathogenic B-cell functions while preserving their physiologic roles. In this study, we investigated the therapeutic potential of inhibiting the enzyme Bruton tyrosine kinase (BTK), a key signaling molecule in both B-cell and myeloid cell activation. Methods The effects of the BTK inhibitor evobrutinib were evaluated in various experimental in vivo models of CNS demyelination, each representing different aspects of disease pathology as well as a naïve healthy condition. The impact on disease onset and severity was determined, and phenotypical alterations in different cell populations were assessed via flow cytometry. Furthermore, functional changes in both murine and human myeloid cells induced by BTK inhibition under specific Fc receptor–dependent stimulation were analyzed in in vitro settings using flow cytometry. Results In a naïve, healthy environment, evobrutinib promoted the development of regulatory B-cell properties. In various experimental models of CNS demyelination, BTK inhibition limited the differentiation of proinflammatory B cells while supporting their regulatory properties. Beyond modulating B-cell responses, BTK inhibition also attenuated the activation of myeloid cells after Fc receptor–mediated antigen uptake, a process assumed to be of importance in conditions, such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein–antibody associated disease. In addition, BTK inhibition was shown to suppress the secretion of proinflammatory cytokines and reduce antigen presentation, further dampening pathogenic immune responses. Discussion These findings highlight the potential of BTK inhibition as a selective and sustainable immunomodulatory strategy for both B cells and myeloid cells in the context of chronic CNS inflammation. Despite their efficacy, broad-spectrum immunosuppressive therapies often fail to provide targeted immune modulation. By contrast, BTK inhibition promotes regulatory B-cell properties while leaving other B-cell functions intact, providing the basis for its broad use—potentially in combination with established anti-inflammatory agents.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d45c864d650e75d6107915d1c803721a2b18f33f" target='_blank'>
              Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease–Driving Inflammation While Promoting Regulatory B Cells
              </a>
            </td>
          <td>
            Sarah Dybowski, Jacqueline Thode, Marie Freier, Darius Saberi, S. Nessler, Anastasia Geladaris, Silke Häusser-Kinzel, M. Ringelstein, Sebastian Torke, Martin S. Weber
          </td>
          <td>2025-11-25</td>
          <td>Neurology® Neuroimmunology & Neuroinflammation</td>
          <td>0</td>
          <td>48</td>
        </tr>

        <tr id="Introduction Zika virus (ZIKV) infection has been associated with neurological syndromes, particularly during outbreaks caused by Asian lineage strains. However, experimental models suggest that African strains may exhibit an equal or more virulent profile. Neuroinvasion by systemic viruses often requires crossing the blood–brain barrier (BBB), which disruption amplifies viral dissemination and neuropathology. Type I interferons (IFNs) are key to restricting ZIKV replication, but their specific role in preserving BBB integrity remains poorly defined. Methods Here, we used human brain microvascular endothelial cells (HBMECs) as a simplified BBB model to compare transcriptional responses and IFN modulation following infection with either the African prototype strain ZIKVMR766 or the Asian epidemic strain ZIKVPE243. The role of endothelial cell–mediated IFN responses was further assessed in vivo by intravascular inoculation of mice with endothelial-specific IFNAR depletion using ZIKVMR766. Results and discussion Infection of HBMEC with ZIKVMR766 triggered a greater number and broader range of differentially expressed genes, especially ones associated with interferon signaling and translational pathways, whereas ZIKVPE243-infected samples clustered closer to non-infected ones. ZIKVMR766 infection also resulted in higher viral titers and faster dissemination across endothelial monolayers. Both strains induced IFN-β expression but suppressed downstream IFN signaling by reducing STAT1 phosphorylation and promoting STAT2 degradation, with these effects being more pronounced for ZIKVMR766. Despite these evasion mechanisms, neutralization assays revealed that endothelial cells-derived IFNs production and response partially restricted viral replication, preserved HBMEC viability, and protected against barrier disruption, with ZIKVPE243 showing greater sensitivity to IFN-β. Importantly, in vivo infection of mice lacking endothelial IFNAR signaling resulted in elevated CNS viral load and increased lethality following ZIKVMR766 infection, underscoring the pivotal role of endothelial IFN responses in viral control, maintenance of BBB integrity, and protection against neuroinvasion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/56674b5024c412f991e7ef83dca244fa427476f0" target='_blank'>
              Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo
              </a>
            </td>
          <td>
            Luan Rocha Lima, Y. M. Mustafá, Paula Luize Camargos Fonseca, S. V. A. Coelho, Pierina Lorencini Parisi, C. Simeoni, L. M. Meuren, Bruno Braz Bezerra, N. C. Mebus-Antunes, F. Matassoli, J. Proença-Módena, Renato Santana Aguiar, L. B. de Arruda
          </td>
          <td>2025-12-03</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) is a progressive neurodegenerative disorder defined by amyloid-β (Aβ) plaques, tau hyperphosphorylation, and neuroinflammation. Although earlier work emphasized brain-resident glia (microglia and astrocytes), recent studies highlight adaptive immune cells, particularly T and B lymphocytes, as modulators of AD pathology. This review synthesizes animal and human findings from 2022–2025 to provide updated insights into the multifaceted roles and therapeutic potential of adaptive immunity in AD. Infiltration of peripheral T and B cells into the brain parenchyma links peripheral immunity to central nervous system (CNS) pathology. Both infiltrating lymphocytes and resident glia show context-dependent dual effects, either exacerbating neurodegeneration or promoting neuroprotection. Therapeutic strategies under active investigation include modulation of CD4+ T cell differentiation, adoptive transfer of regulatory T cells, and next-generation active vaccines for AD. Overall, selective modulation of discrete immune subsets may enable adaptive-immunity-based treatments, a complex yet promising avenue for AD therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3b57de078f4e9067551a7f587763ddb6ea70cdf6" target='_blank'>
              Adaptive Immunity and Alzheimer’s Disease: Dual Roles in Neurodegeneration and Neuroprotection with Therapeutic Implications
              </a>
            </td>
          <td>
            You Min Ahn, Min-Kyoo Shin
          </td>
          <td>2025-12-31</td>
          <td>Biomolecules & Therapeutics</td>
          <td>1</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c50d95b7ee1f0918516a315eb52760cde23237c7" target='_blank'>
              Ferrapoptosis: Discovery of a Hybrid Programmed Cell Death
              </a>
            </td>
          <td>
            Qiuyun Yang, Yang Chen, Yang Shen, Xiao Zhang, Xianliang Chen, Xinnan Zhao, Ruixuan Yuan, Manrui Li, Yang Xu, Xilong Lin, Yihan Sun, Shengyuan Zuo, Xinyang Liu, Zhuo Li, Ying Chen, Shichun Wang, Meili Lv, Lin Zhang, Weibo Liang, Xiameng Chen
          </td>
          <td>2025-11-27</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="The effects of antiretroviral therapy (ART) and treatment interruption on myeloid cell egress from the central nervous system (CNS) during human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection remain poorly defined. We hypothesized that CNS macrophages normally traffic out of the CNS, accumulate during viral infection and inflammation, and are released as inflammation resolves. To test this, we administered intracisternal (i.c.) injections of two different colored fluorescent superparamagnetic iron oxide nanoparticles (SPION) to SIV-infected macaques either early in infection (12–14 dpi) or 30 days before necropsy. SPION are preferentially taken up by perivascular, meningeal, and choroid plexus macrophages, enabling us to track macrophage turnover, infection, and migration. In non-infected macaques, SPION+ macrophages trafficked from the CNS to peripheral sites including the deep cervical lymph node (dCLN), lumbar lymph nodes, spleen, and dorsal root ganglia (DRG). With SIV infection, these cells accumulated in the CNS and showed reduced peripheral trafficking. ART decreased the number of SPION+ perivascular macrophages, and to a lesser extent, meningeal or choroid plexus macrophages. After ART interruption, SPION+ perivascular and choroid plexus macrophage numbers remained stable, whereas SPION+ meningeal macrophages increased. ART eliminated SIV-RNA+ perivascular macrophages, leaving few- scattered SIV-RNA+ cells in the meninges and choroid plexus. Following ART interruption, perivascular macrophages remained virus-negative, but scattered viral RNA+ meningeal macrophages persisted. In non-infected macaques, SPION+ macrophages trafficked to the dCLN, spleen, and DRG, but this trafficking diminished with SIV infection and AIDS with SIVE. Importantly, SIV-RNA+ SPION+ macrophages that exited the CNS were cleared by ART and did not reappear after treatment interruption. Using two differently colored SPION to assess establishment of CNS viral reservoirs, we observed higher numbers of early-labeled macrophages within and outside the CNS in animals with AIDS and SIVE, ART treatment, and ART interruption. These findings support a model in which SIV-infected perivascular macrophages seed an early CNS viral reservoir, while the meninges and choroid plexus undergo continual viral seeding during infection. ART reduces trafficking of infected macrophages out of the CNS and clears the perivascular macrophage reservoir, but SIV-RNA+ meningeal macrophages can persist, in low numbers, and can rebound after ART interruption.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/978817c1cd51902524161c071846dc82c1a681a8" target='_blank'>
              Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS
              </a>
            </td>
          <td>
            Zoey K. Wallis, C. Midkiff, Miaoyun Zhao, P. Autissier, Soon Ok Kim, Addison Q. Amadeck, Yiwei Wang, M. Jakubowski, Tricia H. Burdo, Andrew D. Miller, Qingsheng Li, Xavier Alvarez, Robert V. Blair, Kenneth C. Williams
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Introduction Variability in antibody responses among individuals following vaccination is a common phenomenon. This study employs single-cell transcriptome sequencing to characterize the transcriptomic features underlying these variations during the antibody decline phase after inactivated COVID-19 vaccination. Methods Sixty-five healthy volunteers received two doses of BBIBP-CorV. Antibody levels were measured 109–140 days post-vaccination. From these, 15 samples representing low, median, and high antibody titers were selected for PBMC single-cell RNA sequencing. Results Re-analysis of antibody kinetics revealed that titers during the decline phase are most strongly associated with long-term persistence. Differentially expressed genes were enriched in immune pathways including lymphocyte activation, antigen presentation (MHC-I and MHC-II), and interferon signaling. Significant variation in HLA genes, particularly HLA-B, was observed across PBMC cell types. Cell-cell communication analysis further identified enhanced MHC-I signaling in high-titer groups, dominated by HLA-B interactions with CD8+ T cells. Discussion These findings reveal a state of balanced immune alertness during the decline phase, providing insights into the cellular and molecular determinants of long-term humoral immunity and informing future vaccine design.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e4610a113f57e05290eb85d8cd24d003e8a69792" target='_blank'>
              Single-cell transcriptome profile during the antibody decline phase following inactivated COVID-19 vaccination
              </a>
            </td>
          <td>
            Zhongyi Zhu, Yaling Huang, Jiatong Sun, Meirong Li, Yong Chen, Fubaoqian Huang, Chuanyu Liu, Weijun Chen, Jinmin Ma
          </td>
          <td>2025-12-02</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="General Background Parasitic infections remain a major challenge in human and veterinary health due to their systemic physiological and immunological consequences. Specific Background Beyond tissue damage, parasites induce metabolic disturbances and immune modulation that influence disease progression. Knowledge Gap Integrated experimental evidence linking physiological alterations with immune cell activation and cytokine regulation remains limited. Aims This study aimed to investigate host physiological responses and immune dynamics during experimental Toxoplasma gondii and Plasmodium berghei infections. Results Infected hosts exhibited significant weight loss, fever, hypoglycemia, elevated CD4+ and CD8+ T cell activation, increased pro-inflammatory cytokines IL-6, TNF-α, IFN-γ, and concurrent upregulation of IL-10. Gene expression analysis confirmed significant modulation of IL-6 and IL-10. Novelty The study provides an integrated assessment of physiological parameters, immune activation, cytokine production, and gene expression within a single experimental framework. Implications These findings highlight the complex balance between immune activation and regulation during parasitic infections and support the need for therapeutic strategies targeting immune modulation to improve parasite control while limiting immunopathology. 
Keywords: Parasitic Infection, Host Physiology, Immune Response, Cytokine Regulation, Experimental Model 
Key Findings Highlights: 


Experimental infection induced marked metabolic and thermoregulatory alterations in hosts. 


Adaptive immune activation involved significant CD4+ and CD8+ T cell responses. 


Concurrent pro- and anti-inflammatory signaling reflected immune regulation during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d13266d3422b83b381056bacac987b552d895ee5" target='_blank'>
              Physiological and Parasitological Interactions: Investigating Host Responses to Parasitic Infections through Experimental Analysis
              </a>
            </td>
          <td>
            Aliaa Kadhem Mohsin
          </td>
          <td>2026-01-05</td>
          <td>Academia Open</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Five years after the onset of the SARS-CoV-2 pandemic, post-COVID-19 condition continues to affect millions of subjects with persistent symptoms that significantly impair quality of life. Post-COVID-19 pain, particularly in women, has emerged as a frequent yet underestimated symptom. The validation and identification of animal models that reproduce persistent symptoms after an acute SARS-CoV-2 infection is crucial for a better understanding of the underlying mechanisms. The aim of the current study was to evaluate thermal nociception, biomarkers of inflammation, and nerve tissue damage in a female animal model of post-COVID-19 condition. A SARS-CoV-2 infection model was established by intranasal administration of the Omicron variant (BA.1.17 lineage) in transgenic female C57BL/6 mice expressing the human ACE2 receptor (hACE2). Nociception was assessed using the hot-plate test for 28 days post-infection. Afterwards, animals were sacrificed to analyze plasma inflammatory biomarkers by multiplex analysis. In addition, IL-6, IL-18, and IL-1β expression were evaluated by immunohistochemistry to analyze neural inflammation in the saphenous nerve. The results revealed that heat nociceptive thresholds in infected mice did not significantly differ from those of non-infected, but a trend toward lower thresholds was observed in the infected group (days 14 and 28 post-infection). In addition, a slight modification in pro- and anti-inflammatory cytokines/chemokines in plasma was detected, but no changes in the expression of IL-6, IL-1β, or IL-18 were observed in the saphenous nerve. Based on all the analyses conducted, infection with the Omicron variant of SARS-CoV-2 did not induce thermal sensitization in animals nor alterations in the expression of inflammatory biomarkers in the saphenous nerve. Finally, a slight state of systemic inflammation was present in the infected animals. The absence of detectable changes in this animal model underscores the need for further research to clarify the discrepancies observed in human patients and to explore alternative pathways potentially involved in post-COVID-19 pain syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c5891963e60492cf50fdb97401736f4c20927eb7" target='_blank'>
              Assessment of Nociception and Inflammatory/Tissue Damage Biomarkers in a Post-COVID-19 Animal Model
              </a>
            </td>
          <td>
            Eva M. Sánchez-Robles, C. Rodríguez-Rivera, Nancy Paniagua Lora, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-29</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="NLRP3 inflammasomes are transient large protein aggregates involved in the regulation of the innate immune response but are also associated with endothelial dysfunction during vascular inflammation. While NLRP3 inflammasome assembly and activation is well characterized in immune cells, its role in endothelial cell function remains incompletely understood. This study analyses the function of promyelocytic leukemia (PML) protein, a nuclear scaffold protein that forms so-called PML nuclear bodies (PML-NBs), in the regulation of NLRP3 inflammasome activation in endothelial cell cultures. Following LPS priming and subsequent ATP-induced activation, PML played a dual role: 1. It enhanced NF-kB-dependent transcription of inflammasome components (NLRP3, pro-caspase-1 and pro-IL-1β). 2. At the same time, a post-translational reduction in NLRP3 protein levels and reduced ASC oligomerization were observed, leading to impaired inflammasome activation, as evidenced by lower caspase-1 activity and reduced IL-1β secretion. Proper formation of PML-NBs was critical for this regulatory effect on NLRP3 inflammasome formation, as PML-NBs retained ASC in the nucleus and post-translationally modified NLRP3, presumably affecting its stability. Taken together, these findings suggest that PML represents a regulatory checkpoint in endothelial inflammasome activation, preventing excessive inflammatory responses that could contribute to vascular dysfunction associated with chronic inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/73a9a0c74403d4c59a5290bd06bf6c7239cfe64f" target='_blank'>
              PML Is Limiting NLRP3 Inflammasome Activity in Human Endothelial Cells
              </a>
            </td>
          <td>
            Celine Huajia Liem, Gustav Steinemann, Nona Ghiroltean, Yvonne Yvonne, Hana Sakr, Huyen Nguyen, Oliver Baum, Janine Berkholz
          </td>
          <td>2025-12-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29fe25ea72e27bc7febd50ceacab0f0b8d2a1098" target='_blank'>
              SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.
              </a>
            </td>
          <td>
            T. N. Almanaa, H. Al-kuraishy, A. Al-Gareeb, Maii A. Abdelnaby, A. Alexiou, M. Papadakis, Islam E Abo-ElFetoh, G. Batiha
          </td>
          <td>2025-12-18</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>52</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3fc8ff2573897e0ada53acc75e2ba0024f6203b5" target='_blank'>
              Natural killer cells mediated antibody dependent cellular cytotoxicity response in acute and recovery phases of chikungunya
              </a>
            </td>
          <td>
            Diptee Trimbake, M. Ganu, A. Ganu, Anuradha S. Tripathy
          </td>
          <td>2026-01-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV), a filamentous, enveloped, negative-sense, single-stranded RNA virus, is a common cause of respiratory infections in pediatric and elderly populations, often leading to severe inflammation and lung damage. To date, there is no effective treatment for RSV infection. Therefore, elucidating the antiviral mechanism in RSV infection is critical for identifying potential effective therapeutic targets. Type I interferons (IFN-Is), especially IFN-β, play a key role in the immediate immune response against viral infection by inhibiting viral load and spread. Current studies have shown that ARCN1 (archain 1), the δ subunit of the coat protein complex I complex, is involved in intra-Golgi trafficking and protein transport from the Golgi apparatus back to the endoplasmic reticulum. In this study, we demonstrate that ARCN1 suppresses the anti-RSV innate immune response by promoting E3 ubiquitin ligase STUB1-mediated K48-linked polyubiquitination and subsequent proteasomal degradation of IKKε. Mechanistically, ARCN1 recognizes and binds to the δL motif of STUB1 via its flexible MHD domain while interacting with IKKε. This finding provides a theoretical basis for the development of new antiviral treatment strategies targeting ARCN1.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32c87ced4d49da7da6a4806fe632d757e2e9e8ee" target='_blank'>
              ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation
              </a>
            </td>
          <td>
            Jiamin Cai, Yunfei Ye, Zhengrong Chen, Fei Xu, Xiaoping Li, Mengyun Wu, Ji Zhou, Yuanyuan Shao, Peijie Zhu, Jing Zhao, Jingjing Hu, Yufeng Wang, Cancheng Li, Xiaoyu Tian, Beibei Huang, Tian Xia, Wenjun Wang, Chuangli Hao, Yi Yang, Jinping Zhang
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/94b64011185dfb54ec2d4a0eac04b755388a3366" target='_blank'>
              Vitamin D differentially modulates effector and regulatory T-cell migration across the blood-brain barrier
              </a>
            </td>
          <td>
            Sasha Soldati, Alexander Bär, Felix Blumer, Arindam Pal, Saniya Kari, M. Vladymyrov, Ahmad Danial, Hideaki Nishihara, J. Killick, Adrian Mossu, Elisa Bouillet, Sara Barcos, Manon Galoppin, Maria Rosito, Urban Deutsch, Federica Sallusto, Mireia Sospera, Roland Martin, Fabien Gosselet, James L McGrath, E. Thouvenot, A. Astier, Britta Engelhardt
          </td>
          <td>2025-12-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="In nature, animals encounter diverse pathogens that trigger specific peripheral defense programs and elicit sickness behavior, a set of stereotyped physiological and behavioral changes thought to promote host fitness. Most studies to date have relied on one or a few mouse models of infection, limiting insights into pathogen-specific neuroimmune interactions that generate sickness. We hypothesized that different pathogens might elicit distinct sickness states by engaging different cell types and brain circuits. Using inflammatory models representing bacterial, viral, allergic, parasitic or colitis conditions, we assessed sickness across scales: organismal – behavior and physiology; cellular – brain-wide neural activity; and molecular – single-cell in situ transcriptomics in hypothalamus areas associated with social and homeostatic functions affected during sickness. Remarkably, immune challenges elicited unique repertoires of changes across all scales. Our findings reveal pathogen-specific sickness states encoded by the brain across scales, thereby broadening our understanding of how infections make us sick.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a973ce07eaa0ba52a5d26dc1ae4c7f5dadb199db" target='_blank'>
              Brain-immune interactions generate pathogen-specific sickness states
              </a>
            </td>
          <td>
            Zuri A. Sullivan, Bertrand J. Wong, Vikrant Kapoor, Paula Kathleen Vincze, Harris S. Kaplan, Pia Giraudet, Brianna R. Watson, Adel Misherghi, Sebastian Lourido, Jeffrey R. Moffitt, Catherine Dulac
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d503b9da216c3e9533c8e7c5f25f5ef7851a1e3" target='_blank'>
              Potential Mechanisms and Hypotheses for Pathogenic Microorganisms Triggering Kawasaki Disease
              </a>
            </td>
          <td>
            Jinhan Yu, Linlin Cheng, H. Zhan, Yuan Huang, Siyu Wang, Haolong Li, Yongmei Liu, Yingchun Xu, Ye Guo, Yongzhe Li
          </td>
          <td>2025-12-01</td>
          <td>Clinical Reviews in Allergy & Immunology</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="This review aims to discuss the apparent reduction in pulmonary cancer incidence in the general population during and shortly after the COVID-19 pandemic from a biological and pathophysiological mechanistic point of view. While the epidemiological evidence points to a disruption in the early- and mid-stage diagnostic process, which causes a shift to late-stage lung cancer discovery with no impact on its actual prevalence, an alternative hypothesis based on the intersection of viral and cancer biology could have a real effect on lung carcinogenesis as an independent phenomenon. By weaving together population-level trends, mechanistic insights, and translational oncology, we discuss whether the pandemic-associated decline in lung cancer diagnoses reflects primarily a temporary diagnostic artifact or whether it also reveals biologically relevant intersections between SARS-CoV-2 and pulmonary oncogenesis. The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has exerted profound and multifaceted effects on global healthcare systems, altering patterns of disease detection, management, and outcomes across nearly all medical disciplines. These disruptions generated what has been termed a “diagnostic deficit”, producing a backlog of undetected cancers that have only partially been recovered in subsequent years. This phenomenon, sometimes described as a “COVID-19 debt” in oncology, is thought to contribute to excess late-stage diagnoses and potentially worse medium-term survival outcomes. Beyond the disruption of medical systems, the pandemic also raised a more speculative but biologically intriguing question: could SARS-CoV-2 infection itself, through direct or indirect mechanisms, influence lung cancer biology? Our review aims to critically synthesize the evidence across seven domains to address this dual hypothesis. (1) We examine the observed effects of the pandemic on cancer incidence, highlighting global registry and health-system data; (2) we review SARS-CoV-2 infection biology, including viral entry, replication, protein functions, and treatment implications; (3) we summarize the pathogenesis of lung cancer; (4) we explore the role of immune checkpoints in tumor immune evasion, followed by (5) analyses of immune dysregulation in acute infection and (6) in long COVID; and (7) finally, we evaluate proposed oncogenic mechanisms of SARS-CoV-2, integrating molecular virology with cancer immunology. We conclude that the “diagnostic deficit” phenomenon was a reality during and immediately post-pandemic. However, a definitive answer to the questions related to the impact of the infection as an independent phenomenon would require advanced research information covering the biology of the viral infection and lung cancer oncogenesis: processes that are not currently implemented in routine clinical laboratory investigations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d0bf5466dfce0bf8184f1ba8da30a22761eadbf2" target='_blank'>
              COVID-19 and Lung Cancer Interactions: A Literature Review
              </a>
            </td>
          <td>
            S. László, E. Ianoși, A. Văsieșiu, Mioara Szathmáry, M. Ianoși, Delia-Liana Rachiș, Gabriel Nistor, G. Jimborean
          </td>
          <td>2025-11-30</td>
          <td>Medical Sciences</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1486b2a0665ed52ccf9a17b86e0809646ad8755a" target='_blank'>
              Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
              </a>
            </td>
          <td>
            A. Popa, Elena Popa, Tatiana Dramba, Elena-Adorata Coman, Mihaela Poroch, M. Ungureanu, A. Bacușcă, Ana-Maria Slanina, Gema Bacoanu, V. Poroch
          </td>
          <td>2025-11-25</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4437ab41c95bdd52966491c32a1d506d63726938" target='_blank'>
              A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID.
              </a>
            </td>
          <td>
            Saumya Kumar, Chaofan Li, Liang Zhou, Qiuyao Zhan, Ahmed Alaswad, Sonja Volland, Bibiana Costa, Simon Alexander Krooss, Isabel Klefenz, Hagen Schmaus, Antonia Zeuzem, Dorothee von Witzendorff, Helena Lickei, L. Pueschel, Anke R. M. Kraft, Markus Cornberg, A. R. Koczulla, I. Pink, Marius M. Hoeper, , Susanne Häussler, M. Wiestler, M. Netea, Thomas Illig, Jie Sun, Yang Li
          </td>
          <td>2026-01-14</td>
          <td>Nature immunology</td>
          <td>1</td>
          <td>16</td>
        </tr>

        <tr id="Recent evidence indicates the presence of micro- and nanoplastics in the human brain, with higher accumulation observed in patients with dementia. However, their mechanistic effects on the human brain at the cellular level remain underexplored. Astrocytes play a crucial role in repairing neurons following injury. The dysfunction of these cells can lead to chronic inflammation, a hallmark of neurodegenerative diseases. Here, we investigated the cytotoxic responses of primary human astrocytes exposed to polystyrene particles of two representative sizes, 25 nm and 1 µm, at concentrations of 1 µg/mL and 5 µg/mL for 48 h. Flow cytometry and confocal microscopy revealed the accumulation of particles of both sizes within the cytoplasm. Functional assays revealed reduced cell viability and elevated lactate dehydrogenase release, indicating cytotoxic effects following microplastic exposure. Gene expression analysis showed significant upregulation of MAPK14 and SOD2, indicating oxidative stress activation, and increased expression of pro-inflammatory mediators IL-6, TNF-α, and NF-κB1. In parallel, GLUT1 transcripts and GLUT1-positive cell populations were markedly reduced, suggesting impaired glucose metabolism. Collectively, these findings demonstrate that microplastics disrupt astrocytic homeostasis by inducing oxidative, inflammatory, and metabolic disturbances, leading to a reactive yet metabolically compromised phenotype. This study demonstrates the cellular damage caused by microplastics in astrocytes, which may contribute to a cellular mechanism linking environmental pollutant exposure to adverse effects on human health.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b4a444847bec1a8e3b6343a2e2a6ace142cf5a6c" target='_blank'>
              Polystyrene Micro- and Nanoplastic Exposure Triggers an Activation and Stress Response in Human Astrocytes
              </a>
            </td>
          <td>
            Sonia Kiran, Uvindu Thilanka, Yu Xue, Qing-Xiang Amy Sang
          </td>
          <td>2025-11-21</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab1122feba592e78c752f720f21f2f717ed0c328" target='_blank'>
              Modelling severe COVID-19 in TLR3-mutated hiPSCs-derived lung organoids.
              </a>
            </td>
          <td>
            A. Latini, P. Spitalieri, F. Centofanti, B. Rizzacasa, Donatella Amatore, G. Grilli, Riccardo De Santis, Lorenzo Vaccaro, V. L. Colona, Giulio Puleri, A. Nardone, M. Biancolella, Elena Campione, L. Sarmati, Paola Rogliani, Davide Cacchiarelli, A. Novelli, Federica Sangiuolo, F. Lista, Giuseppe Novelli
          </td>
          <td>2025-12-26</td>
          <td>Cell death discovery</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/97aa2343cc3f40eb7c452dc50f451e6fac835427" target='_blank'>
              The role of pyroptosis during HIV infection
              </a>
            </td>
          <td>
            M. Yaseen, Nizar M. Abuharfeil, H. Darmani, Mohammed N. Shatnawi
          </td>
          <td>2026-01-08</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="The COVID-19 pandemic has demonstrated that its effects go far beyond the initial respiratory illness, with many survivors experiencing lasting neurological problems. Some patients develop a condition known as Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), which includes current issues such as reduced cognitive function, chronic headaches, depression, neuropathic pain, and sensory disturbances. These symptoms can severely disrupt daily life and overall well-being. In this narrative review, we provide an overview of current understanding regarding the neurological effects of COVID-19, with a focus on Long COVID. We discuss possible underlying mechanisms, including direct viral invasion of the nervous system, immune-related damage, and vascular complications. We also summarize findings from cohort studies and meta-analyses that explore the causes, symptom patterns, and frequency of these neurological issues. Approximately one-third of people who have had COVID-19 report neurological symptoms, especially those who experienced severe illness or were infected with pre-Omicron variants. Emerging research has identified potential biomarkers such as neurofilament light chain (NFL) and glial fibrillary acidic protein (GFAP) that may help in diagnosis. Treatment approaches under investigation include antiviral medications, nutraceuticals, and comprehensive rehabilitation programs. Factors like older age, existing health conditions, and genetic differences in ACE2 and TMPRSS2 genes may affect an individual’s risk. To effectively address these challenges, current research is essential to improve diagnostic methods, develop targeted treatments, and enhance rehabilitation strategies. Ultimately, a coordinated, multidisciplinary effort is crucial to reduce the neurological impact of Long COVID and support better recovery for patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ffce28a9cb072c289f8e3889294366d640062728" target='_blank'>
              Neurological Sequelae of Long COVID: Mechanisms, Clinical Impact and Emerging Therapeutic Insights
              </a>
            </td>
          <td>
            Muhammad Danial Bin Che Ramli, Beevenna Kaur Darmindar Singh, Zakirah Zainal Abidin, Athirah Azlan, Amanina Nurjannah, Zaw Myo Hein, Che Mohd Nasril Che Mohd Nassir, Rajesh Thangarajan, Noor Aishah Bt. Mohammed Izham, Suresh Kumar
          </td>
          <td>2025-12-16</td>
          <td>COVID</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Introduction Aging increases vulnerability of the elderly to influenza, but the mechanisms have not been fully understood. Although lethally infected aged mice are frequently used as models of influenza infection in the elderly, they are more suitable for studying mortality rather than the increased disease severity frequently observed in non-lethal infections. Therefore, understanding age-related differences under sublethal infection conditions is crucial. Methods Adult (8–12 months) and aged (22–24 months) mice were infected with a sublethal dose of H1N1 (PR8). Body weight loss, lung viral titers, pulmonary innate immune cell composition, and transcriptional levels of key inflammatory cytokines were assessed. Results Despite similar body weight loss, the aged mice showed significantly higher lung viral titers at day 8. Notably, key innate immune populations, including alveolar macrophages, neutrophils, and eosinophils, showed distinct age-related patterns. In the adult mice, alveolar macrophages negatively correlated with weight loss, whereas no protective immune factor was identified in the aged mice. Moreover, our data showed that persistent viral replication led to distinct innate immune cell composition in the adult and aged mice despite comparable transcription levels of inflammatory cytokines. The numbers and frequencies of both the neutrophils and eosinophils were significantly higher in the virus-persistent adult mice than those in the virus-persistent aged mice. Discussion Our findings reveal skewed acute immune responses to influenza in aged mice, which may partially account for their mild weight loss despite delayed viral clearance and highlight age-related impairments in early antiviral immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5c351ed0e5d3df4fe77cb078ab0d2b65afface5c" target='_blank'>
              Skewed pulmonary innate immune cell composition underlies the delayed influenza clearance in aged mice
              </a>
            </td>
          <td>
            Xiaoyang Cheng, Fang Zhao, Jing Wu, Yanmin Wan, Zhaoqin Zhu, Jialin Jin
          </td>
          <td>2025-12-10</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated not only with respiratory illness but also with profound vascular and coagulation disturbances. Long COVID (LC) is characterized by persistent symptoms such as fatigue, dyspnea, cognitive impairment, and palpitations. Mechanistically, SARS-CoV-2 induces direct endothelial injury, promotes a pro-inflammatory cytokine milieu, and activates platelets, leading to immunothrombosis and impaired fibrinolysis. Consequently, patients exhibit microthrombosis, elevated plasma D-dimer, fibrinogen dysregulation, and persistent hypercoagulability. Clinically, this translates into an increased risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as well as arterial thrombotic events such as myocardial infarction and stroke, which may persist months after acute infection. Understanding the interplay between endothelial injury, inflammation, and coagulation is crucial for risk stratification and the development of preventive and therapeutic strategies. We conducted a systematic narrative review of the literature, including human clinical and mechanistic studies identified through PubMed, Scopus and Web of Science up to 30 September 2025. This review synthesizes current evidence on vascular complications in LC, highlighting endothelial dysfunction as a central pathophysiological nexus linking the acute phase of SARS-CoV-2 infection with chronic LC manifestations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f14dffbb63f077cbdc46f26a8295d84afd04c13d" target='_blank'>
              Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis: A Systematic Review
              </a>
            </td>
          <td>
            Maja Stojanović, Marko D Djuric, Irina B Nenadic, Suzana C. Bojic, Ana Andrijevic, Aleksa Popovic, Slobodan Pešić
          </td>
          <td>2025-12-31</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Background. Post-viral vasculitis represents a heterogeneous inflammatory condition in which persistent immune dysregulation following acute infection or viral reactivation contributes to vascular pathology. SARS-CoV-2, Epstein–Barr virus (EBV), human herpesvirus 6 (HHV-6), and human herpesvirus 7 (HHV-7) are capable of inducing prolonged immune alterations, particularly in mature individuals. 
Objective. To characterize immune dysregulation in patients with post-viral vasculitis associated with SARS-CoV-2 and herpesvirus reactivation, with emphasis on regulatory T cells, adaptive immune remodeling, innate immune activation, and age-related differences. 
Methods. Fifty-eight patients with post-viral vasculitis (post–COVID-19, n = 26; EBV/HHV-6/HHV-7, n = 32) and 20 healthy controls underwent extended immunophenotyping by multiparametric flow cytometry. Patients were additionally stratified by age (19–45 and 45–63 years). 
Results. Post–COVID-19 vasculitis was characterized by reduced regulatory T-cell frequencies and expansion of memoryCD4+  T cells compared with herpesvirus-associated vasculitis. Herpesvirus-associated cases demonstrated pronounced memory T-cell predominance, reduced memory B-cell compartments, and increased cytotoxic NK-cell subsets. Age stratified analysis revealed more severe immune dysregulation in patients aged 45–63 years, with the most pronounced regulatory T-cell depletion observed in post–COVID-19 vasculitis. 
Conclusions. Post-viral vasculitis exhibits virus-specific and age-dependent immune signatures. SARS-CoV-2–associated vasculitis is marked by profound impairment of immunoregulatory mechanisms, particularly in mature patients, whereas herpesvirus-associated vasculitides demonstrate distinct patterns of adaptive and innate immune activation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ffa2838d42060f9645ebd356c40df1bad9138e9" target='_blank'>
              REGULATORY T-CELL ACTIVITY AS A MARKER OF POST–COVID-19 AND HERPETIC SECONDARY VASCULITIS IN YOUNG AND MATURE PATIENTS
              </a>
            </td>
          <td>
            K. Lishchuk-Yakymovych, Valentyna Chopyak, Omelian Synenkyi, R. Pukalyak
          </td>
          <td>2025-12-31</td>
          <td>Anti-Aging Eastern Europe</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background Retinal neurodegenerative diseases, including diabetic retinopathy and age-related macular degeneration, are characterized by the slow, chronic degeneration of photoreceptors. We previously used a chronic low light (CLL) exposure to model slow photoreceptor degeneration in adult zebrafish. Here, we investigate transcriptional, morphological, and functional responses of microglia in the CLL model. Methods Microglia-specific gene expression analysis was mined from our previously reported 3′ RNA-seq data performed at 8 time points during 28 days of CLL exposure. Morphological changes were performed on retinas collected at various time points using immunohistochemistry. Microglial inhibition was accomplished pharmacologically with dexamethasone and genetically using the irf8−/− mutant fish. Finally, we returned the CLL-treated fish to normal light/dark conditions to test whether photoreceptors could recover in the context of chronic stress. Results CLL induced dynamic, time-dependent upregulation of microglia-specific genes consistent with pro-inflammatory and pro-resolving function. Dexamethasone treatment reduced microglial numbers and exacerbated rod and cone outer segment damage, whereas irf8−/− mutants exhibited partial protection against photoreceptor damage. Notably, despite prolonged stress and damage during the CLL exposure, photoreceptor outer segments returned to near-baseline morphology after 28 days of normal light/dark recovery conditions. Discussion Overall, these findings suggest that microglial function in chronic retinal injury is context-dependent as pharmacological and genetic methods of inhibition produced contrasting outcomes depending upon microglial polarization.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3e38a1a439a93a8994094db441f7361b6b9879be" target='_blank'>
              Microglia response and function in a chronic model of photoreceptor damage
              </a>
            </td>
          <td>
            Deepa Raghavan, Olivia Jeakle, Yasmeen Berry, Majd Victor, Ryan Thummel
          </td>
          <td>2025-12-16</td>
          <td>Frontiers in Cell and Developmental Biology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent
 of coronavirus disease 2019 (COVID-19), invades host cells through the
 angiotensin-converting enzyme 2 (ACE2) receptor, leading to cellular injury.
 Because ACE2 is expressed not only in the lungs but also in vascular
 endothelium, the heart, kidneys, and gastrointestinal tract, infection can
 result in multiorgan involvement. SARS-CoV-2 infection disrupts the
 renin–angiotensin–aldosterone system (RAAS), promoting
 vasoconstriction and fibrosis, while activation of the coagulation pathway
 accelerates thrombus formation. In addition, hyperactivation of the innate
 immune system triggers excessive inflammation. Although COVID-19 in children and
 adolescents is generally mild or asymptomatic, some develop multisystem
 inflammatory syndrome in children (MIS-C) several weeks after infection. We
 describe two children who developed MIS-C after SARS-CoV-2 infection. Both had
 fever persisting for more than three days, raised cardiac biomarkers, and
 impaired left ventricular systolic function on echocardiography, with an
 ejection fraction below 45%. Serologic testing confirmed previous SARS-CoV-2
 exposure in each case. The first patient exhibited signs that resembled
 incomplete Kawasaki disease (KD), such as conjunctival injection, a truncal
 erythematous rash, and swelling of the hands and feet. In contrast, the second
 patient presented with acute endocarditis and myocarditis, accompanied by a
 thrombus in the right ventricle. Treatment consisted of intravenous
 immunoglobulin, methylprednisolone, and antithrombotic agents. Their cardiac
 function improved completely, and both recovered without residual complications.
 This report emphasizes the importance of distinguishing MIS-C from KD in
 clinical practice. It also raises the possibility that their overlapping
 features may stem from a shared pathophysiological process linked to ACE2
 expression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aea54585ba82e168c42d6b110dc8541ae4188e36" target='_blank'>
              Pathophysiological Connection between MIS-C Following SARS-CoV-2
 Infection and Kawasaki Disease: The Role of ACE2 Expression
              </a>
            </td>
          <td>
            Naeun Shin, L. Eun
          </td>
          <td>2025-12-01</td>
          <td>Kawasaki Disease</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1908b3b3226f8c7878c6e6b6c337b73f90a53429" target='_blank'>
              Dual-function cytokines as modulators of autophagy: reprogramming inflammatory resolution in severe COVID-19
              </a>
            </td>
          <td>
            Sohrab Khan, Ping Tang, Pingchang Yang, Jing Li, Haiqiang Wu
          </td>
          <td>2026-01-08</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, has had a profound global impact. Diabetes mellitus is a major comorbidity associated with higher infection risk, severe disease, and mortality in COVID-19 patients. This review examines the bidirectional relationship between COVID-19 and diabetes, focussing on immunometabolic mechanisms, post-COVID metabolic effects, and therapeutic implications. A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science for articles published until May 2025 using the terms "COVID-19," "SARS-CoV-2," "diabetes," and "immunometabolism." Peer-reviewed studies addressing clinical, molecular, or therapeutic interactions between the two diseases were included. Evidence shows that SARS-CoV-2 infection aggravates metabolic dysfunction through immune dysregulation, cytokine-mediated inflammation, and β-cell injury. Hyperglycemia promotes viral replication and inflammatory damage, creating a vicious cycle that worsens outcomes. Reports also indicate an increased risk of new-onset and post-COVID diabetes. Certain antidiabetic agents, such as metformin and GLP-1 receptor agonists, may improve prognosis via anti-inflammatory and metabolic effects. Diabetes significantly amplifies the severity of COVID-19 through intertwined metabolic and immune mechanisms. Understanding these interactions provides new insights into disease management and supports the development of targeted immunometabolic therapies for improving outcomes in diabetic patients affected by COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80e954bc39ab4c596e3acc382fff9dbe2db6d37d" target='_blank'>
              COVID-19 in Diabetic Patients: Mechanisms, Risks, and Therapeutic Considerations.
              </a>
            </td>
          <td>
            Rania Hamdy, Amal Z Barakat, Eman J Abuzaid, Tasneem Elsayed, M. Husseiny
          </td>
          <td>2025-12-04</td>
          <td>Reviews in medical virology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Long COVID (LC) is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated chronic condition and is present for at least 3 months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems, including cardiovascular. Extensive literature supports an association between SARS-CoV-2 infection and cardiovascular complications and increased cardiovascular risk after infection. The cardiovascular sequelae after SARS-CoV-2 infection have not yet been comprehensively characterized. A growing body of evidence suggests that endothelial dysfunction is a central mechanism in COVID-19 and has also been identified as a key pathogenic mechanism in LC. Although considerable progress has been made in characterizing the epidemiology, clinical course, and biology of LC, many questions remain unanswered. The incomplete understanding of the pathomechanisms of LC has hampered the development of targeted therapies to date. Further research and data are needed to develop effective therapeutic and preventive tools. Based on current literature this review aims to provide an up-to-date overview of the pathomechanisms affecting the cardiovascular system and the potential role of selected micronutrients, vitamins and minerals, and flavonoids as preventive and therapeutic strategies in LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fecb1ed06a4859e6569f30b68493347d474b7177" target='_blank'>
              Cardiovascular damage and comorbidities related to long COVID: pathomechanisms, prevention, and therapy
              </a>
            </td>
          <td>
            M. Kvandová, P. Balis, B. Kaločayová, Jana Vlkovicova, Silvia Dobrodenkova, A. Puzserova
          </td>
          <td>2025-12-03</td>
          <td>Frontiers in Cardiovascular Medicine</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="ABSTRACT Astrocytes are central to lipid metabolism in the central nervous system. Due to their morphological and functional characteristics, astrocytes can uptake fatty acids (FAs) from the bloodstream and extracellular space and store them in lipid droplets (LD). LD are dynamic organelles, whose accumulation in astrocytes has been shown to occur upon exposure to various stress stimuli. Different hypotheses proposed to explain motor neuron degeneration in amyotrophic lateral sclerosis (ALS) implicate mitochondrial dysfunction and oxidative stress. Mitochondrial dysfunction in astrocytes is associated with elevation of cytoplasmic lipids and lipid‐binding proteins. We observed increased LD in the spinal cord of symptomatic ALS mice, as well as in human transdifferentiated astrocytes obtained from ALS patients. Using a co‐culture model, we examined the effect of FA overload and its impact on astrocyte–motor neuron interaction. LD accumulation was tightly coupled with an NF‐κB‐driven proinflammatory response in nontransgenic astrocytes, correlating with motor neuron toxicity. These results provide additional evidence to the notion that altered energy balance may contribute to neuronal death in ALS. Furthermore, pharmacological inhibition of lactate dehydrogenase (LDH) reversed LD accumulation in mouse and human astrocytes expressing ALS‐linked mutations. Genetic ablation of LDHA similarly reduced LD accumulation in response to FA treatment. Collectively, our data underscore the role of lipid metabolism in astrocyte–neuron interactions in ALS models and suggest that LD accumulation, rather than serving solely as a protective mechanism, reflects a metabolic stress state linked to a detrimental phenotypic transformation in astrocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5605fe78a98aec0380a589f4afae28a324a82f4d" target='_blank'>
              Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes
              </a>
            </td>
          <td>
            Daniel Esteve, Mariana Bresque, Daniel Okhuevbie, Sandhya Ramachandran, Mariana Pehar, Marcelo R. Vargas
          </td>
          <td>2026-01-06</td>
          <td>Glia</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="SARS-CoV-2, the virus responsible for COVID-19, disrupts human cellular pathways through complex protein–protein interaction, contributing to disease progression. As the virus has evolved, emerging variants have exhibited differences in transmissibility, immune evasion, and pathogenicity, underscoring the need to investigate their distinct molecular interactions with host proteins. In this study, we constructed a comprehensive SARS–CoV–2–human protein–protein interaction network and analyzed the temporal evolution of pathway perturbations across different variants. We employed computational approaches, including network-based clustering and functional enrichment analysis, using our custom-developed Python (v3.13) pipeline, BioEnrichPy, to identify key host pathways perturbed by each SARS-CoV-2 variant. Our analyses revealed that while the early variants predominantly targeted respiratory and inflammatory pathways, later variants such as Delta and Omicron exerted more extensive systemic effects, notably impacting neurological and cardiovascular systems. Comparative analyses uncovered distinct, variant-specific molecular adaptations, underscoring the dynamic and evolving nature of SARS-CoV-2–host interactions. Furthermore, we identified host proteins and pathways that represent potential therapeutic vulnerabilities, which appear to have co-evolved with viral mutations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/69099fff2803ece73e94ac8189f87993409fb26a" target='_blank'>
              Temporal Profiling of SARS-CoV-2 Variants Using BioEnrichPy: A Network-Based Insight into Host Disruption and Neurodegeneration
              </a>
            </td>
          <td>
            Sreelakshmi Kalayakkattil, Ananthakrishnan Anil Indu, Punya Sunil, Haritha Nekkanti, Smitha Shet, Ranajit Das
          </td>
          <td>2025-12-05</td>
          <td>COVID</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Sepsis is a life-threatening condition marked by dysregulated immune responses and organ dysfunction, with macrophages playing central roles in both hyperinflammation and immunosuppression. Recent advances highlight mitochondrial metabolism as a key regulator of macrophage polarization and function. Pro-inflammatory M1 macrophages rely on glycolysis and produce high levels of reactive oxygen species (ROS) and cytokines, while reparative M2 macrophages depend on oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO). Mitochondrial dysfunction—characterized by excessive mitochondrial ROS (mtROS), impaired mitophagy, and disrupted fission/fusion dynamics—exacerbates immune dysregulation and tissue injury. Organ-specific macrophage metabolic reprogramming further influences sepsis pathology, particularly in the kidney, lung, and heart. Therapeutic strategies targeting mitochondrial pathways—such as small-molecule modulators, stem cell-derived extracellular vesicles, and RNA-based gene therapies—have shown promise in restoring macrophage homeostasis and improving outcomes. This review underscores the importance of immunometabolic regulation in sepsis and advocates for mitochondria-targeted interventions as a novel precision approach to immune modulation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/28a95befdb160cdec7982590929761d8997fba7a" target='_blank'>
              Mitochondrial immunometabolism in sepsis: orchestrating macrophage polarization and dysfunction
              </a>
            </td>
          <td>
            Ke Yang, Qiang Zhao, Youhan Sun, Li Lin, Xiao Han
          </td>
          <td>2025-12-02</td>
          <td>European Journal of Medical Research</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="ABSTRACT Enterovirus 71 (EV71) is a viral pathogen responsible for causing hand, foot, and mouth disease, which can lead to severe neurological complications. This study aims to elucidate the pyroptosis mechanism underlying brain injury induced by EV71 infection. EV71-infected BALB/c suckling mice exhibited characteristic symptoms, including weight loss, lethargy, and limb weakness. Notably, elevated levels of the inflammatory proteins IL-1β and IL-18 were detected in the brain tissue of the infected mice. Research findings indicate that EV71 infection activates the NLRP3 inflammasome, resulting in an increased release of IL-1β and IL-18. Furthermore, upregulation of the expression of Caspase-1, Caspase-11, and the pyroptosis-related protein GSDMD was observed in the context of EV71 infection. Importantly, the administration of inhibitors targeting Caspase-1 and Caspase-11 led to the downregulation of these protein expression levels and simultaneously reduced the severity of the inflammatory response in the brain tissue. These results highlight the critical regulatory role and cross-talk between Caspase-1 and Caspase-11 in EV71-induced brain injury, which involves inflammatory responses and pyroptosis. The significance of these findings enhances our understanding of the pathogenic mechanisms associated with EV71 infection and offers valuable insights for the development of new therapeutic strategies. IMPORTANCE This study elucidated the molecular mechanism underlying pyroptosis-mediated brain injury during EV71 infection in hand, foot, and mouth disease (HFMD), addressing a critical knowledge gap in neuroinflammatory pathogenesis. Using a BALB/c suckling mouse model, we demonstrated that EV71 infection induced a significant upregulation of the pro-inflammatory cytokines IL-1β and IL-18 in brain tissues. Mechanistically, the activation of the caspase-1/11-GSDMD axis was confirmed via Western blot analysis, which revealed an increase in cleaved GSDMD levels in the presence of EV71, indicating a definitive link between the virus and pyroptotic cell death, as supported by studies on GSDME’s role in EV71-induced cell pyroptosis. Specific inhibitors targeting caspase-1/11 have been shown to effectively suppress protein expression, reduce neuroinflammatory markers, and improve survival rates, as demonstrated in studies involving acute pancreatitis, EAE, and non-canonical cell death. These findings not only advance the understanding of EV71 neuropathogenesis but also identify caspase-1/11 as promising therapeutic targets for mitigating HFMD-associated brain injury. This study elucidated the molecular mechanism underlying pyroptosis-mediated brain injury during EV71 infection in hand, foot, and mouth disease (HFMD), addressing a critical knowledge gap in neuroinflammatory pathogenesis. Using a BALB/c suckling mouse model, we demonstrated that EV71 infection induced a significant upregulation of the pro-inflammatory cytokines IL-1β and IL-18 in brain tissues. Mechanistically, the activation of the caspase-1/11-GSDMD axis was confirmed via Western blot analysis, which revealed an increase in cleaved GSDMD levels in the presence of EV71, indicating a definitive link between the virus and pyroptotic cell death, as supported by studies on GSDME’s role in EV71-induced cell pyroptosis. Specific inhibitors targeting caspase-1/11 have been shown to effectively suppress protein expression, reduce neuroinflammatory markers, and improve survival rates, as demonstrated in studies involving acute pancreatitis, EAE, and non-canonical cell death. These findings not only advance the understanding of EV71 neuropathogenesis but also identify caspase-1/11 as promising therapeutic targets for mitigating HFMD-associated brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c322c9f621ed76545357fb58c7ef5e681afa5b13" target='_blank'>
              Enterovirus 71 infection induces pyroptotic brain injury via synergistic activation of classical inflammasome and viral gasdermin D cleavage
              </a>
            </td>
          <td>
            Tianrun Liu, Baixin Wang, Yingyu Li, Shuming Tian, Xinlong Gao, Yuhan Fan, Xiaomeng Zhang, Limin Yang, Rui Wu, Lei Liu
          </td>
          <td>2025-11-25</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The devastating clinical, psychological, and economic impact of the COVID‐19 pandemic, caused by global spread of the second Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV‐2), has engendered a massive response from the scientific community to rapidly understand the biology of SARS‐CoV‐2 and to develop interventions to prevent infection or progression to life‐threatening disease. Angiotensin converting enzyme‐2 (ACE2) and its interaction with the SARS‐CoV‐2 Spike glycoprotein, which mediates fusion of the virion envelope with the target cell membrane, have emerged as a major pharmacological target, as disruption of the Spike‐ACE2 interaction prevents cells from becoming infected and hence from producing viral progeny. Moreover, the dysregulation of ACE2 that occurs in the context of SARS‐CoV‐2 infection may have broader implications for COVID‐19 pathogenesis. Here we summarize the role of ACE2 as a physiologic regulator of human health, as a facilitator of SARS‐CoV‐2 infection, as a factor in COVID‐19 disease, and as a target for pharmacological interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2e59f0d9c946db9a9c160b8605a6c2ca92d39a0" target='_blank'>
              The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions
              </a>
            </td>
          <td>
            M. McVoy, A. Kummarapurugu
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bce54efd110fde03077139b1afa9c1f4e6856c6b" target='_blank'>
              Single-cell analysis of B cell dysregulation in pediatric sepsis stratified by disease severity.
              </a>
            </td>
          <td>
            Fahd Alhamdan, Stefano Gianoli, Koichi Yuki, S. Koutsogiannaki
          </td>
          <td>2025-12-31</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Previous studies have reported that Enterovirus A71 (EV-A71) infection could activate STING-related signaling pathways in vitro, but the role of STING in EV-A71 infection in vivo and the associated immune regulatory mechanisms remain unclear. Here, we used the STING-specific agonist diABZI to activate STING and STING-knockout mice to jointly study the role and mechanism of regulating STING on EV-A71 infection in vivo. The results showed that activating STING could inhibit the in vivo replication of EV-A71, alleviate clinical symptoms in infected mice, and increase the survival rate. Conversely, STING knockout significantly promoted viral replication in vivo and increased the lethality and severity of EV-A71 infection. Mechanistic studies further revealed that STING activation exerts its antiviral effects by stimulating interferon signaling pathways, upregulating the expression of interferon-stimulated genes (ISGs). Additionally, STING activation also modulated the serum cytokine response profile. Moreover, STING activation drove the expansion of diverse immune cell populations, including T cells, natural killer (NK) cells and myeloid cells. In contrast, STING knockout not only reduced the proportion of thymic T cells and impeded T cell developmental progression from double-positive (DP) to single-positive (SP) stages, but also impaired the effector functions of CD8+ T cells and NK cells during viral infection. In summary, this study demonstrates that STING activation effectively suppresses EV-A71 replication and mitigates infection symptoms by modulating immune and inflammatory responses. These findings provide a foundational framework for understanding how STING coordinates antiviral immunity and inform future investigations into STING-targeted therapies for viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72199499c121db0d6bd3e81f6d9ddb6358a3f1ff" target='_blank'>
              STING Restricts EV-A71 Infection by Regulating T Cell Development and Enhancing Immune Cell Effector Function
              </a>
            </td>
          <td>
            Huiqiang Wang, Ya Wang, Shuo Wu, Lijun Qiao, Wen Sheng, Hai-yan Yan, Kun Wang, Ge Yang, Jian-dong Jiang, Yuhuan Li
          </td>
          <td>2025-11-26</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="With the global rise in population aging, establishing effective strategies for the prevention and treatment of age-related neurodegenerative diseases, as well as their prodromal stage of cognitive frailty, has become an urgent challenge. Recent studies have revealed that the neural basis of both frailty and age-related disorders is closely associated with chronic neuroinflammation and impaired clearance of cellular debris, processes that are primarily regulated by microglia, the resident immune cells of the brain. As aging progresses, microglia exhibit reduced surveillance and motility, diminished phagocytic efficiency, and transition into a proinflammatory, hyperresponsive state. Such maladaptive microglia contribute to synaptic loss, white matter deterioration, and the spread of neurodegenerative pathology. Conversely, single-cell transcriptomic studies have identified distinct microglial subsets, including CD11c+ microglia, which show upregulation of lysosomal and lipid metabolism pathways, enhanced debris clearance, and elevated neurotrophic factor expression. These features suggest that certain microglial populations adopt protective or adaptive phenotypes that preserve neural integrity. However, under chronic inflammation or pathological conditions, even protective microglia may become inflammation-promoting. This review summarizes current evidence on microglial changes in aging, frailty, and neurodegeneration, emphasizing their dual roles and discussing strategies that modulate microglial function to maintain brain health and prevent or treat frailty and age-related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/951a2bde7a1ce8313cd885132ad9f0b3d11cffc8" target='_blank'>
              Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?
              </a>
            </td>
          <td>
            Kentaro Ishikawa, Risako Fujikawa, Kayoko Okita, Fumika Kimura, Takuya Watanabe, S. Katsurabayashi, Katsunori Iwasaki
          </td>
          <td>2025-11-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Background/objectives The complex interplay between sarcoidosis and COVID-19 remains an important area of research, since COVID-19 leads to long-term changes in the immune system. However, COVID-19 is often followed by autoimmune diseases, including newly manifesting sarcoidosis. The goal of this study is to characterize CD4+ T cell subsets, playing a pivotal role in the regulation of innate and adaptive immunity, in the peripheral blood of patients with sarcoidosis after COVID-19. Methods The peripheral blood samples from patients with sarcoidosis (n = 61) were studied. We divided patients into two distinct groups: sarcoidosis patients with no history of COVID-19 (n= 30) and COVID-19 convalescent patients with sarcoidosis within 12–24 weeks after recovery (n = 31). Healthy controls (n = 40) were similar in terms of age and sex to patients with sarcoidosis. Immunophenotyping of peripheral blood cells was performed using a ten-color flow cytometry. Results Sarcoidosis patients with COVID-19 history had higher levels of T-helper cells (Th) when compared to COVID-19 naïve patients with sarcoidosis, but lower levels when compared to healthy controls. In COVID-19 convalescent patients with sarcoidosis, we noted higher absolute numbers and percentages of CD45RA–CCR7– and CD45RA+CCR7– cells within Th subset. Among COVID-19 convalescent patients with sarcoidosis we also found higher levels of T helper 1 cells and T helper 2 cells (with CXCR5–CCR6–CXCR3+CCR4– and CXCR5–CCR6–CXCR3–CCR4+ phenotypes, respectively) when compared to other groups. We also noted a statistically significant increase in central memory CXCR5+CCR6–CXCR3– follicular Th cells, as wells as effector memory CXCR5+CCR6–CXCR3– and CXCR5+CCR6+CXCR3– follicular Th cells in both groups of patients with sarcoidosis vs. healthy controls. Conclusions Our study demonstrated Th cells imbalance in patients with sarcoidosis and COVID-19 history. These findings suggest possible clinical and visual progression of chronic lung sarcoidosis in COVID-19 convalescent patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/532c2a46c2caa9fb95b8e3141b2c680f9a900d65" target='_blank'>
              Immune responses in pulmonary sarcoidosis following COVID-19
              </a>
            </td>
          <td>
            A. Starshinova, Igor Kudryavtsev, Artem Rubinstein, T. Akisheva, A. Golovkin, Z. Korobova, Anastasia Kulpina, D. Kudlay
          </td>
          <td>2025-11-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Many studies have shown an association between herpes simplex virus type 1 (HSV-1) infection and the development of neurodegeneration processes later in life, such as Alzheimer’s disease. The Fas/FasL death pathway plays an important role in the complex regulation of the local inflammatory response and mounting of the specific antiviral response in HSV-1 infection. Here, we applied a mouse model of latent HSV-1 neuroinfection to Fas- and FasL-deficient mice (lpr and gld) to explore whether the lack of functional Fas/FasL pathway protects from inflammation-related neurodegeneration. The latently infected Fas- and FasL-deficient mice (lpr and gld) were not protected from virus replication despite the accumulation of virus-specific cytotoxic T cells. However, the lack of Fas/FasL pathway decreased neuroinflammation- and neurodegeneration-related markers, including cognitive impairment, amyloid-β protein, and tau hyperphosphorylation. The use of a glucocorticoid, dexamethasone, to decrease neuroinflammation in wild-type mice did not protect from cognitive impairment, despite the improved antiviral response. Our data indicate that excessive neuroinflammation via the Fas/FasL pathway during HSV-1 infection is associated with neurodegeneration. Furthermore, the administration of immunomodulatory agents to ameliorate the outcome of HSV-1 latent infection should be restricted to the peak of neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ae344fac498d71f5308786f29214c408bb4c753" target='_blank'>
              Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration
              </a>
            </td>
          <td>
            Magdalena Patrycy, Agnieszka Kauc, Martyna Janicka, Aleksandra Osińska, Andrzej Kowalczyk, Katarzyna Skulska, Małgorzata Antos-Bielska, Marcin Chodkowski, Kristina Eriksson, Małgorzata Krzyżowska
          </td>
          <td>2025-12-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/67b6398ddc5edaa94a066851abec2558753a9728" target='_blank'>
              NLRP1 Shapes Immune and Inflammatory Signatures in Human Melanoma but Not in Mouse Models
              </a>
            </td>
          <td>
            V. P. Targhetta, Raquel de Souza Vieira, Hedden Ranfley, C. N. de Souza Breda, N. O. Câmara
          </td>
          <td>2025-11-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has resulted in more than 7.1 million deaths worldwide since 2019 and is increasingly recognized for its cardiovascular complications beyond respiratory disease. Growing evidence suggests that the SARS-CoV-2 spike protein itself, present during infection or after vaccination, may directly contribute to cardiac dysfunction, including myocarditis, through interaction with angiotensin-converting enzyme 2 (ACE2) receptors expressed in cardiomyocytes. To investigate these effects, we established a lentiviral-based SARS-CoV-2 pseudovirus system expressing spike proteins from the Wuhan and Delta variants and examined their impact on human embryonic stem cell-derived cardiomyocytes (ESC-CMs). Exposure to pseudovirus resulted in significant increases in sarcomere length and promoted syncytium formation in ESC-CMs. Moreover, infection with either Wuhan or Delta spike pseudoviruses caused marked early disturbances in intracellular calcium transient dynamics as early as 1.5 hours post-infection, with partial recovery observed by 24 hours. Transcriptomic analyses further revealed significant dysregulation of key cardiac-related genes involved in cell junction organization, structural integrity, ion channel function, and calcium handling. Together, these findings demonstrate the utility of a lentiviral pseudovirus platform for modeling SARS-CoV-2-induced cardiac injury and highlight a direct pathogenic role of the spike protein in cardiac structural, functional, and molecular abnormalities.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/950f7a0f7fee40884e09b5efaed9521cb1e812b9" target='_blank'>
              SARS-CoV-2 Spike Protein-Mediated Cardiac Dysfunction: Structural Abnormalities, Impaired Calcium Dynamics, and Gene Expression Changes in Human Stem Cell-Derived Cardiomyocytes.
              </a>
            </td>
          <td>
            C. Huang, Chia-Chi Cheng, Si-Han Chen, Dayna Cheng, Sheng-Hsuan Wang, Chiao-Hsuan Chao, Chi-Yen Lee, Jen-Ren Wang
          </td>
          <td>2026-01-01</td>
          <td>Journal of medical virology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Alzheimer's disease (AD) is a neurodegenerative condition with etiology firmly rooted in immune dysregulation. While genetic risk is increased in microglia, the brain's resident myeloid cell, myeloid cells throughout the body show high enrichment for disease risk genes as well. The role of peripheral immune cells in AD pathogenesis is relatively unknown, however, and may play important roles in waste clearance. Leveraging a cohort of idiopathic normal pressure hydrocephalus (iNPH) patients from which we have paired brain, cerebrospinal fluid (CSF), and peripheral blood monocytes (PBMCs), we have investigated cross‐compartment transcriptional changes to better understand how peripheral immune function is altered in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3bc0a153888f2b0e5ad0041bcf1fe1f80d60abc5" target='_blank'>
              Single Cell Transcriptomics of Paired CSF and Blood Immune Populations Reveals Unique Macrophage Population with Relevance to Alzheimer's Disease
              </a>
            </td>
          <td>
            Beth Stevens, S. Marsh, Rebecca Fulthorpe, Sarah Murphy, Tushar Kamath, Vahid Gazestani, David J. Lieb, T. Eisenhaure, Vishal Sarsani, Miguel Reyes, J. Gobom, C. Clish, H. Zetterberg, V. Leinonen, Evan Macosko, N. Hacohen
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>121</td>
        </tr>

        <tr id="Abstract The composition of the gastrointestinal microbiome is correlated with numerous immune-mediated systemic diseases, but underlying mechanisms remain unclear. In murine studies, we recently identified microbiome Bacteroidota-derived bacterial molecules, serine-glycine lipodipeptides (S/G lipids), as mediators of microbiome-systemic innate immune system crosstalk. By altering microbiome production of S/G lipids, we documented that proinflammatory responses of splenic monocytes could be regulated. Transcriptomic analysis revealed that this regulation occurred by modulating the mRNA levels of inhibitors of the TLR/NF-κB pathways such as Trem2. The present murine study had 2 goals: (1) to determine if our approach allows for modulation of activated innate immune cells, that is, macrophages rather than splenic monocytes, in a site of inflammation and (2) to document that our approach regulates cellular expression of the disease-relevant TLR/NF-κB pathway inhibitor, TREM2, at the protein level. We now report that decreasing microbiome-derived S/G lipid levels enhances proinflammatory responses and decreases expression of TREM2 in activated peritoneal macrophages (PMs). Furthermore, after lowering microbiome S/G lipid production, administering S/G lipids normalizes both PM proinflammatory responses and TREM2 expression. The harnessing of the microbiome and S/G lipids to modulate proinflammatory responses and TREM2 expression in activated innate immune cells suggests the therapeutic potential of this approach in inflammatory diseases such as Alzheimer’s disease, atherosclerosis, autoimmunity and liver disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c34be3dd6832658a5856e15692c227c2eb5c2fa8" target='_blank'>
              Harnessing the microbiome to regulate myeloid TREM2 expression and innate immune responses
              </a>
            </td>
          <td>
            Saki Mihori, Frank Nichols, Evan R. Jellison, C. Blesso, Vincent Graziano, Vijay Rathinam, Robert B Clark
          </td>
          <td>2026-01-01</td>
          <td>ImmunoHorizons</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31b66cdc5218c0816b0bd18cc296ad74d29aceff" target='_blank'>
              Immune dysregulation triggered by inflammatory cytokines in patients with severe respiratory infections.
              </a>
            </td>
          <td>
            Jingwei Li, Shufan Liang, Yalun Li, Jiayang Wu, Changshu Li, Jiadi Gan, Weimin Li, Chengdi Wang
          </td>
          <td>2026-01-15</td>
          <td>Respiratory research</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition emerging during the COVID-19 pandemic, strongly associated with prior SARS-CoV-2 infection. Characterized by systemic inflammation affecting multiple organs, MIS-C presents a complex clinical picture including fever, gastrointestinal distress, cardiac dysfunction, and neurological manifestations. Although its exact pathogenesis remains incompletely understood, immune dysregulation is recognized as a central mechanism. This review examines current understanding of MIS-C pathogenesis, focusing on immune dysfunction and viral triggers, particularly SARS-CoV-2. We analyze both innate and adaptive immune responses, cytokine storm dynamics, molecular mimicry, and virus-induced inflammatory cascades. Additionally, we discuss potential immunomodulatory therapeutic strategies and identify future research directions to improve MIS-C management and treatment outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb906afaca8efa1a4927662eab78d7c57c8c42b9" target='_blank'>
              MIS-C pathogenesis: immune dysregulation & viral triggers
              </a>
            </td>
          <td>
            Tiantian Xu, Jiamin Zhang, Xiangyuan Hou, Xinyu Xie, Junye Qi, Chang-bing Wang, Yuqing Yan, Lu Kuang, Bing Zhu
          </td>
          <td>2025-11-26</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Dendritic cells (DCs) play a central role in both the development and maintenance of adaptive immunity by their ability to prime and regulate T cell function. These interactions between DCs and T cells are crucial to the pathogenesis of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Myeloid differentiation primary response protein 88 (MyD88) signalling is pivotal in the pathogenesis of MS and EAE; however, its specific contributions across various cell types in the context of these conditions remain inadequately understood. In this study, we reanalysed single-cell RNA sequencing data from MS patients and revealed significant upregulation of MYD88 in DCs and CD4+ T cells isolated from PBMCs of MS patients. Single-cell RNA sequencing analysis revealed that during the peak phase of EAE, Myd88 is highly expressed in moDCs and pDCs compared to cDCs. Notably, the absence of Myd88 in DCs resulted in significantly reduced interactions with T cell clusters. Our in vivo and in vitro results showed that while MyD88 deficiency did not affect lymphocyte production in the thymus, it resulted in impaired Th1 and Th17 cell differentiation and diminished T cell activation. Mechanistically, MyD88-/- DCs exhibited impaired maturation and a reduced production of pro-inflammatory cytokines, such as IL-6, TNF-α, and IL-12, which may be linked to their role in directing Th1 and Th17 cell differentiation. Our findings suggest that MyD88 is essential for the priming of inflammatory T cells and the activation of DCs, and their interactions with T cells, underscoring its role in neuroinflammation. This study highlights the potential therapeutic implications of targeting MyD88 pathways in MS and related disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07143d3aea4af59d5ef86ee7d3bbbaf941891061" target='_blank'>
              MyD88 Deficiency Protects Mice From Experimental Autoimmune Encephalomyelitis by Influencing Both Dendritic Cells and T Cells.
              </a>
            </td>
          <td>
            Wen Si, Gaochen Zhu, Qianling Jiang, Xin Ma, Guan Yang
          </td>
          <td>2025-12-09</td>
          <td>Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="SARS-CoV-2 accessory proteins (APs), particularly ORF3a and ORF9b, have emerged as key modulators of host-pathogen interaction and potential contributors to long COVID. Of the 13 predicted APs, only nine are expressed during infection – termed Infection-related APs – while the remaining are classified as Putative APs. Despite this distinction, extensive gene overlap among APs underscores the remarkable adaptability of SARS-CoV-2 viral genome. This review delves into the diverse roles of the original Wuhan APs and their Omicron counterparts in shaping host immunity, with an emphasis on their ability to suppress type I interferon (IFN-I) signalling, modulate cellular metabolism, and trigger inflammatory/apoptotic pathways. By integrating immunopathological insights with evolutionary dynamics and structural perspectives, this review provides a comprehensive understanding of the mechanism underlying Omicron’s reduced pathogenicity and highlights promising, yet unexplored, therapeutic targets within the SARS-CoV-2 accessory proteome.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6086782319f7c4f70392309ce0b182e4c6409aa6" target='_blank'>
              Hidden players of COVID-19: the evolving roles of SARS-CoV-2 accessory proteins
              </a>
            </td>
          <td>
            Miguel Padilla-Blanco, Tránsito García-García, Juozas Grigas, B. D. López-Ayllón, Juan J Garrido, María A. Oliva, María Montoya
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8deeff08e830947bbac726ab174809a2743f1eb1" target='_blank'>
              S100A8/A9 Inhibition Reduces Splenic Myelopoiesis and Improves Outcomes After Stroke
              </a>
            </td>
          <td>
            Hyun Ah Kim, A. Al-sharea, Hannah X. Chu, Sung-Chun Tang, Samoda Rupasinghe, Shenpeng R. Zhang, P. Nagareddy, Grant R. Drummond, T. Arumugam, Andrew J. Murphy, C. Sobey, Man K.S. Lee
          </td>
          <td>2025-12-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>76</td>
        </tr>

        <tr id="Significance Persistent neurological disease after COVID-19 is a major problem, yet the underlying mechanism is unclear. Using mouse-adapted SARS-CoV-2, we show that infection confined to the respiratory tract triggers long-lasting loss of dopaminergic neurons in the olfactory bulb and substantia nigra, mirroring pathology in COVID-19 decedents. These deficits arise without viral persistence but with sustained microglial activation and inflammatory gene expression resembling human neurodegenerative disease. Behavioral analyses reveal corresponding neurobehavioral impairments. Antiviral therapy alone fails to prevent most of these effects, whereas combining antivirals with corticosteroids, even when initiated three days after infection, restores behavioral function. These findings identify inflammation as the major driver of post-COVID neurological sequelae and suggest early immunomodulation as an effective intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b584d18974b0aa971de59c6e27544a571d208d19" target='_blank'>
              Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection
              </a>
            </td>
          <td>
            A. Verma, Lu Tan, Noah Schuster, Skyler L Moye, Li-Chun Lin, Shearon A. Lowery, Eazhisaivallabi Duraisami, Juan E Abrahante Lloréns, Qiang Qiu, Marco Hefti, D. K. Meyerholz, Mitchell C Coleman, C. R. Yu, Mark W Albers, Stanley Perlman
          </td>
          <td>2026-01-07</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Neuroinflammation is a hallmark of both acute and chronic neurodegenerative diseases and is driven, in part, by activated glial cells, including microglia. A key regulator of this inflammatory response is the NLRP3 inflammasome, an immune sensor that can be triggered by diverse, unrelated stimuli such as pathogen-associated molecular patterns, cellular stress, and mitochondrial dysfunction. Despite progress in targeting NLRP3-mediated immune activation, many drug candidates fail, potentially due to the limited availability of physiologically relevant disease models. The SIM-A9 murine microglial cell line, established in 2014, has emerged as a widely used model for studying neuroinflammation; however, its proteome has not yet been systemically characterized. In this study, we investigated the proteomic landscape of SIM-A9 microglia treated with classical pro-inflammatory stimuli, including lipopolysaccharide (LPS) and extracellular ATP and nigericin (NG), to induce NLRP3 inflammasome activation. Using complementary proteomic approaches, we quantified 4903 proteins and observed significant enrichment of proteins associated with immune and nervous system processes. Differentially expressed proteins were consistent with an activated microglial phenotype, including the upregulation of proteins involved in NLRP3 inflammasome signaling. To our knowledge, this is the first comprehensive proteomic analysis of SIM-A9 microglia. These findings provide a foundational resource that may enhance the interpretation and design of future studies using SIM-A9 cells as a model of neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/59bd3b9c1de0363b2421f1d539e8f44ae1afeb6f" target='_blank'>
              Characterization of the Proteomic Response in SIM-A9 Murine Microglia Following Canonical NLRP3 Inflammasome Activation
              </a>
            </td>
          <td>
            Nicolas N. Lafrenière, Karan Thakur, Gerard Agbayani, Melissa Hewitt, Klaudia Baumann, J. Sandhu, A. Haqqani
          </td>
          <td>2026-01-09</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Intracellular pathogens must evade cytotoxic immunity to establish persistent infection. Although immune escape is typically viewed through a biochemical lens, the ability of certain pathogens to alter the mechanical properties of infected cells suggests that biophysical mechanisms may also contribute to the process. Here, we show that a subset of CD4+ T cells infected with the human immunodeficiency virus (HIV) resist elimination through a soft phenotype that inhibits killing by mechanosensitive cytotoxic T lymphocytes (CTLs). This phenotype arises from the combined effects of the HIV virulence factor Nef, which remodels the actin cytoskeleton, and intrinsic heterogeneity in the basal cytoskeletal properties of infected T cells. Pharmacological or genetic perturbations that reverse Nef signaling to the cytoskeleton or that stiffen the filamentous-actin cortex sensitize infected cells to CTL-mediated lysis. Taken together, these findings define a novel, biophysical paradigm of immune evasion with implications for HIV cure strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a4f51743a919ef271e4cd1d83a51db2f6165482" target='_blank'>
              HIV Nef amplifies mechanical heterogeneity to promote immune evasion
              </a>
            </td>
          <td>
            Louise Leyre, Farah Mustapha, Alberto Herrera, Esther Lee, Emily Huntsman, P. Zumbo, J. Weiler, Parul Sinha, Ethan Naing, Connor Smith, Colin C. Kovacs, Micheal Galiano, Nada Wahman, D. Betel, Kiera L. Clayton, Morgan Huse, R. B. Jones
          </td>
          <td>2025-12-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="Neurocognitive impairment is a prevalent co-morbidity in virologically suppressed people living with HIV (PLWH), yet the underlying mechanisms remain elusive and treatments lacking. We explored use of participant-derived directly induced neurons (iNs) to model neuronal biology and injury in PLWH. iNs retain age- and disease-related donor features, providing unique opportunities to reveal important aspects of neurological disorders. We obtained primary dermal fibroblasts from six virologically suppressed PLWH (range: 27-64 years, median: 53; 83% Male) and seven matched people without HIV (PWOH) (range: 27-66, median: 55; 71% Male). iNs were generated using transcription factors NGN2 and ASCL1, and validated by immunocytochemistry, single-cell-RNAseq, and electrophysiological recordings. Transcriptomic aging analyses confirmed retention of donor age-related signatures. Bulk-RNAseq identified 29 significantly differentially expressed genes between PLWH and PWOH iNs. Of these, 16 were downregulated and 13 upregulated in PLWH iNs. Protein-protein interaction network mapping indicates iNs from PLWH exhibit differences in extracellular matrix organization and synaptic transmission. IFI27 was upregulated in PLWH iNs, complementing independent post-mortem studies demonstrating elevated IFI27 expression in PLWH-derived brain tissue. FOXL2NB-FOXL2-LINC01391 expression was reduced in PLWH iNs and negatively correlated with neurocognitive impairment. Thus, we identified an iN gene signature of HIV revealing mechanisms of neurocognitive impairment in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ed7c586e77d0113c401ac4f4b8dda15f9a05841" target='_blank'>
              Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV.
              </a>
            </td>
          <td>
            P. N. Ostermann, Youjun Wu, S. Bowler, Samuel Martínez-Meza, M. A. Siddiqui, David H Meyer, Alberto Herrera, Brandon A Sealy, Mega Sidharta, K. Ramnarine, Leslie St. Bernard, Desiree Byrd, R. Jones, Masahiro Yamashita, Douglas F. Nixon, L. Ndhlovu, Ting Zhou, Teresa H. Evering
          </td>
          <td>2025-11-25</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Enterovirus A71 (EV-A71) is a critical global pathogen, primarily causing Hand-Foot-and-Mouth Disease (HFMD) but frequently leading to severe neurological complications, including fatal neurogenic pulmonary edema (PE). This review elucidates the complex interplay between viral pathogenesis and the host immune response. EV-A71 utilizes receptors like SCARB2 and PSGL-1 for entry, while its proteases (2Apro, 3Cpro) efficiently evade innate immunity by cleaving key signaling adaptors (MAVS, TRIF), suppressing Type I IFN response. Critical to disease progression is the age-dependent vulnerability in infants and the subsequent shift toward immunopathology. Severe disease is driven by a systemic cytokine storm and T cell dysregulation, characterized by a loss of control from Treg cells and a profound Th17/Treg imbalance, resulting in high levels of pathogenic cytokines (e.g., IL-17A, IFN-γ). Clinical progression is predicted by specific biomarkers, including Treg depletion, monocyte exhaustion (PD-1/PD-L1), and suppressed regulatory signaling (low cAMP). These findings highlight that effective therapeutic strategies must target host-mediated damage through immunomodulation (e.g., by exploring interventions against key pathogenic axes like IL-6 and IL-1β) and call for the development of next-generation vaccines capable of eliciting balanced cellular immunity to prevent immunopathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c94423fb623958f352400377f15120efff0cd02" target='_blank'>
              The Host Immune Response to Enterovirus A71 (EV-A71): From Viral Immune Evasion to Immunopathology and Prognostic Biomarkers of Severe Disease—A Narrative Review
              </a>
            </td>
          <td>
            Anna Andronik, Dawid Lewandowski, Artur Sulik, Kacper Toczyłowski
          </td>
          <td>2025-11-25</td>
          <td>Viruses</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS) characterized by immune system dysfunction, inflammation, and demyelination. This review examines the intricate roles of cytokines in regulating neuroinflammation and influencing adaptive immune responses. Proinflammatory cytokines, including IL-6, IL-17, and IFNγ, drive pathological processes by promoting immune cell activation and tissue damage, while anti-inflammatory cytokines, such as IL-10 and IL-22, contribute to immune regulation and neuroprotection. 
Furthermore, the review explores the emerging role of novel cytokines in MS pathophysiology, shedding light on newly identified immune mediators and their implications for disease progression. By analyzing cytokine profiles and their interplay with adaptive immunity, we gain valuable insights into the immunopathogenic mechanisms underlying MS. This comprehensive examination aims to deepen our understanding of the cytokine-mediated dynamics in MS, offering potential biomarkers for disease activity and guiding future research directions. 
A literature search was conducted across multiple databases, including PubMed, NCBI, and MDPI, to identify studies relevant to the role of cytokines in MS and the involvement of adaptive immunity in the disease process. Articles were selected using predefined keywords such as cytokines, multiple sclerosis, and adaptive immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/12a8ada64a6d7e8d787217af98434e6eb514c019" target='_blank'>
              Cytokine Dynamics in Multiple Sclerosis: Modulating Adaptive Immunity in Neuroinflammation
              </a>
            </td>
          <td>
            Yara Mualla, Jehan S Alrahimi
          </td>
          <td>2026-01-14</td>
          <td>Journal of Biological Insights</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Background Rhinovirus (RV) is the most common trigger of viral-induced pediatric asthma exacerbations. The impact of IL-13-driven inflammation, common in pediatric asthma, on airway epithelial antiviral and inflammatory responses to RV remain unclear. Objective Determine how IL-13-driven T2 inflammation modulates pediatric bronchial epithelial cell responses to RV infection. Methods Bronchial epithelial cells (BECs) were collected from children with (n=50) and without (n=11) asthma. They were differentiated at an air-liquid interface for 21 days, pretreated with IL13 (10ng/mL) for 7 days to model T2 inflammation, then infected with RV-A16 (MOI 0.5). RNA sequencing of BECs was performed prior to and on days 2, 4, 7, and 10 post infection. Linear and generalized additive models partnered with pathway analysis identified differentially expressed gene clusters. Results RV infection, IL-13 stimulation, and their interaction each induced differentially expressed genes (7,808; 10,251; and 7,095 genes, respectively; FDR<0.05). IL-13 pretreatment did not alter RV load or a cluster enriched for interferon response and regulation genes, including IFNB1, IFNL1-3, STAT1/2, and CXCL10/11. In contrast, IL-13 reduced expression of distinct antiviral effectors (e.g. MX1/2, RSAD2, IFITM1-3; FDR=1.85×10⁻⁴) and increased a secondary proinflammatory response cluster enriched for IL-15, TNF, ER stress, and cell-death pathways (FDR=3.63×10⁻⁶). These clusters correlated with viral load in RV-infected cells, but IL13 pretreatment eliminated those associations. Conclusions IL-13 does not modify viral load or interferon induction but selectively suppresses epithelial antiviral effector programs and enhances secondary inflammatory pathways during RV infection. These findings provide mechanistic insight into how T2 inflammation contributes to viral-triggered asthma morbidity. Key Messages – IL-13 did not alter rhinovirus viral load or epithelial interferon induction but selectively suppressed antiviral effector programs. This indicates that T2 inflammation reshapes antiviral defenses downstream of interferon signaling rather than impairing interferon production itself. – IL-13 enhances a distinct secondary proinflammatory cluster enriched for IL-15, TNF signaling, ER stress, and cell-death pathways. These late-phase responses may contribute to the heightened airway inflammation and injury observed during viraltriggered exacerbations in T2-high pediatric asthma. – IL-13-driven changes decouple epithelial immune responses from viral load, revealing mechanisms that may persist even with anti-IL-4Rα/IL-13 therapy. These findings identify epithelial antiviral effector pathways and IL-15/TNF-associated inflammatory programs as potential therapeutic targets for patients who experience breakthrough viral exacerbations despite IL-13 blockade. Capsule Summary IL-13 did not alter rhinovirus load or epithelial interferon but selectively suppressed antiviral effectors and amplified secondary inflammatory pathways, revealing how T2-inflammation may worsen viral-triggered asthma exacerbations and contribute to breakthrough exacerbations despite IL-4Rα/IL-13-targeted therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8534d6df54bf150ef5da348dfd8ea2420fc6c8b1" target='_blank'>
              IL-13 Modulates Antiviral Effector and Proinflammatory Pathways in Rhinovirus-Infected Pediatric Bronchial Epithelium
              </a>
            </td>
          <td>
            P.C. Dela Cruz, Basilin Benson, N. Jayavelu, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, C. Gates, M. White, Nyssa B. Samanas, Kourtnie Whitfield, T. Hallstrand, Steven F. Ziegler, Gail H. Deutsch, Matthew C. Altman, Jason S. Debley
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="The systemic inflammatory response syndrome (SIRS) is a complex and multifactorial life-threatening reaction triggered by trauma or infection (sepsis). Since the dynamics of immune cells, cytokines and novel markers such as circulating extracellular vesicles (EVs) remain incompletely elucidated, we aimed to provide a comprehensive multiparametric characterization of this severe response, to identify potential prognostic and therapeutic targets. We conducted a multiparametric and sequential quantification of up to 25 immune cell circulating populations using next-generation flow cytometry, assessed plasma cytokine levels with Luminex technology, and the characterized and quantified EVs and their microRNA content. Peripheral blood samples were taken at 0, 24 and 72 h after SIRS onset from 25 patients with polytrauma-induced SIRS (PT group) and 25 developed SIRS from other origins, such as pulmonary or urinary infections (NP-denoting non-polytrauma group). Samples from 21 healthy donors (HD) were analysed as a control group. Statistical analyses were performed to compare experimental groups (PT, NP, HD) and to evaluate correlations between experimental findings and patients’ outcomes for potential prognostic markers discovery. SIRS patients exhibited increased leukocyte counts driven by neutrophil mobilization combined with a reduction of dendritic cells and lymphocytes early after the SIRS. The PT group showed an increase in classical monocytes, myeloid-derived suppressor cells (MDSCs), and mesenchymal stromal cells compared to HD. These dynamics occurred alongside substantial chemokine release, including IL-8, G-CSF, CCL2 in both SIRS groups, MIF in PT and CCL4 in NP. Both SIRS groups experienced a pronounced cytokine storm with simultaneous release of both pro- and anti-inflammatory cytokines, and increased of plasma EV levels. Our findings suggest that elevated IL-8 concentrations and increased counts of circulating monocytes and MDSCs are associated with worse prognosis and may serve as valuable prognostic indicators in SIRS patients. Our study demonstrates the dynamic kinetics of multiple cell subsets, cytokines and EVs during SIRS, highlighting differences between SIRS initiated by polytrauma versus non-polytrauma events and identifying correlations between biological findings and patient outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/678d0938855cd21885f7e9dce3eb4d79dc760ecc" target='_blank'>
              Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysis
              </a>
            </td>
          <td>
            Gerardo J. Martí-Chillón, S. Muntión, J. Flores-Montero, Javier González-Robledo, Luís Corchete, Julio Pozo, L. Osugui, S. Preciado, M. Gómez-Redondo, Juan F. Blanco, A. Navarro-Bailón, V. Sagredo, Julia Almeida, A. Orfao, F. Sánchez-Guijo
          </td>
          <td>2025-11-21</td>
          <td>Journal of Translational Medicine</td>
          <td>1</td>
          <td>29</td>
        </tr>

        <tr id="Background/Objectives: Notwithstanding the declaration by the World Health Organization in May 2023 regarding the conclusion of the COVID-19 pandemic, new cases of this potentially lethal infection continue to be documented globally, exerting a sustained influence on the worldwide economy and social structures. Contemporary SARS-CoV-2 variants, while associated with a reduced propensity for severe acute pathology, retain the capacity to induce long-term post-COVID syndrome, including in ambulatory patient populations. This clinical phenomenon may be attributable to potential autoimmune reactions hypothetically triggered by antiviral antibodies, thereby underscoring the need for developing novel, universal vaccines against COVID-19. The nucleocapsid protein (N), being one of its most conserved and highly immunogenic components of SARS-CoV-2, presents a promising target for such investigative efforts. However, the protective role of anti-N antibodies, generated during natural infection or through immunization with N-based vaccines, alongside the potential adverse effects associated with their production, remains to be fully elucidated. In the present study, we aim to identify potential sites of homology in structures or sequences between the SARS-CoV-2 N protein and human antigens detected using hyperimmune sera against N protein obtained from mice, rabbits, and hamsters. Methods: We employed Western blot analysis of lysates from human cell lines (MCF7, HEK293T, THP-1, CaCo2, Hep2, T98G, A549) coupled with mass spectrometric identification to assess the cross-reactivity of polyclonal and monoclonal antibodies generated against recombinant SARS-CoV-2 N protein with human self-antigens. Results: We showed that anti-N antibodies developed in mice and rabbits exhibit pronounced immunoreactivity towards specific components of the human proteome. In contrast, anti-N immunoglobulins from hamsters showed no non-specific cross-reactivity with either hamster or human proteomic extracts because of the lack of autoreactivity or immunogenicity differences. Subsequent mass spectrometric analysis of the immunoreactive bands identified principal autoantigenic targets, which were predominantly heat shock proteins (including HSP90-beta, HSP70, mitochondrial HSP60, and HSPA8), histones (H2B, H3.1–3), and key metabolic enzymes (G6PD, GP3, PKM, members of the 1st family of aldo-keto reductases). Conclusions: The results obtained herein highlight the differences in the development of anti-N humoral responses in humans and in the Syrian hamster model. These data provide a foundational basis for formulating clinical recommendations to predict possible autoimmune consequences in COVID-19 convalescents and are of critical importance for the rational design of future N protein-based, cross-protective vaccine candidates against novel coronavirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/313d9d3a801fa8c844cca98ae433671df465c85a" target='_blank'>
              Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties
              </a>
            </td>
          <td>
            A. Rak, Y. Zabrodskaya, P. Wong, I. Isakova-Sivak
          </td>
          <td>2025-12-22</td>
          <td>Antibodies</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/771410b03d87068a10e94d950bf031d6651b10a5" target='_blank'>
              Local tolerance and innate immune activation of primary human respiratory cells exposed to flagellin
              </a>
            </td>
          <td>
            G. Barbin, Itziar Sanjuán-García, Mireille Caul-Futy, Christine Caul-Futy, Cindia Ferreira Lopes, R. Bonfante, Edouard Sage, Anne-Sophie Lacoste, Jean-Michel Saliou, D. Cayet, R. Macloughlin, M. Baldry, Charlotte Green-Jensen, Arndt G Benecke, Nathalie Heuze Vourc’h, Song Huang, J. Sirard, Samuel Constant
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Aging is a major risk factor for increased morbidity and mortality following acute respiratory virus infections. To elucidate the immune determinants underlying viral pathogenesis and delayed lung repair in the aged lung, a comprehensive time-course study was conducted. Single-cell RNA sequencing (scRNAseq) and high-dimensional flow cytometry were utilized to compare lungs from young and aged mice infected with influenza A virus (IAV). Aged hosts displayed diminished alveolar macrophage (AM) and dendritic cell (DC) but elevated monocyte-derived macrophage (MoM) and interstitial macrophage (IM) presence following infection. Additionally, enhanced accumulation of adaptive immune cells, including CD4+ tissue-resident helper (TRH) cells, CD8+ tissue-resident memory (TRM) cells, and a B cell subset resembling age-associated B cells, was observed in the memory phase. Pathway analysis revealed that elevated type I and II interferon (IFNα/γ) signaling, especially in MoM/IM subsets, distinguished the aged hosts from the young. Inhibition of IFNα/γ signaling after viral clearance improved long-term respiratory outcomes and reduced both IM and TRH populations in aged mice. These findings highlight the pivotal role of IFNα/γ signaling, likely within MoM/IM subsets, in driving the exuberant persistence of adaptive immune cells and chronic immunopathology in the aged lung following acute viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79fbb4abcb1eeb6127549b886296b47a4c3b2fa0" target='_blank'>
              Temporal single-cell analysis reveals age-associated delay in immune resolution after respiratory viral infection
              </a>
            </td>
          <td>
            Yue Wu, Chaofan Li, Jinyi Tang, Xiaochen Gao, I. Cheon, Bibo Zhu, Ruixuan Zhang, C. Fain, S. Hu, H. Narasimhan, Gislane de Almeida Santos, K. Ayasoufi, Aaron J. Johnson, Hui Zong, Chongzhi Zang, Haidong Dong, Jie Sun
          </td>
          <td>2025-12-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma and bronchiectasis. Increasing evidence implicates respiratory viruses as predominant triggers, though the underlying immunopathogenic mechanisms remain poorly understood. Narrative This review synthesises current knowledge on the interplay between viral pathogens at the airway epithelial barrier, including structural and immunological mechanisms that may dysregulate antiviral immunity in chronic respiratory diseases. Furthermore, we discuss how perturbations in the respiratory microbiome, characterised by reduced microbial diversity, can modulate host antiviral immune defences. Conclusions Collectively, these interconnected factors create a permissive environment predisposing to viral infection and exacerbations in chronic respiratory diseases. Understanding the complex interactions between airway structure, interferon-mediated antiviral responses, inflammation and microbiota is essential for developing targeted therapies to effectively manage virus-induced exacerbations and reduce disease burden.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b8c32ceb7bc80ebe41ab7ed5118c911d3d8ae6b4" target='_blank'>
              Mechanisms driving immunopathogenesis of viral exacerbations in chronic respiratory disease
              </a>
            </td>
          <td>
            J. Mckenzie, Charlotte Carter, M. M. Jackson, Aran Singanayagam, Anand Shah
          </td>
          <td>2026-01-02</td>
          <td>Thorax</td>
          <td>1</td>
          <td>3</td>
        </tr>

        <tr id="Numerous studies report cognitive impairment in COVID-19 patients from the acute to post-acute phases, linked to blood inflammation affecting blood–brain barrier (BBB) permeability and causing leakage of glial and neuronal proteins. However, a clear classification of these cognitive deficits and molecular blood events over time is still lacking. This narrative review summarizes the neuropsychological consequences of COVID-19 and evidence of altered cytokines and BBB disruption as potential mediators of cognitive impairment across post-infection phases. Post-COVID-19 cognitive dysfunction appears to follow a temporal course, evolving from acute focal deficits in attention, working memory, and executive function to more persistent multidomain impairments. We reviewed key cytokines released into the blood during COVID-19 infection, including antiviral (IFNγ, CXCL1, CXCL10), inflammatory (IL-1β, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, GM-CSF, TNFα), and monocyte chemoattractants (MCP1/CCL2, MCP3/CCL7, MIP-1α/CCL3, GM-CSF, G-CSF). This analysis shows that several inflammatory and viral cytokines remain elevated beyond the acute phase and are associated with cognitive deficits, including IL-6, IL-13, IL-8, IL-1β, TNFα, and MCP1 in long-term post-COVID-19 patients. In addition, we examined studies analyzing changes over time in neurovascular unit proteins as biomarkers of BBB disruption, including extracellular matrix proteins (PPIA, MMP-9), astrocytes (S100β, GFAP), and neurons (NFL). These proteins are elevated in acute COVID-19 but generally return to control levels within six months, suggesting BBB restoration. However, in patients followed for over a year, BBB disruption persists only in those with cognitive impairment and is associated with systemic inflammation, with TGFβ as a related biomarker. Although cognitive sequelae can persist for over 12 months after SARS-CoV-2 infection, further studies are needed to investigate long-term neurocognitive outcomes and their link to sustained proinflammatory cytokine elevation and brain impact.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4fb013c3f3c6ebd3f776a435e4fa286d2050e4fb" target='_blank'>
              Cognition, Cytokines, Blood–Brain Barrier, and Beyond in COVID-19: A Narrative Review
              </a>
            </td>
          <td>
            Ana Barajas, Gemma Riquelme-Alacid, América Vera-Montecinos, Belén Ramos
          </td>
          <td>2026-01-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>1</td>
          <td>3</td>
        </tr>

        <tr id="Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are two post-viral diseases, which share many common symptoms and pathophysiological alterations. Yet a mechanistic explanation of disease induction and maintenance is lacking. This hinders the discovery and implementation of biomarkers and treatment options, and ultimately the establishment of effective clinical resolution. Here, we propose that acute viral infection results in (in)direct endothelial dysfunction and senescence, which at the blood-brain barrier, cerebral arteries, gastrointestinal tract, and skeletal muscle can explain symptoms. The endothelial senescence-associated secretory phenotype (SASP) is proinflammatory, pro-oxidative, procoagulant, primed for vasoconstriction, and characterized by impaired regulation of tissue repair, but also leads to dysregulated inflammatory processes. Immune abnormalities in ME/CFS and long COVID can account for the persistence of endothelial senescence long past the acute infection by preventing their clearance, thereby providing a mechanism for the chronic nature of ME/CFS and long COVID. The systemic and tissue-specific effects of endothelial senescence can thus explain the multisystem involvement in and subtypes of ME/CFS and long COVID, including dysregulated blood flow and perfusion deficits. This can occur in all tissues, but especially the brain as evidenced by findings of reduced cerebral blood flow and impaired perfusion of various brain regions, post-exertional malaise (PEM), gastrointestinal disturbances, and fatigue. Paramount to this theory is the affected endothelium, and the bidirectional sustainment of immune abnormalities and endothelial senescence. The recognition of endothelial cell dysfunction and senescence as a core element in the aetiology of both ME/CFS and Long COVID should aid in the establishment of effective biomarkers and treatment regimens.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05f509ceb8b137061e93b7aab33e7a19306f4d96" target='_blank'>
              Virus-induced endothelial senescence as a cause and driving factor for ME/CFS and long COVID: mediated by a dysfunctional immune system
              </a>
            </td>
          <td>
            Massimo Nunes, Loren Kell, Anouk Slaghekke, Rob Wüst, B. Fielding, D. Kell, E. Pretorius
          </td>
          <td>2026-01-09</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>29</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2025', '2026'],
    y: [3, 4],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>